NYSA TI Single-Page 1
In fact, that's an area that has received a lot
Abstract
In fact, that's an area that has received a lot of attention from the NIH, and I think people are spending more effort on interracial and ethnic differences.
Fields
- Named Organization
- American Cancer Society
- American College of Cardiology
- American Heart Association (Voluntary health organization that focuses on cardiac health)
Voluntary health organization that focuses on cardiac health and stroke. AHA occasionally teams with tobacco retailers to engage in promotions/fund-raisers (see http://www.smokefree.net/doc-alert/messages/247136.html and http://www.rawbw.com/~jpk/stand/Pictures.html).- American Journal of Public Health (periodical)
- Americans for Nonsmokers' Rights (Anti tobacco organization)
Concerned with clean indoor air.- Beverly Hills Restaurant Association (Industry front group)
Set up c. 1988 by the Tobacco Institute to clandestinely fight a local smoking restriction (TI00380927-0949, Pag. -0946).- California Air Resources Board
- Californians for Nonsmokers' Rights (Americans for Nonsmokers rights precursor)
Precursor organization to Americans for Nonsmokers Rights- Center for Indoor Air Research (CIAR) (Industry formed/funded air research organization)
Nonprofit organization funded by the tobacco industry. CIAR was formed in March 1988 by tobacco companies "to sponsor "high-quality research on indoor air issues and to facilitate communication of research findings to the broad scientific community."- Congressional Research Service (Criticized 1993 EPA ETS report)
Criticized EPA's January 1993 report designating passive smoke as a carcinogen- Environmental Protection Agency (EPA)
- Federal Register (publication)
- McDonald's Corp.
- Ministry of Health and Welfare (Japan)
- National Institutes of Health (NIH)
- National Licensed Beverage Association
- National Research Council
- New England Journal of Medicine
- Nonsmokers Rights (California anti-smoking organization created by Stanton Glan)
- Occupational Safety and Health Administration (OSHA)
- Price Waterhouse (Accounting firm)
- R.J. Reynolds Corporation (second tier subsidiary of RJR Industries)
- Tobacco Institute (Industry Trade Association)
The purpose of the Institute was to defeat legislation unfavorable to the industry, put a positive spin on the tobacco industry, bolster the industry's credibility with legislators and the public, and help maintain the controversy over "the primary issue" (the health issue).- *University of California (use specific branch)
- University of California San Francisco
- Washington Technical Information Group, Inc.
- World Conference on Smoking and Health
- World Health Organization (Concerned with global public health)
International organization concered with public health worldwide - American College of Cardiology
- Named Person
- Alsop, L. Susan
- Barr, Glen
- Bero, Lisa A., Ph.D. (Epidemiologist, UC San Francisco)
- Feinstein, Diane
- Garfinkle, Larry
- Glantz, Stanton
- Grossman, Ted
- Lee, Peter N. (TAC Biostatistician)
Frequently funded by the tobacco industry to criticize and discount published and epidemiological studies that linked between tobacco smoking and health damage.- *LeVois, Maurice (use LeVois, Maurice Emile, Ph.D.) (industry consultant)
1996 submitted comments to EPA, worked with PN Lee on IARC rebuttal.- Lowe, Michael
- Mahler, Sara
- Mayor, Francisco
- Michaels, Robert
- Parmley, Bill
- Penn, Arthur
- Pfeffer, William, Jr.
- Rossi, Bob
- Rossi, Robert
- Samet, Jonathan
- Siegel, Michael B., M.D. (Epidemiologist, Boston U, School of Public Health, Anti-Toba)
- Toon, Michael
- Wald, Nicholas J., Ph.D. (Colleague of Sir Richard Doll, coauthor with Law of secondha)
Professor of Preventive Medicine, Wolfson Institute of London, Colleague of Sir Richard Doll, coauthor with Law of secondhand smoke metaanalysis- Warner, Kenneth E., Ph.D (Plaintiff's expert, health care costs)
Plaintiff- Woods, Rosemarie
- Wynder, Ernest
- Barr, Glen
- Master ID
- TI10111465-1821
Related Documents: - Date Loaded
- 16 Mar 2005
- Box
- 8820
Document Images
1
2
3
4
5
6
7
8
9
I0
Ii
12
13
14
15
16
17
18
19
20
21
22
23
24
25
457
is very ligtle independent cardiovascular epidemiologyon
those groups in general.
In fact, that's an area that has received a lot
of attention from the NIH, and I think people are spending
more effort on interracial and ethnic differences.
As a general rule, though, when you look at the
major risk factors for heart disease, the importance of
those risk factors seem to be pretty much, to my
understanding, independent of ethnicity, although there are
some subgroups, for example, that are more prone to
hypertension, such as blacks, but the effect of the
hypertension on the heart, where it doesn't seem to be
different in blacks than whites.
So I wouldn't see the question that you're
raising as a particularly strong limitation on the studies.
It would be nice if we could do the perfect study
and have perfect stratification by everything imaginable,
but I don't think you'll ever find a study that you can't
find something to criticize.
MR. SIRRIDGE: You're familiar with the migrant
studies and how heart disease, risk and risk factors change
from Asian --
DR. GLANTZ: Which studies?
MR. SIRRIDGE: Migrant. It's a type of
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T11011-1644

1
2
3
4
5
6
7
8
.9
i0
Ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
epidemiologic study--
DR. GLANTZ :
MR. SIRRIDGE :
458
Yes. Yes.
-- where people move to different
places and then their rates are compared against those of
them who stayed in countries.
There have been a number of studies which have
measured Japan and places in the east with Hawaii and also
with California, of all places.
There has been a gradation of rates with a much
higher risk for people who have moved here, suggesting the
power and influence of traditional western risk factors. Is
that true?
DR. GLANTZ: I'm generally familiar with those
studies from talking to colleagues about them and reading
about them in the press. I wouldn't purport to be an expert
on them.
My understanding from this sort of general
scientific knowledge is that the main changes that seem to
account for those things are changes in diet, and again, no
one is saying that diet isn't one of the risk factors for
heart disease.
It's important, I think, though, when you look at
the ETS data, that they fact that we find reasonably
consistent risks around the world, that, to me, is evidence
that, again, the effects of ETS exist independent of those
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T!1011-1645

1
2
3
4
5
6
7
8
9
i0
Ii
12
13
14
15~
16
17
18
19
2O
21
22
23
24
25
459
changes.
MR. SIRRIDGE: Doctor, isn't it also true the
there are problems comparing epidemiologic studies on heart
disease from different countries?
DR. GLANTZ: That's such a vague statement.
MR. SIRRIDGE: All right. Would you agree with
this statement: "The problem of comparability of
epidemiologic data across different countries where racial
ethnic groups is evident for cardiovascular diseases."
DR. GLANTZ: Who said that?
MR. SIRRIDGE: Anthony Padednick, Department of
Community and Preventive Medicines, University of New York
Stoneybrook. It's a chapter in a book he wrote in 1989,
called "Racial and Ethnic Differences in Disease".
DR. GLANTZ: Well, I mean, I'm not familiar with
that~book and can't comment on it. I think that, as a
general point, one needs to consider those differences when
thinking about the studies, and I have, in my analysis of
these studies.
Another thing that I think speaks directly to
this, and I'm sure Dr. Wells will address is, is when he did
an analysis of the studies and separated the U.S. studies
from the non-U.S, studies, you get quite comparable results,
and also when you look at studies -- better studies -- which
control for more of the potential confounding variables, you
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1646

1
2
3
4
5
6
7
8
9
I0
ll
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
460
get highe~ risks than when you don't.
So the confounding, which we've heard so much
about in the cross examination so far, if anything, is
probably reducing the estimated risks.
I think, while as a general statement, that quote
you read perhaps is true. I think, in terms of ETS and
heart disease it's not a problem.
MR. SIRRIDGE: My point here, poctor, is that the
ETS studies are from all over the world. They control for
very few of the traditional major risk factors, and the
relative risks seem too high to be plausible according to
commentators of that evidence.
DR. GLANTZ: I don't agree with that statement.
I mean, I can speak to -- I mean, that's not an accurate
statement.
MR. SIRRIDGE: Are you familiar with the report
by the Congressional Research Service with respect to that?
DR. GLANTZ: Yes.
MR. SIRRIDGE: I'm sure Mr. Repace gave you a
copy of it, didn't he?
DR. GLANTZ: No. I have a copy of it, but I got
it from -- I don't even know who gave it to me --
MR. SIRRIDGE: But you've discussed this --
DR. GLANTZ: -- who it was --
MR. SIRRIDGE: -- you've discussed it with
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
Tl1011-1647

1
2
3
4
5
6
7
8
9
I0
ll
12
13
14
15
'16
17
18
19
2O
21
22
23
24
25
461
Mr. Repac%?
DR. GLANTZ: I don't think so, actually. I don't
recall. I've discussed it with several people. I don't
think I've talked to him about it. I'll be happy to -- I
mean, it's a piece of trash.
First of all, if I could quote from it --
JUDGE VITTONE: Dr. Glantz.
DR. GLANTZ: Oh, okay. I'm sorry.
MR. SIRRIDGE: You would like a question?
JUDGE VITTONE: Yes. Ask it.
DR. GLANTZ: Well, he's been making statements
rather than asking questions.
JUDGE VITTONE: Well, let me worry about that.
DR. GLANTZ: Okay.
JUDGE VITTONE: Okay. Now, do you have a
question, Mr. Sirridge?
MR. SIRRIDGE: I do, indeed.
I'd like to read you a statement from the
Congressional Research Service.
DR. GLANTZ: Yes.
MR. SIRRIDGE: You probably have it in front of
your too.
DR. GLANTZ: Yes, I've just gotten it.
MR. SIRRIDGE: "The most likely explanation of
these large risks" --
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T!1011-1648

1
2
3
4
5
6
7
8
9
i0
ii
12
13
14
15
16
17
18
19
20
21
22
23
24
25
462
. DR. GLANTZ: Where -- where --
MR. SIRRIDGE: I'm sorry. From page 6 of the
CRS, dated March 23rd, 1984. Your paper is cited, in fact,
in the footnotes there.
"The most likely explanation of these large risks
from passive smoking, epidemiological studies for heart
disease, is the absence of control for other factors. There
are many important causes of heart disease (for example,
diet, lack of exercise, lack of preventive health care) that
may be engaged in by smokers. That is, there is much
evidence that smokers tend to be less concerned about health
risks in general. In general, studies do not and perhaps
cannot control for many of these factors. If smokers' wives
share in these behaviors, the relationships found in the
epidemiologic studies are spurious."
Did you consider that statement in reaching your
conclusions for the 0SHApanel?
DR. GLANTZ: Actually, I just realized that I
don't have that document here. Do you have a copy I could
read, before commenting on it? There were two reports, and
I brought the one on economics rather than the one you're
quoting from.
MR. SIRRIDGE:
DR. GLANTZ:
MR. SIRRIDGE:
I have one copy, is all I have.
If I could just --
There's another one from September
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI 1011-1649

1
2
3
4
5
6
7
8
9
I0
Ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
13th.
DR. GLANTZ:
MR. SIRRIDGE:
DR. GLANTZ:
but I want to be accurate.
MR. SIRRIDGE: Okay.
DR. GLANTZ: I'm sorry.
thing.
question.
it.
463
But I'll --
Certainly, I'll let you read that.
Yes. I'm not trying to be difficult
I brought the wrong
JUDGE VITTONE:
[Pause.]
JUDGE VITTONE:
That's okay.
Let's hear the question first.
DR. GLANTZ: Yes. I've forgotten.
MR. SIRRIDGE: I've forgotten the precise
JUDGE VITTONE: Yes. That's why I'd like to have
MR. SIRRIDGE: Okay.
JUDGE VITTONE: Okay.
MR. SIRRIDGE: The question is, Doctor, this
appears to be a statement by some analysts who have reviewed
the evidence and have an understanding of the mechanisms and
the risk factors associated with heart disease. True?
DR. GLANTZ: No. And the reason for that, and
the reason for -- apparently, there is yet a third
Congressional Service document because I have seen the one
BAYLEYREPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1650

5
6
7
8
9
I0
II
12
13
14
15
16
17
18
19
20
21
22
23
24
25
464
that you had, in which the authors point out that they are
economists, not biomedical scientists, and really aren't
competent to comment on the biological evidence.
I found that report a remarkably irresponsible
document. I mean, I would never write a paper for
publication that said I'm not competent to make these
statements, which, if I could have found the correct
document, and I will provide to the record if need be.
THe other thing, and the very, very fundamental
flaw that exists in the CRS study is, it presumes a
threshold for both lung cancer and heart disease, and there
is no evidence accepted by the general scientific community
that the threshold effect exists.
! think, first of all, the authors of that
report, by their own admission, were not competent to write
it..
Secondly, the assumptions they made are at great
variance with established scientific view.
Third, I checked about this and asked what kind
of peer review did these documents get before they were
released, and the answer was none.
So I think that document is an appalling
document. It's an embarrassing document. I had previously
thought the Congressional Research Service did good work,
and I hope that that's an exception to the rule.
BAYLEYREPORTING, INC.
(202) 234-7787 (800) 368-8993
T!1011-1651

1
2
3
4
5
6
7
8
9
I0
Ii
12
13
15
16
17
18
19
2O
21
22
23
24
25
465
MR. SIRRIDGE: We' ll let others decide whether
it's an exception, whether it's accurate.
opinion.
DR. GLANTZ :
MR. SIRRIDGE :
DR. GLANTZ :
That's true. I'm entitled to my
Absolutely.
Dr. Glantz, you mentioned this
morning that -- in fact, I was interested in your view that
the relative risk for environmental tobacco smoke and heart
disease could be i0.
DR. GLANTZ: The data are -- if you look at, I
think it was the Garland study done and not a terribly big
one, from a statistical point of view, the relative risk
could be anywhere in that 95 percent confidence interval
with equal probability.
I was not saying that I thought it was 10. I was
just making a statistical statement based on that one study.
If you look at the pooled estimate, the 95
percent confidence intervals are, in fact, quite narrow.
They're about plus or minus .l, or probably even a little
less than that, so I do not think the relative risk is
MR. SIRRIDGE: Was the Garland ~tudy the one
where they made the huge mathematical error?
DR. GLANTZ: No. The Garland study, there was a
typographical error in the paper, which Garlan subsequently
published an erratumm on. There was not a mathematical
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
Tl1011-18~-52

1
2
3
4
5
6
7
8
.9
i0
II
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
466
error in their work.
I actually, when people started claiming that,
called Garland and asked him about it, and he sent me a copy
of the erratum which had already been published.
I believe they interpolated two numbers or
printed the log instead of the actual numbers, but the
analysis was correct.
MR. SIRRIDGE: And the risk went from 14.7 down
to 2.7? Is that your memory?
DR. GLANTZ: The correct result -- the result in
Garland's paper, as published with the erratum, had the
correct number. Me did not change what he said the risk
was. What they did was corrected a typo.
The analysis that was done in that paper was done
correctly.
MR. SIRRIDGE: What do you think the risk is, if
it's ~ot I0 -- you said you didn't think it was 10?
DR. GLANTZ: I think it's around 1.3 -- 1.2 to
1.4, somewhere in there.
MR. SIRRIDGE: Well, Doctor, haven't there been
comments made by qualified analysts and scientists in the
ETS area that even that risk is too high compared to the
cardiovascular risk that's been reported for active smokers?
DR. GLANTZ: Well, most of the criticism I'm
aware of has come from the tobacco industry's consultants.
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1653

1
2
3
4
5
6
7
8
9
i0
Ii
12
13
14
15
16
17
18
19
20
21
22
24
25
467
I know of ~wo independent scientists who have raised the
issue -- Nicholas Wald and Richard Pito from England. Pito,
I was very discouraged to hear, hadn't read our work when he
was making the criticisms, which I thought was pretty
irresponsible.
The issue does come up and it is addressed in my
testimony because the risks are higher than you would expect
if you assume a linear dose response relationship.
The risks for active smoking and heart disease
are about 2 to 4, depending on the presence of other risk
factors.
The passive smoking risk is about 1.3, so since
the dose that a non-smoker gets of ETS may be I percent of
what a smoker gets, it does seem that the risk is too big,
but that's the reason I presented the animal data that I did
and the platelet data because it appears to me that, first
of all, that nonsmokers responses to passive smoking are
qualitatively different than smokers' responses, and that
there's a very, very steep dose response relationship at low
doses, so there's no reason to assume a linear or a
sublinear curve, and I think that the animal and clinical
data supports a superlineal curve that the additional
effects at very high doses that a smoker gets produce
relatively small changes over the relatively low doses that
a nonsmoker gets.
BAYLEYREPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1654

1
2
3
4
5
6
7
8
9
i0
ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
468
I think the experimental evidence, both the
animal data and also the clinical studies, supports that
view.
MR. SIRRIDGE: Your Honor, I'd like to take back
that estimate of 45 minutes, because I'm going slower than I
thought I might.
JUDGE VITTONE: Okay. You're coming up on 3:00,
and you started at 2:30.
MR. SIRRIDGE: And you recall I have 17 numbers
to examine under.
JUDGE VITTONE: I understand.
MR. SIRRIDGE: Thank you.
Let me ask --
JUDGE VITTONE: At this point, it may be
appropriate for me to ask, both the questions and the
answers, if we can tighten then up a little bit, it would be
appreciated.
MR. SIRRIDGE:
DR. GLANTZ:
it difficult but we'll try.
JUDGE VITTONE: Well, the longer we stay here,
maybe the tighter the answers will get.
MR. SIRRIDGE: That's usually what happens, Your
Honor.
I'll do my very best.
I think both of us are going to find
DR. GLANTZ: That's how I get papers out of my
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
Tl1011-1655

1
2
3
4
5
6
7
8
9
i0
II
12
13
14
15
16
17
18
19
20
21
22
23
24
25
469
students, ~oo.
MR. SIRRIDGE: Dr. Glantz, let me add a third
dissenter to your view, 1.3 is the right risk and not too
high. It comes from an OSHA consultant who will be
testifying later this week, Dr. Jonathan Samet.
DR. GLANTZ: Yes.
MR. SIRRIDGE: Are you familiar with him?
DR. GLANTZ: I think I met him once, but I know
who he is.
MR. SIRRIDGE: He writes in a publication in
1992, entitled, "Environmental Tobacco Smoke":
"The extent of the excess risk associated with
passive smoking seems high in view of the relative risks
observed in active smokers, approximately twofold
increases," and he cites the Surgeon General for that.
DR. GLANTZ: Yes. So what's the question?
MR. SIRRIDGE: Would you agree that there is now"
a third dissenter? You knew of two and I'm adding one.
DR. GLANTZ: I would say that in 1991, when he
probably wrote that, that was probably an accurate
representation of his view. I don't know what his current
views on it are. You can ask him when he's here.
It's important that a lot of the evidence on
passive smoking and heart disease is relatively recent, and
when you quote from old documents, like the '86 Surgeon
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
Ti1011-1656

1
2
3
4
5
6
7
8
9
i0
iI
12
13
14
15
16
17
18
19
20
21
22
23
24
25
470
General's !eport or the National Research Council's report,
that said there's not enough evidence to say, those were
accurate statements when they were made because that was
before most of the evidence was published.
Most of it dates from the late '80s and into the
early '90s, so I don't know what Samet's view would be
today.
MR. SIRRIDGE: He certainly had the benefit of
your paper in 1991. Would that have been helpful to him?
DR. GLANTZ: Did he cite our paper?
MR. SIRRIDGE: Yes, he did.
DR. GLANTZ: Yes. Well, it was a new paper then,
and it takes a scientific community a while a to reach a
consensus.
MR. SIRRIDGE: Doctor, would you agree that
several risk factors, such as lack of exercise, diabetes and
Type A behavior pattern, were almost never controlled for in
the epidemiologic studies that you have referred to and
relied on for your views?
DR. GLANTZ:
MR. SIRRIDGE:
DR. GLANTZ:
I should just leave this one up.
I can move this along by just --
Well, you're asking questions, and
I'm trying to give you responsible answers.
MR. SIRRIDGE: Thank you very much.
DR. GLANTZ: I would say that, as direct
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI 1011-1657

1
2
3
4
5
6
7
8
-9
i0
II
12
13
14
15
16
17
18
19
20
21
22
23
24
25
471
covariates~ no; indirectly through controlling for
socioeconomic status, diet, and things like that, yes, to
some extent.
MR. SIRRIDGE: So socioeconomic status controls
for lack of exercise?
DR. GLANTZ: To some extent.
MR. SIRRIDGE: What study is that?
DR. GLANTZ: I would have to go get you the
references. That's some that's generally known. I mean,
it's something that's generally known among people who work
in this area.
Again, I think it's very important that, in
Wells' work, when he showed the better job you did of
controlling for the potential confounders, the higher the
risks attributed to ETS got. I think that's a very
important finding because it shows that these potential
confounders are not giving you an inaccurate view of what's
happening, but rather, if anything, obscuring the ETS
effect.
MR. SIRRIDGE: Dr. Glantz, do you know if any of
the studies controlled for coffee drinking?
DR. GLANTZ: Not to my knowledge.
MR. SIRRIDGE: Hasn't there been an association
reported in the range of 1.3 to 2.5 for heart disease --
DR. GLANTZ: I'm not familiar. I mean, other
BAYLEYREPORTING, INC.
(202) 234-7787 (800) 368-8993
T!1011-1658

i
2
3
4
5
6
7
8
9
i0
ii
12
13
14
15
16
17
18
19
20
21
22
23
24
25
472
than heariHg things in the popular press from time to time
about coffee drinking, I'm not familiar with that data.
MR. SIRRIDGE: Would you be surprised if the OSHA
consultant, Neil Benowitz, published a study quoting the
fact that there's an association of 1.3 to 2.5 relative risk
for coffee drinking and heart disease?
DR. GLANTZ: Would I be surprised? I don't have
any reaction one way or the other to what Neil does. He was
an independent scientist.
published a study?
MR.. SIRRIDGE:
Why should I be surprised if he
Do you think controlling, or do
you think taking coffee into account, would have added
another risk factor to examine, to determine, whether the
risk of 1.3 is an accurate risk? Does socioeconomic status
take care of coffee drinking?
DR. GLANTZ: I'm not aware of any evidence that
coffee driniking is correlated with ETS exposure in a way
that could possibly influence the outcome of these studies,
so my answer is, I would be very surprised if that ended up
being an important factor.
MR. SIRRIDGE: Wouldn't the relationship be,
Doctor, whether cigarette smoking is correlated with coffee
drinking, and then, therefore, you have a coffee drinker in
the home, and isn't that the kind of dietary habits that
people cite when they write articles, saying that those
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T! 1011-1659

1
2
3
4
5
6
7
8
9
10
iI
12
13
14
15
16
17
18
19
~.0
21
22
23
24
25
habits ten~ to conglomerate in households? There is the
tie-in, Doctor.
DR. GLANTZ:
MR. SIRRIDGE:
473
I don't understand the question.
The question is, cigarette smoking
is related to coffee drinking.
on it?
on it?
Isn't that true?
DR. GLANTZ: I don't know that for a fact.
MR. SIRRIDGE: Would you like to see an article
DR. GLANTZ: Pardon me?
MR. SIRRIDGE: Would you like to see an article
DR. GLANTZ: Well, I can -- I mean, if you want -
- I mean, I'm not going to -- the CRS study I had read
before, I'm not going to speed read a scientific article and
give you a judgment on whether I think it's good or not. If
you want to give it to me, I'll be happy to read it later,
and I can respond in a post-hearing comment.
MR. SIRRIDGE: Let me ask, then: there are
cardiovascular studies, studies on cardiovascular disease,
which do control for coffee drinking as a potential risk
factor.
DR. GLANTZ: I'm not in the position to answer
that one way or another as an expert.
MR. SIRRIDGE: Doctor, you mentioned several
mechanisms, in your view, that ETS may be involved in the
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1660

1
2
3
4
5
6
7
8
9
I0
II
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
474
development of atherosclerosis. These are proposed
theories, or hypotheses, aren't they, Doctor?
DR. GLANTZ: The explanations of the mechanisms
of atherosclerosis that I discuss are current best
understanding of how atherosclerosis is initiated and
continues. This is an area which people have researched and
will research for years.
I would say they represent the current consensus
view of what happens which, in science, is instantly the
can't hypothesis and theory. So I would say that it is the
current hypothesis and theory, but that also means it's our
current state of knowledge.
MR. SIRRIDGE: Doctor, are you more careful when
you write in journals about things being theories and
proposed hypotheses than you were this morning?
DR. GLANTZ: Yes.
MR. SIRRIDGE: Are you more careful?
DR. GLANTZ: No, I've tried to be very careful
what I write. For one reason, I know you guys will take it
apart. I mean, I published a document with the restaurant
study, that I'm sure will get to you, that had an append±x
full of numbers, and found the one typographical error in it
for me.
MR. SIRRIDGE: I didn't see that study.
DR. GLANTZ: Well, you didn't, but the tobacco
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T11011-1661

1
2
3
4
5
6
7
8
9
10
Ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
475
companies Bid. So I plan on all my things being very
carefully reviewed by them.
MR. SIRRIDGE: In fact, if you called them
proposed theories or research hypotheses in your articles,
you stand by that today?
DR. GLANTZ: Well, that's not the kind of
language I usually use when I'm writing, generally.
[Pause.]
JUDGE VITTONE:
MR. SIRRIDGE:
JUDGE VITTONE:
MR. SIRRIDGE:
Mr. Sirridge :-
I'll move off that.
Are you almost done?
I'm sorry. I'll move it "along.
Let me just finish that line, because it does take a while.
I'm sorry.
JUDGE VITTONE: Sure. That's all right. Go
ahead.
MR. SIRRIDGE: Your Honor -- or, actually, Dr.
Glantz -- I won't ask you a question.
DR. GLANTZ: You can.
[Laughter]
JUDGE VITTONE: I'm not sure how much value I'll
give.
MR. SIRRIDGE:
be very helpful.
JUDGE VITTONE:
As long as it's short, that would
You want yes and no answers?
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
Tl1011-1662

1
2
3
5
7
8
-9
I0
ii
12
13
14
15
16
17
18
19
20
21
22
23
24
25
476
MR. SIRRIDGE: Yes. I like yes and no answers.
I like the courtroom.
Dr. Glantz, isn't it a fact the
pathophysiological data are too limited in scope to prove
any of your postulated mechanisms as to how ETS may cause
heart disease?
DR. GLANTZ: I would say that the mechanisms we
suggest are consistent with a large body of data that's
understood about the mechanisms of the induction and
promotion of heart disease.
MR. SIRRIDGE: I'm quoting Dr. Samet again from
that same publication:
"Pathophysiological mechanisms can be postulated
with the increased risk associated with passive smoking,
although the relevant experimental data are still limited in
scope. "
DR. GLANTZ: I would say that in 1991, when he
probably wrote that, that was an accurate statement. The
experimental data, the work that we've done, that I reported
here, work by Arthur Penn and others, has all been published
within the last couple of years, so it really post-dates
that article.
I think probably when he made that statement, it
was accurate. I mean, we would have -- and perhaps I did
say tentative hypothesis, or something in the paper Bill
BAYLEYREPORTING, INC.
(202) 234-7787 (800) 368-8993
Tl1011-1663

1
2
3
5
6
7
8
9
I0
ll
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
477
Parmlee and I wrote, I noticed you looking through -- at
that point, there was evidence that benzopyrene and certain
of the other chemical constituents of ETS played a role in
atherosclerosis.
Since then, there's been direct experimental
evidence by us and Arthur Penn, who was funded by the Center
for Indoor Air Research, in fact, that have provided direct
cooperation, and I think that significantly strengthens the
case, and that all came out in the last couple of years.
MR. SIRRIDGE: All the questioners who follow me,
take that up, and I'll try to move along to save time.
Doctor, you mentioned meta analysis in your
remarks this morning.
DR. GLANTZ: Yes.
MR. SIRRIDGE: Have you done a meta analysis on
the studies that contained data on work place exposure to
ETS and that relationship with heart disease?
DR. GLANTZ: No, I haven't. The reason I haven't
is I think that there aren't enough of them and I think
they're too small to have it really make much sense.
For the same reason, if you look in our 1991
paper -- Bill Parmley's and my 1991 paper -- we did not
include any analysis of non-fatal endpoints, which are
included in my testimony.
The reason we mentioned we didn't include a
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TII011-1664

1
2
3
5
6
7
8
9
i0
ll
12
13
14
15
16
17
18
19
2O
21
22
23
25
478
formal analysis was we thought it was premature. There
wasn't enough data to do it well.
MR. SIRRIDGE: Well, Doctor,would you agree with
Mr. Martonik, who stated yesterday that studies with work
place exposure data on ETS, would be preferable studies for
OSHA to analyze in terms of the relationship between ETS
and --
DR. GLANTZ: I don't particularly agree with
that, no.
MR. SIRRIDGE: You don't agree with it?
DR. GLANTZ: No.
MR. SIRRIDGE: Do you know which epidemiologic
studies do have work place data?
DR. GLANTZ: The one -- let's see. The Dobson
study, Peter Lee study, and the Svendsen study, I believe.
MR. SIRRIDGE: What do those studies show with
respect to work place exposure?
DR. GLANTZ: The Dobson study showed no
significant effect. That I could state clearly, because I
looked at this morning.
The Peter Lee study and the Svendsen study, I
can't recall. If you want to stop, I can look at them.
MR. SIRRIDGE: Well, we're rolling now, so my
time is drawing to a close.
You deal with the issue of publication bias in
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
Tl1011-1665

1
2
3
4
5
6
7
8
9
I0
Ii
12
13
14
15
16
17
18
19
20
21
22
23
24
25
479
your statement submitted for the record?
DR. GLANTZ: Yes.
MR. SIRRIDGE: Have you done an actual study on
the issue of publication bias with respect to environmental
tobacco smoke and the literature on heart disease?
DR. GLANTZ: I haven't, but Roger Beaglehole, who
is with the epidemiology department in, I think, Wellington,
New Zealand has, which included contacting everybody he
could imagine in the whole world, and he made a presentation
at the World Conference on Preventive Cardiology in Oslo
about a year ago, and said that he could find no evidence of
publication bias.
Lisa Bero and I have published a study on
publication bias and lung cancer and ETS and concluded that
there wasn't any.
And by the same criteria that were used in that
paper, my guess is that we would reach a similar conclusion.
The reason for that is that publication bias is
usually defined and, indeed, it's defined in some of the
comments submitted on behalf of the tobacco industry as a
bias against publishing studies that don't reach statistical
significance.
In fact, if you look at the individual studies,
as I pointed out in my remarks before lunch, many of the
studies don't reach statistical significance. So, if
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T!1011-1666

1
2
3
4
5
6
7
8
9
i0
ii
12
13
14
15
16
17
18
19
20
21
22
23
24
25
480
anything, ! think there's a bias toward publication of so-
called negative ETS studies.
Another thing which I think contributes to that
is it's area where there's a tremendous amount of interest
in it, and so I think that helps get this work published,
and the other thing is that the tobacco industry is screened
so loudly about publication bias that I think editors, in
fact, have a pro publication bias for studies related to
ETS.
MR. SIRRIDGE: Doctor, did Mr. Repace or someone
else from OSHA -- someone else with OSHA -- send you a copy
of the submission from Dr. Maurice LeVois?
DR. GLANTZ: Yes.
MR. SIRRIDGE: You've seen that publication?
DR. GLANTZ: That one, I have seen and read it,
yes.
MR. SIRRIDGE: It addresses the possibility that
there could be publication bias in the sense that negative
studies would not even be submitted. In that regard,
Doctor, have you ever wondered why studies from some of the
huge data bases in this country, in the smoking and health
field, have not appeared with -- articles have not
appeared -- in the literature regarding ETS and heart
disease?
DR. GLANTZ: You've asked two questions.
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI 1011-1667

1
2
3
4
5
6
7
8
9
I0
II
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
481
. The first question is --
MR. SIRRIDGE: I'm sorry about that.
DR. GLANTZ: No, that's okay. What do I think
about Mr. LeVois' submission.
MR. SIRRIDGE: I said, had you seen it.
DR. GLANTZ: Yes. Oh, have I seen it, yes.
Then I was going on to characterize it, but go ahead.
DR. GLANTZ: Well, no, go ahead. If we could,
could we finish with that and then we could address the
second question separately?
JUDGE VITTONE: What is the question right now?
It was lost.
DR. GLANTZ: The second question was, am I
surprised that other studies haven't-been done using the
existing large data bases?
MR. SIRRIDGE: I didn't say surprised. I said,
have you ever wondered why?
DR. GLANTZ: Oh.
JUDGE VITTONE: Can you answer that?
DR. GLANTZ: Have I ever wondered why? Oh, I,
frankly, haven't much thought about it. I mean, there are
many things in life that one hasn't thought about i~.
JUDGE VITTONE: Next question.
MR. SIP, RIDGE: Okay.
DR. GLANTZ: I'll let you lead me to where you're
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T11011-1668

1
2
3
4
5
6
7
8
9
i0
ll
12
13
14
15
16
17
18
19
20
21
22
23
24
25
going.
482
MR. SIRRIDGE: That's fine. Have you contacted
any researchers who work with the large prospective smoking
and health data bases and asked whether they have done any
analyses on the question of ETS exposure and heart disease?
DR. GLANTZ: In response to Mr. LeVois' comment,
I did over the weekend, yes, since I somehow guessed you
would ask me.
MR. SIRRIDGE:
DR. GLANTZ:
Who did you contact?
I talked to Michael Toon at the
American Cancer Society, who is responsible for the CPS I
and CPS II data sets.
MR. SIRRIDGE: Have they done such an analysis?
DR. GLANTZ: He said that they done a preliminary
analysis that showed an increase in risk, and I sent him
Mr. LeVois' study and asked him what he thought of it, and
he had some very serious problems with it.
First of all, unlike most scientific papers, it
doesn't include a method section, so we can't really tell
exactly what he did. In fact, one of the real marks of a
poor quality study is the lack of a methods section.
In particular, he doesn't seem to have controlled
for any of the confounding variables that you have expressed
concern over. In particular, he didn't control for AIDS,
which is a very important confounding variable.
BAYLEYREPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1669

1
2
3
4
5
6
7
8
9
I0
ll
12
13
15
16
17
18
19
2O
21
22
23
24
25
483
_Another problem with using the CPS I and II data
sets is they only have -- the CPS I data set had no
questions about passive smoking on the questionnaire, as I
understand it. The CPS II, I believe, had just a single
question, and the only -- in Mr. LeVois' analysis of those
data, he only looked at being married to a current smoker.
So, for example, there's no measure of duration
of exposure, and if you were married to a smoker for 50
years and then the person died, and you got the
questionnaire the next day, you would have been counted as
unexposed.
So Mr. Toon's preliminary analysis -- and these
all seem like reasonable criticisms to me -- was that there
are real serious flaws with the analysis that was done.
Larry Garfinkle had used one of those two data
sets -- I don't know which -- to do a study on passive
smoking and lung cancer.
MI~. SIRRIDGE:
DR. GLANTZ:
CPS I.
Okay. CPS I, which came up with an
elevation and risk that didn't reach statistical
significance, and was fairly roundly criticized on the
grounds that it wasn't an appropriate data set to use, which
he actually said in his paper.
When he subsequently did a case control study, he
came up with results much more consistent with Hariyama and
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
Ti1011-1670

1
2
3
4
5
6
7
8
9
l0
Ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
484
others.
I think the criticism that the Access received
about the misuse of the CPS data sets on passive smoking, I
think has led them to be very cautious about drawing
conclusions.
Now, I have asked Michael Toon to run a proper
analysis on those data sets for me, which I will -- if he
has time -- attempt to submit in a posthearing comment, but
I can't promise that they're going to do that. They may
feel, with some justification, that that's just simply not
an appropriate use of that data.
Just because a data set is big, that doesn't make
it. appropriate to do a given study.
MR. SIRRIDGE: I can't remember what the question
was.
Doctor, you indicated earlier to me, when I asked
you whether you had submitted your materials on heart
disease to the Environmental Protection Agency.
DR. GLANTZ: Um-hum.
MR. SIRRIDGE: The EPA has not issued a risk
assessment on ETS and heart disease, have they?
DR. GLANTZ: The EPA -- now, could you be precise
about what you mean -- you mean a risk assessment in the
same sense as the document that was released in, I think,
December of '92?
BAYLEYREPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1671

1
2
3
4
5
6
7
8
9
I0
ll
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
485
. MR. SIRRIDGE: That is correct.
DR. GLANTZ: That is a correct statement. The
EPA has not conducted a formal agency analysis of passive
smoking and heart disease.
materials?
MR. SIRRIDGE:
DR. GLANTZ :
Despite receiving your voluminous
I didn't send them voluminous
materials. They asked me to write a review of the current
state of the literature as of 1990, I believe, which I did.
It was never meant to be a formal agency document, in the
sense that the lung cancer risk assessment document, as the
document that it was prepared for was a review document
written by invited outside authors.
It was never, as I understand it, meant to be an
EPA agency document.
It was reviewed through a different peer review
mechanism. It was just a different kind of document. I
didn't send them voluminous materials. It was about 25
pages and what they asked me to write.
JUDGE VITTONE:
contemplation.
MR. SIRRIDGE:
JUDGE VITTONE:
Mr. Sirridge, you're in
I,m prepared to pass the baton.
Thank you very much.
MS. SHERMAN: Your Honor, Dr. Glantz has been
answering questions for over an hour now. I think that
BAYLEYREPORTING, INC.
(202) 234-7787 (800) 368-8993
T!1011-1672

1
2
3
4
5
6
7
8
9
i0
II
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
maybe a skort break would be in order.
JUDGE VITTONE: All right.
minute recess.
[Recess]
JUDGE VITTONE:
questioning.
486
We'll take a five-
Mr. Rupp, you're next in line for
MR. RUPP: Yes, I am, Your Honor, and thank you
very much. I have identified myself for the reporter. The
people whom I am representing are the same as Yesterday, and
the reporter has acknowledged that she has that information.
I am also joined today by Abrahm Hoffman and
Konrad Bonsack of Price Waterhouse, and they'll be assisting
me in a portion of the examination. I will give business
cards for those gentlemen to the reporter, if that's
acceptable.
JUDGE VITTONE: Okay.
MR. RUPP: Dr. Glantz, when I was preparing for
this examination last night, I must say I was struck by the
range of your. expertise, particularly so far as tobacco is
concerned. That is, you published in the past on tobacco
and advertising, tobacco and economics, tobacco and taxes,
tobacco and health, the social psychological dynamics of
tobacco.
I noticed passages with respect to what you
called addiction to tobacco. It's really quite a Catholic
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T!1011-1673

1
2
3
4
5
6
7
8
9
I0
ll
12
13
15
16
17
18
19
20
21
22
23
24
25
487
interest ygu have in tobacco.
DR. GLANTZ: Thank you.
MR. RUPP: Would you regard yourself to be a
longstanding anti-tobacco activist in a political sense?
DR. GLANTZ: Yes.
MR. RUPP: Are you also the founder, in 1983 or
1982, of Americans for Nonsmokers Rights, at that time,
called Californians for Nonsmokers Rights?
DR. GLANTZ: It was in December of 1980.
MR. RUPP: In those early days -- the early
1980s, if you will -- I take it there were fewer anti-
tobacco actvists at that time then there are currently,
certainly, so yours was a bit of a frontier operation, in a
sense?
DR. GLANTZ:
MR. RUPP:
Yes.
Do you remember a speech you gave --
and I'm going to go a little later now, but it's an
interesting speech, I thought -- at the 7th World Conference
on Tobacco and Health in Perth, Australia, in April of 1990?
DR. GLANTZ: Yes.
MR. RUPP: Let me quote to you from that speech,
if I may.
Your Honor, I'm going to ask this to be marked as
an exhibit, and I think it would be Exhibit 17. I will
offer it at the conclusion of my examination on it, if I
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1674

1
2
3
4
5
6
7
8
9
10
ll
12
13
14
15
16
17
!8
19
2O
21
22
23
24
25
may.
488
JUDGE VITTONE: All right.
(The document referred to was marked for
identification as Exhibit 17.)
MR. RUPP: Let me quote to you from the second
page of that speech, Dr. Glantz.
After having discussed some smoking restriction
proposals that you had made at a previous conference in
1983, you made this statement:
"It's very nice to see that some of the same
ideas that a few of us were advocating in 1983 which were
viewed as so strange, radical, and hopeless, have now become
so very mainstream. So not only am I talking about history,
but I'm even presenting ideas that are accepted, and I'm
having a very hard time coping with this. As I tell people,
I've gone from being a lunatic to being an expert, and I
don't think I've changed that much except that I've gained
weight, because, you see, I don't smoke and I don't drink
much, and I don't engage in high-risk sexual activities, and
all that's left is food."
I take it the use.of the word "lunatic" was
perhaps hyperbole?
DR. GLANTZ: Yes, that was a joke.
MR. RUPP: Okay.
DR. GLANTZ: If you listened to a tape, people
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1675

1
2
3
5
6
7
8
9
I0
Ii
12
13
14
15
16
17
18
19
20
21
22
23
24
25
laughed.
the tape.
489
MR. RUPP: Yes, they did, and I have listened to
In a later portion of the speech --
DR. GLANTZ: Let me --
JUDGE VITTONE: Gentlemen -- gentlemen.
DR. GLANTZ: If I could respond, because --
JUDGE VITTONE: I'm going to --
DR. GLANTZ:
mischaracterized.
MR. RUPP:
-- I don't want to be
Let me ask a question.
anything.
said that.
JUDGE VITTONE: I don't think he's characterized
M~. RUPP: I haven't. I'm asking you whether you
DR. GLANTZ: I told that joke, yes.
MR. RUPP: Right.
At a later portion of the speech, you said:
"Well, I did do a paper on science yesterday,
which they let me put on the program or I would have told
you about sticky platelets today. One of the great assets
that we have stumbled onto in the fight over smoking are
nonsmokers," end of quote.
Now, the question I have is this: That statement
almost suggests to me that you were quite pleased to think
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1676

1
2
3
4
5
6
7
8
9
I0
Ii
12
13
14
15
16
17
18
19
20
21
22
23
24
25
490
that nonsmokers might be put at risk by other people's
tobacco smoking because that would be a political advantage
to you. Do I read the incorrectly?
DR. GLANTZ:
MR. RUPP:
DR. GLANTZ:
Yes, you read it incorrectly.
Okay.
It's very important to state that my
interest in this area followed from the science not the
other way around.
MR. RUPP:
DR. GLANTZ:
Mr. Rupp.
I'm sure that it did.
I'm glad that you recognize that,
MR. RUPP: Let me go on and quote further from
the speech. You indicate here that it's very important for
anti-tobacco activists to be as visible as possible and to
try to involve the media in the efforts as much as possible.
You say, and I quote:
"And if you do something that is politically
invisible, it will get covered. The tobacco companies can
suppress features but they can't suppress news stories. The
second thing you should not be is a health fascist. You
should be an environmental lunatic. You are against air
pollution. The environmental groups and good government
groups in the United States have been particularly helpful.
"And the last thing is you need to convince
legislators that if they oppose you, they will be perceived
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
Ti 1011-1677

1
2
3
4
5
6
7
8
9
i0
ii
12
13
.14
15
16
17
18
19
20
21
22
23
24
25
491
as dupes of the cigarette companies, and Dick, whom we
referred to earlier and will be shown in the transcript, has
already talked about the very negative image that has."
Now, the question I have is this: With this kind
of verbiage -- and I take it this isn't a joke -- it's going
to be a bit of a leap for some of us to make to also view
you as a purely objective science, prepared to call things
as you see them, without regard to politics or without
regard to a hidden agenda. Can you help us?
DR. GLANTZ: Pardon me? I didn't hear the
question. I was just -- I was thinking about something
else.
MR. RUPP: In light of comments of this sort,
which clearly this was not meant in jest because it's part
of a very long passage --
DR. GLANTZ: Um-hum.
MR. RUPP: -- it's very difficult for -- it's
going to be very difficult for a number of people to make
the leap into viewing you also as an independent objective
scientist, not one having a political agenda in presenting
statements of the sort you presented here.
Can you help us get back into the objective
scientific arena?
DR. GLANTZ:
MR. RUPP:
Sure. Let me --
Put it this way. You --
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1678

1
2
3
4
5
6
7
8
9
I0
ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
492
DR. GLANTZ:
question --
MR. RUPP:
DR. GLANTZ:
MR. RUPP:
Now, Mr. Rupp, you asked me a
Let me make it easy for you.
-- so let me answer it.
How does one --
DR. GLANTZ: Mr. Rupp --
JUDGE VITTONE: Gentlemen -- gentlemen --
DR. GLANTZ:
question --
MR. RUPP:
-- Mr. Rupp, you asked me a
Fair enough.
DR. GLANTZ: -- now let me answer it.
MR. RUPP: Fair enough.
DR. GLANTZ: I'm a Professor of Medicine at the
University of California, San Francisco. My professional
career depends on being first and being right, as any
scientist at a first rate academic institution, and I am
very proud of the fact that I was one of the early
scientists to recognize the seriousness of passive smoking
as an issue and how to deal with it as a problem.
Now, the passages that you are reading there were
from a speech at a meeting. They include hyperbole, they
include jokes. I am, as you may or may not know, a fairly
colorful speaker. But it is absolutely -- and I want to
underline absolutely not true -- to say that I have in any
way twisted the science around to justify some preconceived
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
Tl1011-1679

1
2
3
4
5
6
7
8
9
i0
Ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
493
political.position.
If I were presented with evidence which I found
compelling, say that my past positions on this scientific
issue are wrong, I would change my positions, as I have on
many issues, scientifically, when presented with the data.
I think, just as Surgeon General Koop, whose
similar accusations have been directed on and many health
professionals, I think it is ethically incumbent in a health
professional to take public health action when you know what
I know about this disease.
Whether or not I am objective, my work is of
scientific high quality, things like that, that is for my
peers to judge, not for me. But I can tell you that the
University of California has found this work acceptable,
that the State of California has, and many other independent
groups.
In fact, the only organized groups that have
found our work on ETS of low quality has been the tobacco
companies, so I --
MR. RUPP: Well, we'll --
DR. GLANTZ: -- stand on my record. And I am
proud of the fact that I have acted on my scientific
knowledge. But it is very important, Mr. Rupp, for you and
your clients to understand the causality here. The actions
that I have taken in this area have been because of my
BAYLEYREPORTING, INC.
(202) 234-7787 (800) 368-8993
T!1011-1680

1
2
3
4
5
6
7
8
9
i0
Ii
12
13
14
15
16
17
18
19
9.O
21
22
23
24
25
494
scientifiG knowledge not the other way around.
MR. RUPP: All right. At a later portion of this
speech you say, "The higher up you go in the political
system the harder it is generally, and the good principles
of guerilla war pick a target you can beat. And if you
don't have the money or the clout on the national
legislation, get local legislation, no matter how small the
place is, a place where you can start to win."
Do you regard this proceeding at OSHA to be a
guerilla war?
DR. GLANTZ: No.
MR. RUPP: What is this?
DR. GLANTZ:
MS. SHERMAN:
DR. GLANTZ:
This is the OSHA proceeding.
This is what?
It's an OSHA proceeding.
I would
add, in fact, one of the slides I took out of my
presentation to try to shorten it, was a statement from the
Roper poll done for the Tobacco Institute in 1978, that
identified the issue of the effects on smoking on nonsmokers
is very important.
MR. RUPP: I think that's already in the record,
as a matter of fact.
DR. GLANTZ: And I also -- well, okay, maybe
someone else put it in.
And also in that same report are discussions of
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T11011-1681

1
2
3
5
6
7
8
9
i0
iI
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
495
just the same points that you were quoting from in that
speech that I gave, and, in fact, my ideas in this area,
came from reading the Tobacco Institute's research, which I
think was quite good in this area, and whoever did it back
in 1978, was a very smart person, because they predicted how
th~s whole issue has evolved.
MR. RUPP: I'll take that back to them. I'll
take them back to them.
may.
DR. GLANTZ:
MR. RUPP:
Let me ask another question, if I
Okay.
Near the end of the speech you
congratulate the people who had received awards frbm the
anti-smoking organizers who had been responsible for the
meeting, and then pointed to a fellow who had not received
an award, and you say:
"But, you know, activists need to not only be
rewarded, and I also took exception, I had no objection at
all to the people who were given awards on the first day,
but I did notice there was not a single lunatic among them,
but they should not be screwed either by people who were
supposed to be on their side, and I think the message that
that sent, the word got around, and when there are good
people working in the health agencies, and there are many
good people who want to go out a little bit on the edge,
they need to see that they will be rewarded."
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T! 1011-1682

1
2
3
4
5
6
7
8
.9
i0
ii
12
13
14
15
16
17
18
19
20
21
22
23
24
25
496
Is that really what this -- would you apply those
kind of comments to this proceeding?
DR. GLANTZ: I think it's totally inappropriate
for this thing. I mean, I was giving a speech. It was a
colorful speech, it was hyperbole, and it was -- if you
listen to the tape, people laughed through parts of it. I
think this is a completely different sort of proceeding that
you're dealing with here and, in fact, the times are
completely different.
MR. RUPP: I hope that's true.
DR. GLANTZ: Yes.
MR. RUPP: Your Honor, I'd like to offer this
transcript into the record of the hearing as Hearing Exhibit
17.
JUDGE VITTONE:
MS. SHERMAN:
Any objection?
I think it would probably be better
for t~e purposes of the transcript, unless you're going to
ask some more questions from it, that you enter it with your
own exhibits at the time your people testify.
MR. RUPP: Again, I won't be testifying, and we
have no one testifying on our behalf who is going to cover
this ground again. I think it's important that the full
transcript be in the record because I don't want it said at
any point by anyone that I took something out of context, so
I think Dr. Glantz' view of words should be in context and
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1683

1
2
3
4
5
6
7
8
9
l0
ll
12
13
14
15
16
17
18
19
20
21
22
23
24
25
497
comprehensive.
MS. SHERMAN: Okay. If you will make a copy
available for Dr. Glantz to review, then I --
MR. RUPP: I would be more than happy to do that.
MS. SHERMAN: -- don't have any objection to it.
MR. RUPP: Thank you very much.
JUDGE VITTONE: Okay. Do you want to wait,
though, until you've had a chance to review this or do you
have no objection now?
MS. SHERMAN: Well, if Mr. Rupp is very concerned
about getting it in, I would not mind you allow it in the
record subject to Professor Glantz' comments on it, after he
has had a chance to review it.
MR. RUPP: I have no problem with that. There's
a rebuttal period, and he, of course, can say anything he
cares to about it.
JUDGE VITTONE: Okay. Could you identify it more
specifically?
MR. RUPP: Yes, I can, Your Honor.
It is entitled, Seventh World Conference on
Tobacco & Health, Perth, Australia, April 1990 Transcript.
The speaker is listed as S. or Stanton Glantz.
JUDGE VITTONE: All right.
DR. GLANTZ: Your Honor, since it's being entered
into the record, I'd like to just offer a couple of very
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T11011-1684

1
2
3
4
5
6
7
8
9
I0
i'i
12
13
14
15
16
17
18
19
20
21
22
23
24
25
498
brief comments.
MR. RUPP: I'm going to object to that. There is
a rebuttal period, and that's what the rebuttal period is
for.~ I've asked questions, you've answered them, and I
appreciate your answers.
JUDGE VITTONE: What's the rebuttal period --
MR. RUPP: You'll have an opportunity for a
rebuttal period, but my time runs and I'll ask the
questions.
JUDGE VITTONE: Which the rebuttal period will
follow at the close of the formal testimony here, right now,
which is planned for December 2nd. There will be a period
of time in which parties can submit additional comments.
You will have that opportunity as well as anybody
else who testifies at this proceeding.
DR. GLANTZ: All right. I'm not --
MR. RUPP:- There are a number of articles --
JUDGE VITTONE: Gentlemen -- gentlemen --
DR. GLANTZ: Well, I'm not going to be able to
travel back to Washington.
JUDGE VITTONE: You're not going to have to
travel back. You can submit them in writing, if you like.
MS. SHERMAN: Mr. Rupp, we'll make that
available.
JUDGE VITTONE: There will be a formal period
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
Ti1011-1685

1
2
3
4
5
6
7
8
9
l0
II
12
13
14
15
16
17
18
19
20
21
22
23
24
25
where people will come back for the rebuttal period to
testify again.
I will receive what you have identified as
Exhibit 17 in the record.
(The document previously marked for
identification was received into evidence as
Exhibit 17.)
JUDGE VITTONE:
opportunity to review it.
will be able to submit any kind of written analysis or
comments that you want to make.
area?
All right.
499
Dr. Glantz, you will have an
During the rebuttal period, you
Mr. Rupp, are we moving onto another
MR. RUPP: Yes.
I'm just going to identify a
couple of additional documents of the same sort, and I'm not
going to ask questions about them, but, again, I think it
appropriate that Dr. Glantz be given copies.
I would like to offer their entry into the record
at this point, and then subject to any comments he may care
to make or any objections Ms. Sherman may have, I would
request that they be received in evidence at this time.
MS. SHERMAN: Can you make these available to him
by tomorrow morning?
MR. RUPP: I certainly can.
Let me identify them, then, at this point.
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T11011-1686

1
2
3
4
5
6
7
8
9
I0
ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
5OO
One is an editorial entitled, Achieving a Smoke-
Free Society. It appeared in the publication Circulation, I
think the only article by that name that Dr. Glantz has
published.
There is a 1983 brochure from Californians for
NonSmokers Rights, entitled, Thank you for Not Smoking.
Also in 1983, article from Californians for
NonSmokers Rights, which begins with the.sentence: On
June 3rd, San Francisco Mayor Diane Feinstein signed an
important piece of legislation to control air pollution.
An article by Stanton Glantz and Joe Ti and
Kenneth Warner on tobacco advertising on consumptibn,
Evidence of a Causal Relationship.
Finally, legislative approaches to a Smoke-Free
Society by Peter Hanower, Glen Barr, and Stanton Glantz, and
this is a publication from the Americans for NonSmokers
Rights as well.
We will, as I said, make sure the Dr. Glantz as a
copy of all of these publications.
MS. SHERMAN: I don't quite understand. Are you
just entering these into the record as a public citizen, or
are you going to ask Dr. Glantz some questions about them?
What is the purpose of this?
MR. RUPP: If there were time, I'd love to ask
questions of them, but --
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T11011-1687

1
2
3
4
5
6
7
8
• 9
10
II
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
501
MS. SHERMAN: Okay. Well, what is --
MR. RUPP: -- at this point --
MS. SHERMAN: -- purpose of your submission?
MR. RUPP: -- we will be making presentations to
OSHA on the basis of these articles, so I think they need to
be in the record.
We'll make copies of these for Dr. Glantz. We
can get them to you by mail, or we can give them to OSHA to
be provided to you through OSHA, whichever you would prefer.
JUDGE VITTONE: Why don't you just mail them to
him. Are you going to attach exhibit numbers to that?
MR. RUPP: Yes, I can do that. Why don't we do
that now so that we have no confusion.
In the order in which I read them it would be
Exhibit No. 18, Exhibit No. 19, Exhibit No. 20, Exhibit No.
21, and Exhibit No. 22, and I will provide them in that
order as well.
(The documents referred to were marked for
identification as Exhibits No. 18, 19, 20, 21,
and 22.)
JUDGE VITTONE: Exhibits No. 18 through 22
identified by Mr. Rupp, will be received into the record in
this proceeding.
(The documents referred to, having been
previously marked for identification as Exhibits
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
Tl1011-1688

1
2
3
4
5
6
7
8
9
i0
ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
502
No. 18, 19, 20, 21, and 22, were received in
evidence.)
MR. RUPP: Thank you very much, Your Honor.
Dr. Glantz, let me move now, if I may, to the
portion of your testimony that dealt with the impact of
smoking restriction ordinances in the state of California.
My understanding is that your first study of the affect of
such ordinances was prepared in March of '92, is that
correct?
MR. GLANTZ: I believe so.
MR. RUPP: And my further understanding is that
at that time you were studying four California cities --
Beverly Hills, San Luis Obispo, Lodi, and Bellflower, had
imposed such ordinances, is that correct?
MR. GLANTZ: I believe so.
MR. RUPP: And you relied on sales data collected
by the California State Board of Equalization that presented
taxable restaurant and total retail sales data on a
quarterly basis, is that correct?
MR. GLANTZ: Yes.
MR. RUPP: After your first study on June I,
1992, you issued a short report in which you responded to,
and I quote, "several criticisms the tobacco industry has
advanced" concerning your findings. Do you recall that?
MR. GLANTZ: Yes.
BAYLEYREPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1689

1
2
3
4
5
6
7
8
9
I0
ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
503
MR. RUPP: The first criticism you identify is,
and again, I quote, "That the numbers are wrong, other
surveys reveal there was a drop in sales." And I take it
you're ascribing that to the tobacco industry.
To that you responded, and again, I quote from
the document, "IT is important to emphasize that the data we
used on restaurant sales did not come from a survey we did.
These values are from the sales figures reported to the
California State Board of Equalization for purposes of
paying sales taxes. The only way that these numbers could
be wrong is if the restaurants were lying on their tax
returns. Do you remember making that statement?
MR. GLANTZ: Yes.
MR. RUPP: And I think you repeated a statement
along those lines this morning, did you not?
MR. GLANTZ: I believe so.
MR. RUPP: I'd like to ask you a series of
questions about that sentence, and I'd like to quote first
in that.connection from a research paper published in 1994
by the Clairmont Graduate School entitled "The Impact of
Tobacco Control Ordinances on Restaurant Revenues in
California." The paper, which you undoubtedly have seen,
but if you have not, I can give you one, states in part as
follows, and I quote:
"The State Board of Equalization combined sales
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T!1011-1690

1
2
3
4
5
6
7
9
I0
ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
5O4
from bars. not subject to smoking restrictions and sales from
restaurants in one classification, making it difficult to
isolate the effects of smoking restrictions.,,
Were you aware, Dr. Glantz, that the SBE figures
upon which you were relying were lumping bar and restaurant
sales into the same category?
MR. GLANTZ: There are actually three
subcategories. In one of the three subcategories which is
the smaller of the three, that is correct. We were aware of
that. Also the statement that you quoted, that the only way
the Board of Equalization numbers could be wrong is if
someone lied, turned out to not be correct, because the
Board of Equa%ization actually found a couple of reporting
errors in their data which...
MR. RUPP: I think I'm aware of those and we'll
come to those in just a moment.
Let me read you another of the caveats found in
the Clairmont publication, and this, perhaps, goes to the
point you were just starting to go into. "State Board of
Equalization data exhibit considerable volatility. Yearly
changes of 20 to 30 percent are not uncommon. Some of this
volatility arises from late reporting of revenue unrelated
to changes in business activity."
Were you aware that that is, in fact, the case
with the SBE figures?
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1691

1
2
3
4
5
6
7
8
9
10
ll
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
5O5
. MR. GLANTZ: That was true for a couple of
quarters of data. We actually caught those errors because
the numbers changed by a lot more than the underlying
variability, and we asked the Board to please check them,
and they did find, I believe, two reporting errors that
turned out to be important, and those were corrected.
MR. RUPP: I think we're talking about two
separate phenomena. We're going to get to what you're
talking about in a moment. I'm talking now about...
MR. GLANTZ: Then I don't understand the
question.
MR. RUPP: Let me finish my question.
I'm talking now about the volatility that stems
from late and early reporting of sales figures by the
restaurants to the California State Board of Equalization
Are you aware that there is a problem in volatility stemming
from early and late reporting of sales figures by
restaurants to the SBE?
MR. GLANTZ: Based on my conversations with the
Board of Equalization, except for the couple of instances
that we've been alluding to, I don't think that's a major
problem, nor did the people I talked to. We were concerned
about that and spent quite a lot of time talking to people
at the Board's research arm to deal with that question.
It's a legitimate issue.
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8S93

1
2
3
4
5
6
7
8
o9
I0
Ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
5O6
_ MR. RUPP: Mr. Rossi was one of the people with
whom you consulted?
MR. GLANTZ: Yes.
MR. RUPP: The Clairmont publication that I
mentioned a few minutes earlier goes on to explain, and I
quote, "If a vendor files a late report, the SBE will ensure
that those taxable sales are reported in the appropriate
quarter only if in the prior year the vendor accounted for
at least ten percent of the taxable revenue in the vendor's
classification. When there are many vendors in a particular
classification, late .filed revenues of one quarter may be
lumped with the revenues of the succeeding quarter. This
practice can cause large quarterly revenue changes unrelated
to business activity."
Did you ever discuss that with Mr. Rossi, as we
have?
MR. GLANTZ: Yes.
MR. RUPP: Did he confirm to you as he did to us
and to the Clairmont authors that that was, indeed, a
problem?
MR. GLANTZ: What he told me when we talked about
this was that those changes tended to sort of balance out.
When you're looking for changes, which is what we were
looking for in our study, that generally wasn't a big
problem. There were a couple of instances that we found. I
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T! 1011-1693

1
2
3
4
5
6
7
8
9
I0
II
12
13
14
15
16
17
18
19
20
21
22
23
24
25
507
believe one was in Paradise. I can't remember where the
other one was. Where it was a significant enough amount of
money that it introduced significant artifacts into the
results. But as a general issue, he did not indicate to us
that in terms of the kind of study we were doing, that that
would be a big problem.
It's also important to emphasize that the
Clairmont study you're quoting from concluded no effective
restaurant ordinances on business, and I hope you will enter
that into the record.
MR. RUPP:
moment.
We'll certainly get to that in a
MR. GLANTZ: Thank you.
MR. RUPP: Robert Rossi of the SBE has informed
us that there is yet another problem with the SBE figure so
far as our objectives today are concerned and the use to
which you've made of the figures, frankly. That is that
sales also can be placed in the wrong quarter due to early
reporting. Were you aware of that problem?
MR. GLANTZ:
MR. RUPP:
MR. GLANTZ:
I didn't hear the question.
Early reporting. That is...
Would you repeat the whole question?
was eating a piece of ice.
MR. RUPP: No problem.
Robert Rossi of the SBE has informed us that
BAYLEYREPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1694

1
2
3
4
5
6
7
8
9
i0
II
12
13
14
15
16
17
18
19
2O
22
23
24
25
5O8
there's also a problem with early reporting. If there's
early reporting of revenues they will also be placed in the
wrong quarter. Were you aware that that was a problem?
MR. GLANTZ: Again, when I discussed this with
him a couple of years ago when we started this study, he
seemed to think that these errors all tended to balance out
in terns of the overall figures.
MR. RUPP: Did Mr. Rossi ever tell you that No
effort was ever made by the California State Board of
Equalization sua sponde. On its own, if you will, to
investigate any of these kinds of issues the numbers simply
went in where they went in, and no systematic effort unless
somebody requested a relook at the figures. No systematic
effort was made to determine which quarter the monies should
be put into, the report should go into. They were entered
by date received. Were you told that by Mr. Rossi?
MR. GLANTZ: You're asking very specific
questions, and I'm trying to give you specific answers.
Those p~oblems were generally discussed, and Mr. Rossi at
our request, we provided him with all of our data, our
analysis of their data, and asked him to check that stuff
for us. I don't know if we had the specific conversation
that you're alluding to, but I do remember him telling me
one time that since we had started doing our study there had
been a tremendous amount of interest in making sure all of
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T11011-1695

1
2
3
4
5
6
7
8
9
I0
ii
12
13
14
15
16
17
18
19
20
21
22
23
24
25
509
this stuff was right. To the best of my knowledge, the
numbers that we were using accurately reflect the sales --
at least in terms of measuring changes. Mr. Rossi was very
helpful to us, and another fellow whose name I can't
remember, in trying to ensure that we had numbers which were
representative of what was actually going on.
MR. RUPP: The fact is, Mr. Glantz, it's not that
Mr. Rossi reached out to you to try to make sure that your
figures were accurate, but the reaching out went the other
way, was it not? Let me describe the situation...
MR. GLANTZ: Can I answer the question?
MR. RUPP: Let me describe a situation and see
whether it's correct.
MR. GLANTZ: I'd like to answer the question.
MR. RUPP: If you'll let me ask the question,
please. I've not completed forming the question.
MR. GLANTZ: I'm sorry.
MR. RUPP: The situation that I have in mind is.
this one. I know that you're aware that your original study
included a transposition error for restaurant sales made in
San Luis Obispo for the fourth quarter of 1990. That's the
error to which you referred.
My understanding is that you had used a figure Qf
approximately $15 million for restaurant sales during that
quarter.
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1696

5
6
7
8
9
I0
ll
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
510
MR. GLANTZ: That's not correct.
MR. RUPP: Let me finish the question, and you
can point out where I'm in error, and I appreciate that.
You had used a figure, and i'll be precise,
$15,033,000 when the State Board had actually reported
$10,533,000. That initially proved to be a disturbing error
since the $i0 million sales figure would have represented an
alarming drop in restaurant sales.
My understanding is that when you learned thit
the reported figure was ten, saw that the reported figure
was ten, you went to Mr. Rossi and asked him to check
whether the figure could not be higher. Now is my
understanding wildlyinaccurate, or inaccurate in any
respect?
MR. GLANTZ: It's very misleading. You are
correct in saying that we approached Mr. Rossi, because we
were very concerned that our study, that the data we used
was accurate. There were two different problems. We had
started working with him in terms of making sure the data
was accurate very, very early in the process, before we had
published anything.
There are two errors that you're talking about
which are two distinct errors, and it's important to
understand the difference.
MR. RUPP: I think there were three.
BAILEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T11011-1697

1
2
3
4
5
6
7
8
9
I0
II
12
13
14
15
16
17
18
19
20
21
23
24
25
511
MR. GLANTZ: I'm talking specifically about the
San Luis Obispo.
The first error was in the initial report we
published as an Institute for Health policy monograph. I
decided to just publish all of the data to make it available
to anybody who wanted to check our work. As luck would have
it, a very key quarter, the first quarter of the San Luis
Obispo ordinance, there was a transposition error in the
table in the report.
MR. RUPP: That's the one to which I referred.
MR. GLANTZ: Right. But it's very important to
state for the record that the number that was in our
computer data base, the statistical file that was used for
the actual analysis, was the correct number.
MR. RUPP: In your private data base.
MR. GLANTZ: In the data base which was used to
do t~e statistical..
MR. RUPP:
error.
But in the publication it was in
MR. GLANTZ: The publication had the wrong number
in it, but the number that was used to compute the
statistical results, which were also reported in that
report, was correct. So the results in the report, the
conclusions in the report, were correct.
MR. RUPP: But unless someone went back and did
BAYLEYREPORTING, INC.
(202) 234-7787 (800) 368-8993
T11011-1698

1
2
3
4
5
6
7
8
9
I0
ii
12
13
14
15
16
17
18
19
20
21
22
23
24
25
512
the statistical calculation, they would look at the $i0
million figure and be misled. That was not the correct
figure.
MR. GLANTZ: That's the second problem that
existed. The second problem was that there was a
significant reporting error in that quarter in San Luis
Obispo, which we did approach Mr. Rossi about and they
subsequently corrected.
That was not the only data point that we
approached him about. We went through all of the data and
looked for statistical outliers, and any outliers that we
found during the entire period of the study, and there were
several others, we asked them to go back and double check to
make sure they were accurate points. This is the standard
scientific procedure that you use when you're doing a
statistical analysis, and outliers can lead you to very
misleading results.
MR. RUPP: My understanding is that Mr. Rossi
informed you at that time that when the SBE discovers errors
in SBE sales figures, the SBE does not publish revised
figures. The errors remain undisclosed.
Do you know of any practice by SBE that is
different from Mr. Rossi's explanation? That is any
systematic revisions they either undertake, or any revisions
that they themselves published, other than on specific
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1699

1
2
3
4
5
6
7
8
9
i0
ll
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
513
requests of a researcher such as yourself?
MR. GLANTZ: I don't know the answer to that.
For the record, the corrections that we have we requested
from them in writing so that we had documentary evidence.
MR. RUPP: And, indeed, you published the letter
in one of your publications?
MR. GLANTZ: We made it available to people
because we'd been accused of lying. I wanted to make it
clear that we hadn't fabricated anything.
What the Board of Equalization's policies on this
are, I have no idea. I have never asked Mr. Rossi. I was
concerned that we base our work on accurate numbers.
MR. RUPP: We've talked thus far about three
different kinds of errors, or three different kinds of
problems with the SBE figures. One is the lumping of
restaurant sales and bar sales into the same category. The
second, actually we talked about four. The second is late
reporting of revenue figures to SBE so that they are put
into th~ wrong quarter. The third is early reporting of
figures to the SBE which puts them into the wrong quarter
but an early quarter. And the final problem is simple
mathematical errors which can occur, of course, in anybody's
statistical empire, including yours and mine, I suppose.
MR. GLANTZ: We didn't make any mathematical
errors, we made a typing error.
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1700

1
2
3
4
5
6
7
8
9
i0
ii
12
13
14
15
16
17
18
19
20
21
22
23
24
25
514
- MR. RUPP: I see. Maybe that's a fifth, then.
In light of those four problems...
MR. GLANTZ: Wait, wait. Excuse me. We did not
make a mathematical error. I want the record to clearly
reflect that. And to the best of our knowledge, based on
our discussions with Bob Rossi and the other people we
talked to in the research department at the Board of
Equalization, we were using numbers which were
representative of what was going on.
Finally, it's important to state that there are
~actually three subcategories of restaurant sales and the bar
revenues only affect one of those, and it's a relatively
small, the sm~llest of the three categories.
So I think that the questions that you're asking
really don't accurate represent the actual nature of these
problems.
MR. RUPP: Let me just...
MR. GLANTZ: The other point...
JUDGE VITTONE: Gentlemen.
MR. GLANTZ: ...that's very important, is that we
acknowledge...
JUDGE VITTONE: Dr. Glantz...
MR. GLANTZ: ...these things in our paper.
JUDGE VITTONE: Dr. Glantz.
You've gone far enough.
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
Tl1011-1701

1
2
3
4
5
6
7
8
9
I0
Ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
515
MR. RUPP: If you could just... We're going to
be here an awfully long time, and I'm going to be standing
here pleading with the Judge for more time, and he's going
to be looking at me with darts in his eyes as indeed he has
every right to be, and I'm going to be looking at you with
darts in my eyes. So if you'd answer the questions that I
ask. I'm not asking for a long exegesis of the state of the
world, I just have specific things I'd l~ke to know. You
have an opportunity for rebuttal. So listen to my
questions, please answer them.
We'll come back to the question of whether you
have made mathematical errors in this at a later ~oint. The
question I have for you is this. In light of the problems
we've described, is it not an overstatement to say that the
only way the numbers you reported in your 1992 publication
could occur if the restaurants were lying on their tax
returns. Is that an overstatement, Mr. Glantz?
MR. GLANTZ: I've already said that it was.
MR. RUPP: All right, let me move on then.
MR. GLANTZ: At the point you made it, we were
unaware of these other problems.
MR. RUPP: Excuse me.
MR. GLANTZ: Mr. Rupp, you want to ask your
questions, I want to answer completely.
MR. RUPP: I have no question pending at this
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1702

1
2
3
4
5
6
7
8
.9
i0
iI
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
point.
MR. GLANTZ:
previous one.
516
I was finishing answering the
JUDGE VITTONE: Gentlemen. You ask a question,
answer the question, then we go on to the next question. I
understand what you're trying to do, Dr. Glantz, but we'll
move along a lot better right now and get finished here so
we can move on to the next witness.
MR. RUPP: Dr. Glantz, I'd like now to examine
the first report you prepared, the March 1992 report, and to
facilitate that I've had portions of that report blown up
into charts. Basically it's a photographic enlargement so
that whatever appeared in the original paper which is in the
record, appears on this chart.
Again, the first report focused on four
California cities.
MS. SHERMAN: Excuse me a moment, Mr. Rupp.
I
see that one of them says Exhibit A.
(The document referred to was marked for
identification as Exhibit A.)
MS. SHERMAN: Is it labeled such in Dr. Glantz's
report?
MR. RUPP:
(Pause)
MR. RUPP:
Let me figure that out.
Dr. Glantz, can you see that if I put
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T11011-17'03

1
2
3
4
5
6
7
8
9
i0
iI
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
517
it here? -Is that too far away?
MR. GLANTZ: I can see that it's generally a
reproduction of our report. I can't read the numbers from
here.
MR. RUPP: I think it's less important for you
because you will have these in front of you. If you do not,
I will give you a copy.
MR. GLANTZ:
are.
MS. SHERMAN:
Would that be helpful?
It depends on what the questions
I would also like for you to make
available a copy for the record if it is not labeled Exhibit
A in his report, so when somebody reads the transcript we'll
be able to tell what document was being discussed.
MR. RUPP: That's a fair point, and I think the
answer is that they are not labeled. They're labeled here
A, B, C, D, and subsequently, with letters. I don't think
they quite match Dr. Glantz's table numbers in his various
charts. So I will offer these into the record.
MS. SHERMAN: That's what I was afraid of. Do
you have a more realistic size to offer for the record?
MR. RUPP: I also have a smaller size. If you'd
like to compare the two and then accept the smaller size,
that probably is the better thing to do so that you're not
burdened with these large viewgraphs.
MS. SHERMAN: Thank you.
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
Ti1011-1704

1
2
3
4
5
6
7
8
9
I0
ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
518
MR. RUPP: I'll offer those when we're done.
MS. SHERMAN: Thank you.
JUDGE VITTONE: Off the record.
(Discussion held off the record)
JUDGE VITTONE: On the record.
MR. RUPP: I'd first like to understand the
methodology you used in the three models that you utilized
to look at these data. Would you help me with that?
MR. GLANTZ: Yes. We did three analyses.
JUDGE VITTONE: Wait a minute.
Does he have a copy of whatever that is in front
of him right now?
MS. SHERMAN: No, he does not.
JUDGE VITTONE: Can we get him a copy?
(Witness handed documents by Mr. Rupp)
MR. RUPP: Dr. Glantz, I think we do not have to
understand all of the intricacies of this, so I'm going to
describe the methodology as I understand it. I'd like you
to correct me if I have mischaracterized you in any
significant way, the methodology, that is. Would you do
that?
MR. GLANTZ: Okay.
MR. RUPP: My understanding is that what you did
is took the SBE restaurant sales data and utilized multiple
regression econometric models. The model included certain
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
Tl1011-1705

1
2
3
4
5
6
7
8
9
I0
11
12
13
14
15
16
17
18
19
2O
21
22
23
25
the data are, or whether they're hard or good or bad.
519
variables, to explain the changes in restaurant sales over
time, and those variables, as I understand them are year,
for the underlying time trend; quarter for seasonal
adjustments; and a variable to indicate whether or not an
ordinance was in effect at the time. I'm quoting from one
of your publications, I hope accurately.
MR. GLANTZ: Yes.
MR. RUPP: My understanding is that the variables
contained in the models that you used are so-called dummy
variables, also a phrase that you've used in your papers.
~MR. GLANTZ: Some of them were, yes.
MR. RUPP: And they are so called because in a
sense they aren't hard economic data per Se. Rather,
they're variables that can be represented by a zero or a
one, a yes or a no.
MR. GLANTZ: That's not an accurate
representation.
MR. RUPP: Okay, would you explain that, please?
MR. GLANTZ: You use dummy variables or indicator
variables to indicate a dichotomous variable, thatis
something like the ordinance. It either is or is not
present.
MR. RUPP: That's a yes or a no.
MR. GLANTZ: No, it has nothing to do with what
It
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T!1011-1708

1
2
3
4
5
6
7
8
9
i0
ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
520
has to do. with the kind of data that you're measuring.
MR. RUPP: Exactly. I do understand that.
MR. GLANTZ: Time is not entered as a dummy
variable. The presence of the ordinance is.
MR. RUPP: Fair enough.
My understanding is that what you then did is you
looked at or arrayed the data in three different ways in the
original publication.
separate compartments.
MR. GLANTZ:
MR. RUPP:
They're represented here in three
Yes.
First you looked at total restaurant
sales as reported, I was going to say as reported'to the
CBE, but as the CBE was showing the State Board of
Equalization, was showing those data on the books at that
time. Total restaurant sales over the quarters that you
looked at.
MR. GLANTZ: Yes, subject to the corrections we
discussed earlier.
MR. RUPP: Also you look at restaurant sales as a
fraction of total retail sales. Is that correct?
MR. GLANTZ: That's correct.
MR. RUPP: Finally, you looked at restaurant
sales in what you call controlled cities, and compared those
to restaurant sales in the banned cities.
MR. GLANTZ: That's correct.
BAYLEYREPORTING, INC.
(202) 234-7787 (800) 368-8993
Tl1011-1707

1
2
3
4
5
6
7
8
9
I0
ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
521
~.~. RUPP: I know that in an update of your
original study you stopped talking about restaurant sales
directly, and instead, addressed the impact of smoking bans
by limiting your attention to the two ratios that I
described. That is, restaurant sales as a percentage of
total retail sales; and restaurant sales in the banned
cities compared to the control cities, is that correct?
MR. GLANTZ: Yes. Can I explain why we did that?
MR. RUPP: I think I'm going to come to that. I
think I understand it, and you tell me if my understanding
is correct.
MR. GLANTZ: Okay.
MR. RUPP: I take it you abandoned the direct
sales approach because you concluded that the other two
approaches represent a better and more rigorous way and more
appropriate approach for analyzing the impact of restaurant
smoking bans than the direct sales method. Is that
basically correct? And I'm going to suggest an explanation
for why you may have concluded that.
MR. GLANTZ: That's basically correct.
MR. RUPP: The explanation that at least occurs
to me as a possibility is that unlike the direct sales
method, the two ratios permit you to take into account
population growth, inflation, and changes in underlying
conditions in a way that the direct sales method does not.
BAYLEYREPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1708

1
2
3
4
5
6
7
8
9
10
II
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
522
Is that reasonably accurate?
MR. GLANTZ: Can you repeat the three reasons? I
think it is, but I want to be accurate here.
MR. RUPP: Population growth, inflation, and
underlying economic circumstances.
MR. GLANTZ:
statement, yes.
MR. RUPP:
I would say that's an accurate
Let's look at a couple of pieces of
data from this chart, and this is Exhibit A. It depicts the
results of all three of the approaches to the original data,
and the regression analyses for each of the cities you
examined. Because this does look like a little bit of a
jumble, let's focus on a single city, and let's take
Bellflower.
MR. GLANTZ:
MR. RUPP:
Okay.
First what you've done is you've taken
a mean quarterly failed, that is the figure marked as
$9,723,000. Three zeros have been dropped here.
MS. JANES: Yes. That's correct.
MR. RUPP: And those are sales figures averaged
over the 22 quarters for which you had data.
MR. GLANTZ: Yes.
MR. RUPP: Then you showed whether the imposition
of a smoking ban had a positive, negative, or indeterminate
effect on restaurant sales, and as I understand it, that is
BAYLEYREPORTING, INC.
(202) 234-7787 (800) 368-8993
T!1011-1709

1
2
3
4
5
6
7
8
9
I0
ll
12
13
14
15
16
17
18
19
20
21
22
23
24
25
523
the column that's labeled BL, is that correct?
MR. GLANTZ: Yes, Beta L. Right.
MR. RUPP: Bellflower shows a negative value here
of $1,103,000, and that figure suggests the presence of a
smoking ban was accompanied by a reduction in retail sales,
if that's the only figure you looked at. Correct?
MR. GLANTZ: That's a misleading and
irresponsible statement, because the next number, the
standard air, the $811,000 is something that you have to
take into account when assessing the first number.
MR. RUPP: Right. We'll get along so much better
if you can just answer the question. I said if you look at
that figure alone, which would suggest that I was not going
to look at it alone, you wouldn't have characterized it as
irresponsible, would you?
MR. GLANTZ: Well, if you just looked...
MR. RUPP: Listen to the question that I ask and
respond to it. All right?
If you look at this figure alone, it suggests
that the ban had a negative impact on the sales, does it
not?
MR. GLANTZ: If that's allyou looked at, yes.
JUDGE VITTONE: Mr. Rupp, I don't want to
interrupt, but when you say "the figure" I don't think
the...
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T!1011-1710

1
2
3
4
5
7
8
9
i0
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
524
MR. RUPP: I'm sorry. I stand corrected.
The $1,103,000, standing alone suggests a decline
in restaurant sales as a function of the ban in Bellflower,
is that correct?
MR. GLANTZ:
MR. RUPP:
Yes.
In Beverly Hills, the positive value
suggests that the presence of a smoking ban was accompanied
by an increase in retail sales, is that correct?
MR. GLANTZ: Yes.
MR. RUPP: This figure, which starting with the
base of $25 million some odd dollars, appears to increase by
$2 million and the first (inaudible) is $1800. So it
suggests standing alone an increase.
MR. GLANTZ: If you ignore the standard air...
MR. RUPP: If you ignore the standard air.
MR. GLANTZ: All right.
MR. RUPP: When you studied restaurant sales
initially, as a fraction of total retail sales in the
smoking city, the R-squared numbers fall quite decidedly,
relative to the results that you got when you studied direct
restaurant sales, did they not?
MR. GLANTZ: I didn't understand the question.
MR. RUPP: I'm not focusing on the R-squared
column, which is the column, as I understand it, that in
statistical terms describes for us the degree of explanatory
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1711

1
2
3
4
5
6
7
8
'9
I0
ii~
12
13
14
15
16
17
18
19
20
21
22
23
24
25
power, the variables built into the model has proven to
have. So that the higher the number the closer it is to
one, the more explanatory the model appears to have
according to the R-squared figure.
way?
525
MR. GLANTZ: That's not... Well...
MR. RUPP: Would you like to explain that another
MR. GLANTZ: Go ahead.
MR. RUPP: My point here is, and I'm not making a
qualitative judgment about whether leads are unacceptable or
acceptable in scientific terms. I'm just saying they're
getting lower as you move from model one which yoE projected
perhaps for the reasons you described earlier, to model two,
which is a fraction of the total retail sales, to model
three, which is comparison of control cities and banned
cities. The explanatory powers of the models appear,
according to the R-squared numbers, to be decreasing.
The R-squared depends on another thing. That is,
it depends on the variance in the observations that are
going into the computation, so the R-square isn't just the
explanatory power of the variables. It also depends on the
magnitudes of the numbers. That's why you look at an
associated P value.
MR. GLANTZ: Of course.
The other thing which is important in terms of
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T!1011-1712

1
2
3
4
5
6
7
8
9
i0
ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
526
this line-of questioning, is that if in fact the model is
not predictive of change, which is essentially the
conclusion we drew here, a negative conclusion, then you
would expect the R-square numbers to be small in fact. The
fact that the R-square numbers are larger for the total
sales than the other one is because the time is a very
important variable because of inflation and the other issues
that you mentioned, and that sort of artificially inflates
the R-squared. That's one of the criticisms that several
people made, including some of my colleagues, of using the
total sales data, which is why we, in those subsequent
studies, use the other approaches which you mentioned.
MR. RUPP: There's another problem, is there not,
or another series of problems, is there not, in connection
with the use of control and banned cities that may explain
the apparent loss of explanatory power in the model, and
that is that the third of these models depends very greatly
on comparability and demographic characteristics in terms of
age and mix of population, extent of education, income
level, commuter patterns, prevalence of smoking, number and
mix of restaurants in the ban and the control cities. That
is if you lose comparability there, if you're comparing
apples and oranges, one would intuitively expect that your
model wouldn't perform all that well. Isn't that correct?
MR. GLANTZ: Yes, that's why we, in the final
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T11011-1713

1
2
3
4
5
6
7
8
9
i0
II
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
527
publication that appeared in the American Journal of Public
Health, if you compare the control cities we used in the
original study, the one you're exhibiting here, and the
final work we published, some of them were changed because
people did raise that as an issue, and we put a lot more
effort into trying to match the cities.
MR. RUPP: But that's an extremely difficult
task, I would say.
MR. GLANTZ: If you look in the appropriate table
in the American Journal of Public Health paper, I think we
ended up with pretty good matches. It's getting harder as
more cities pass ordinances, we're kind of running out of
control cities, but that didn't affect the work that we
published in the American Journal of Public Health.
MR. RUPP: Have you ever compared the results ....
MS. SHERMAN: Excuse me, Your Honor. Could we
have a one minute recess? Apparently they're losing the
recordability on the microphone, and they'd like to adjust
JUDGE VITTONE: Can we do this in place, instead
of everybody leaving?
(Pause)
JUDGE VITTONE: Back on the record, please.
MR. RUPP: Thank you, Your Honor.
Let's focus for a moment on the significance of
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T!1011-1714

1
2
3
4
5
6
7
8
9
I0
Ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
528
using restaurant sales as a percentage of total retail
sales, see how good that is and what the theory is being the
notion. Again, to save time, let me tell you what my
understanding is and you tell me if my understanding is
basically correct. The premises that are motivating you to
use that approach.
Isn't it true that with or without a smoking ban,
restaurant sales could change because the population might
increase or there might be a recession?
MR. GLANTZ: Yes.
MR. RUPP: If the population grew, you'd expect
an increase in restaurant sales, would you not?
MR. GLANTZ: Yes, probably.
MR. RUPP: And if there were a recession, you'd
expect a decrease in restaurant sales. Correct?
MR. GLANTZ: In total sales? Yes.
MR. RUPP: So in the case of a change in
population and economic conditions, restaurant sales and
total retail sales should rise or fall roughly together,
should they not? That was the premise, and the only reason
one would try to relate this.
MR. GLANTZ: Yes.
MR. RUPP: And you expected, did you not, that
there would be a reasonably stable relationship as you
utilize what we'll call model two, a reasonably stable
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1715

1
2
3
4
5
6
7
8
9
10
ll
12
13
14
15
16
17
18
19
20
21
22
23
24
529
relationship between total restaurant sales and total retail
sales.
MR. GLANTZ: That's what we found when we
analyzed the time period before the ordinances. One of the
reasons we went back for at least five years before the
ordinances passed to get our baseline was to estimate that,
one of the reasons, was to estimate that affect and the
underlying variability.
MR. RUPP: Now I'm going to show you a second
chart. Dr. Glantz, my friends at Price Waterhouse, what
they've done for me here is they have arrayed the sales
data, restaurant sales data and retail sales data for the
city of Bellflower, California from 1986 through 1990 and
that covers a period before the smoking ban was in effect.
MR. GLANTZ: Yes.
MR. RUPP: This chart shows the percentage change
in Bellflower restaurant sales from quarter to quarter over
time, and also the same things for Bellflower, total retail
sales, right?
MR. GLANTZ: That's correct.
MR. RUPP: It comes from your data, it's
presented in Table I, A-I of your original report.
The problem I have with this as I look at it , is
I do not see the expected stable or steady relationship.
indeed, very often, restaurant sales go up when retail sales
BAYLEYREPORTING, INC.
(202) 234-7787 (800) 368-8993
T!1011-1716

!
2
3
4
5
6
7
8
9
i0
ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
530
go down, and I'll give you a specific example of what I'm
talking about.
If you look, for example, at the first quarter of
1989, restaurant sales in Bellflower, before the ban, fell
by seven percent, while retail sales rose by 15.9 percent,
so we found ourselves with a gap of 22 percent.
MR. GLANTZ: Yes, but Mr. Rupp, if you look at
Exhibit B, you'll see that's very unusual.
(The document referred to was marked for
identification as Exhibit B.)
MR. GLANTZ: In most cases they do track pretty
well. And my guess is that if you were to comput~ the
cross-correlation function over time of these two graphs
that you presented, it would show reasonable concordance
over time. You're really selecting,, obviously you've just
presented this to me, but you've really selected the one and
only point... Pardon me, there's one other point where
there's a discordance, and that's the third quarter of 1993.
All the rest of them tend to move together.
MR. RUPP: Let me suggest to you, I'll accept
what you've said insofar as I have, for illustrative
purposes to begin, chosen one quarter that shows the largest
swing, and that is a 22-23 percent swing. But do we need to
go through some of the other swings to say that they are
quite substantial? Ten, 12, 15 percent is not uncommon for
BAILEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1717

!
2
3
4
5
6
7
8
9
l0
ii
12
13
14
15
16
17
18
19
20
22
23
24
25
531
a swing between restaurant and retail sales from quarter to
quarter?
MR. GLANTZ: The real issue is are these things
cross-correlated over time. The other issue which is
important in this, which isn't really seen in a graph like
this, is what the standard error of that variability it,
which decreases ad the number of data points increases.
That's what determines the ultimate sensitivity of your
study.
MR. RUPP: Is it possible, Dr. Glantz, that this
absence of a systematic relationship, what I believe to be a
systematic relationship, or you can characterize it somewhat
differently, but the absence of a, let's say total
relationship, may be a partial explanation for the loss of
explanatory power, your R-squares are s~owing as you move
from model one to model two.
MR. GLANTZ: I don't agree with that. I don't
agree with your characterization of the data, and I don't
agree with the conclusion you drew based on that
characterization.
MR. RUPP:
MR. GLANTZ:
In what respects do you disagree?
The first way I disagree, as I
mentioned, when you're looking at a relationship between two
variables over time, you want to look at the cross-
correlation between the two variables. The thing that's
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1718

1
2
3
4
5
6
7
8
9
l0
ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
532
important-in terms of our model is that averaged over time,
the standard error of the variation remain reasonably small.
The second thing is that the lower value of the
R-squared that was observed was, I think, largely due to the
fact that the underlying inflation and population growth
variables which you've talked about earlier, are essentially
taken out when you compute the fraction of retail sales to
the ratio of the comparison cities. So if you look at the
individual coefficients in the regression model, which we
didn't include here, the most that R-squared is attributed
to time, in what you're calling model one. The reason 'for
that, and in fact the reason that we stopped using the total
sales in the subsequent studies, including the one I
testified to today which is our current best study, was
because the time variable, because of all the problems with
the time variable that you have alluded to yourself. Many
people suggested that we abandon that variable.
So I'd have to go back and look at the actual
statistics, but my guess is the big difference between the
R-squareds in the three models has to do with taking out the
time worth with the explanatory variances associated with
the time variable because you have, by using fraction of
total retail sales, to some extent normalized for population
growth, underlying economic conditions, and inflation.
MR. RUPP: Here's the problem I have with that
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
Ti1011-1719

1
2
3
4
5
6
7
8
9
i0
ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
533
explanation. That would be all very good, I will argue, and
you tell me why I would argue this in vain, if the bans that
we're talking about existed over long periods of time.
We're looking at Bellflower here.
MR. GLANTZ: Yes.
MR. RUPP: But if you look at Beverly Hills, you
had a ban that was in effect for three and a half months.
If you look at a number of other cities that are included in
the various models that you performed, you also have short
periods of time. So that a correlation over a five, six,
seven year period that might give you a high correlation
figure if you were to look at that, is pretty irrelevant, is
it not? Because what's significant is the extent to which,
without regard to anything happening with respect to
smoking, within the pertinent time period, restaurant sales
and total retail sales were tracking one another. And when
you're looking at shifts of this sort, we looked at one of
22 percent, you've got a model that can't possibly do all
that goo9 a job, giving you a snapshot over any constricted
period of time, at what truly is going on. Where is that
wrong?
MR. GLANTZ: That'swhy we did the subsequent
studies which collected a lot more data.
MR. RUPP: We'll come to some of those data too.
Let's continue, then, to look at Bellflower. Let
BAYLEYREPORTING, INC.
(202) 234-7787 (800) 368-8993
Tl1011-1720

1
2
3
4
5
6
7
8
9
I0
II
12
13
14
15
16
17
18
19
20
21
22
23
24
25
534
me ask you to focus on another aspect of the Bellflower
data. Do you know the extent to which the total retail
sales data in Bellflower reflect new automobile sales?
MR. GLANTZ: I'm aware from Bob Rossi that there
are significant automobile dealerships in Bellflower.
MR. RUPP: It's an automobile dealer mecca, is it
not?
MR. GLANTZ: If you say so. I've never...
MR. RUPP: Would you be surprised to learn that
between 35 and 40 percent of total retail sales in
Bellflower, in any given quarter, will be new automobile
sales?
MR~ GLANTZ: I can't testify to that one way or
the other.
MR. RUPP: Would you expect restaurant sales in
Bellflower to track automobile sales with all that much
closeness? I hate to use the layman's term, but...
MR. GLANTZ: To the extent that automobile sales
reflect the underlying economic conditions in the region,
which is an important variable, especially in California,
they'd be related. That may be what accounts for those two
points which you've identified where there's the high level
of discordance.
MR. RUPP: Let me show you yet another chart, and
this is the last of the new charts that I'll show you.
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T11011-1721

1
2
3
4
5
6
7
8
9
i0
II
12
13
14
15
16
17
18
19
20
21
22
23
24
25
535
Let me characterize this first, if I may, and
then I'll give it to you and ask you whether you have any
problem with that characterization.
What i'm going to show you is a chart from Price
Waterhouse that shows me for Bellflower during the period
for which you've depicted data, total retail sales minus
automobile sales, new car sales, and that line is wiggles up
and down a little bit, but it's generally flat. And then I
look at automobile sales alone during that period, and what
I have are tremendous peaks and valleys showing that where
you have a recession, automobile sales go very badly, while
general retail sales don't necessarily reflect anything like
the same kind of dip.
(pause)
MR. GLANTZ:
question.
If I can just ask a clarifying
MR. RUPP: You sure dan.
MR. GLANTZ: The index for auto dealers, what
does that mean?
MR. RUPP: Maybe I could prevail upon one of my
colleagues to answer that question. On the basis of i00
percent for the first period...
MR. GLANTZ: I didn't hear the answer.
MR. RUPP: On the basis of i00 percent. Oh,
excuse me, I now understand. Those figures are indexed.
BAYLEYREPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1722

1
2
3
4
5
6
7
8
9
i0
II
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
536
Those are-indexed with I00 percent being the starting
period, then we're talking about percentage changes month to
month. It was believed by us to be a way of showing changes
from month to mont that would reveal exactly what was going
on. So the i00 on the left hand side is not $I00 million or
$i00 thousand, it's an index of $i00.
MR. GLANTZ: Is that number based on the average
over the period of interest, or is it simply the first
quarter of 1991?
MR. RUPP: The first quarter of 1991. We start
where we had the data to start, and we indexed from that
point on.
The question I have for you on the basis of
that...
MS. SHERMAN: Just a minute, Mr. Rupp. Do you
have a large chart so that we can...
MR. RUPP: No, unfortunately, I do not.
worked this one up.
MS. SHERMAN:
are talking about.
MR.~RUPP:
apologize for this.
any possibility of your sitting with him for a moment?
will avoid this in the future, you can be sure.
(Pause)
We just
So we can't see what the two of you
That is a problem. I really do
It is the only one we have. Is there
We
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1723

1
2
3
4
5
6
7
8
9
I0
ii
12
13
14
15
16
17
18
19
20
21
22
23
24
25
537
My thanks to Ms. Sherman for being so
cooperative.
The question I have for you on the basis of that
chart, and some of the other discussion we've had is really
a relatively simply one. Does not that chart indicate quite
clearly that there's something conceptually quite wrong
about your second, or misconceived about the second model
and the one you've chosen to rely on, and the misconception
is in this. Doesn't that reveal that we are trying to
compare here apples and oranges. The factors that influence
general retail sales are not necessarily at all the same
factors that will affect restaurant sales, or to take a sub-
part of that general question, the factors that influence
automobile sales are not even the same factors that
influence general retail sales in any given locality.
MR. GLANTZ: I don't think this graph necessarily
supports that statement.
MR. RUPP: It's not an unreasonable view of the
state of facts though, is it?
MR. GLANTZ: I don't really care to have you put
words in my mouth. If you go consult with the people who
come see me about statistics at UCSF, I will tell them one
problem with using percentages is that basically all these
numbers are heavily influenced by one point. And if there
was something strange going on in the first quarter of 1991,
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T!1011-1724

5
6
7
8
9
i0
ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
538
that could heavily affect the results here.
So I really can't reach any conclusions based on
this. If you wish to, that's your prerogative, obviously.
MR. RUPP: Okay, I appreciate that.
MR. GLANTZ: But this graph is heavily
conditioned on one number or two numbers.
MR. RUPP: We'll have to be gentlemen and agree
to disagree about that, won't we?
MR. GLANTZ: Okay.
MR. RUPP: Let me move on. Let's look now at the
percentage changes in Bellflower restaurant and retail sales
as we go from the 3rd quarter of 1989 to the 4th quarter of
1989.
MS. SHERMAN: Which chart are we on?
MR. RUPP: Exhibit C.
(The document referred to was marked for
identification as Exhibit C.)
Let's look at Exhibit C.
JUDGE VITTONE: Do you have another one for Dr.
Glantz?
MR. RUPP: Yes, we do.
JUDGE VITTONE: It's getting close to 5:00
o'clock here. I can tell.
What you'll see there, Dr. Glantz, as we look at
the data, is that restaurant sales rose from $I0 million to
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1725

1
2
3
4
5
6
7
8
9
i0
II
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
539
$Ii million during that quarter, while total retail sales
fell from 87 to 82 million dollars. So restaurant sales
rose 12 percent while retail sales rose by 5.9 percent,
about an 18 percent swing in that quarter.
MR. GLANTZ: I don't see...
MR. RUPP: I'm asking you to look at the third
quarter 1989 to the fourth quarter of 1989. I know this is
a period well before the ban...
Mr. Rupp.
MS. SHERMAN:
MR. GLANTZ:
I think you have the wrong chart,
The chart that you've given me only
has one line on it.
retail sales.
MS. SHERMAN:
1989 on it.
MR. RUPP:
talking about B.
There's nothing in here about total
There's nothing in here that says
So the record is clear, we're still
MR. GLANTZ: I thought you were talking about C.
I'm not very good with pictures, I guess.
MR. RUPP: Just so it's clear, and I know you
were searching for the right numbers when I was asking the
question, so let me ask the question again. I'm going to
ask you to look at the third quarter of 1989 to change to
the fourth quarter of 1989. Restaurant sales rose from i0
million...
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T!1011-1726

1
2
3
4
5
6
7
8
9
10
ii
12
13
14
15
16
17
18
19
20
21
22
23
24
25
54O
MR. GLANTZ: Wait, wait. Slow down. Which do
you want me to look at?
MR. RUPP: Third quarter '89 to fourth quarter.
Restaurant sales rose there from $i0 to $ii
million, while total retail sales fell from $87 million to
$82 million, I'm rounding off.
MR. GLANTZ: The graph, Exhibit B, doesn't have
that information on it.
MR. RUPP: No, it has to be computed, as a matter
of fact, but what that computation shows is restaurant sales
rose by 12 percent during that quarter while retail sales
fell by 5.9 percent, whatever the reason.
The observation I'm making, and I 'd ask you
whether you have any problem with it, is that you can get
very substantial quarter to quarter shifts in these figures
that can be for a whole host of reasons, can you not?
MR. GLANTZ: That's the issue that we were
discussing previously. My guess would be, just looking on
this, it's just cooperation. Obviously you just put this in
front of me and I can't do statistics in my head.
MR. RUPP:
(Pause)
MR. RUPP:
Give me just a second, if you will.
Assume with me, because I'm not going
to sit there and ask you to do the calculations either in
your head or with a calculator.
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
Ti1011-1727

1
2
3
4
5
6
7
8
9
I0
iI
12
13
14
15
16
17
18
19
20
21
22
23
24
25
541
MR. GLANTZ: Thank you.
MR. RUPP: But assume we have the 18 percent gap
during that are from random fluctuations or some other
reason. And assume that you had a restaurant smoking ban
that was in imposed in the city of Bellflower at that
point, immediately following the 18 percent gap. Just like
Rosemarie Woods' 18 minute gap, okay?
MR. GLANTZ: Right.
MR. RUPP: You have the 18 percent gap. Let's
assume that the imposition of the ban caused an 18 percent
drop in restaurant sales immediately, reflected in sales
throughout the quarter.
Under your second model, you would show no
change. That is, you would show that the ban had had no
adverse impact because its effect was simply to bring
restaurant sales back down into line with retail sales that
had obviously dropped for some other reason, having nothing
to do with smoking. Is that not correct?
MR. GLANTZ: No, that's not a really accurate
representation of the way the model works.
MR. RUPP: You explain how it does work, then.
MR. GLANTZ: For many of the reasons that you've
been discussing, it's very, very difficult, I think, in fact
I think impossible, to look at quarter to quarter changes.
That's why we've looked at the data over a long period of
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1728

5
6
7
8
9
i0
Ii
12
13
14
15
16
17
18
19
20
21
22
23
24
25
542
time. WeJre looking for a net average in the effect of the
ordinance. So we don't look at one quarter, we look at
several quarters that the ordnance was in force. That's why
it's your prerogative to ask these questions, but the study
I testified to was the American Journal of Public Health
version of this, which was based on much more data than
we're discussing here, and we're really focusing in on
simply one city rather than all 15 of them.
MR. RUPP: I'm simply trying to understand how
the model works.
MR. GLANTZ: The important distinction between
your understanding and what we actually did is that the
model doesn't look at one quarter or another quarter. It
looks at the period when the ordinance was in force, however
long that was, and the period where it wasn't in force. It
asks the question, on the average, was there a change above
the underlying variability.
MR. RUPP: But that's interesting, Dr. Glantz,
because .in your testimony this morning as well as in your
printed statement, you reached some fairly firm conclusions
about the impact of the ban in Beverly Hills, California.
How long was that ban in effect?
MS. JANES: That ban was only in force for about
a quarter and a half.
MR. RUPP: Three and a half months.
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T!1011-1729

1
2
3
4
5
6
7
8
9
i0
Ii
12
13
14
15
16
17
18
19
20
21
22
23
24
25
543
MR. GLANTZ: It slopped into two reporting
periods. But if Beverly Hills had been all that we had,
then I wouldn't be saying any of these things. But we
actually were asked by the reviewers of the AJPH paper to
exclusively test the hypothesis that there was a 30 percent
drop, and we were able to reject that at the .001 level,
despite the fact that for Beverly Hills there was very, very
limited data.
MR. RUPP: What you've just told me though is
that, and I'm quoting, and it can be read back by the
reporter if you have any doubts, that it is impossible to
look at one quarter. One cannot reach conclusions on the ba
sis of one quarter's data. I would have expected you to say
that, and the reasons are these.
MR. GLANTZ: You would or wouldn't have?
MR. RUPP: Would have expected you to say that.
And the reasons are these. All of those reasons we
discussed at the beginning. The problems of the State Board
of Equalization figures, the bar and restaurant lumping
problem, the late and early filing problem. And while those
may ease out over time, or may not, looking at data in a
single quarter is a highly suspect approach, is it not?
MR. GLANTZ: That's why we didn't look... If the
only data we had had would have been Beverly Hills, we would
have never published anything. But...
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1730

2
3
4
5
6
7
8
9
l0
ll
12
13
15
16
17
18
19
2O
21
22
23
24
25
544
MR. RUPP: Very specific claims were being made
of a 30 percent drop in Beverly Hills. I showed a Tobacco
Institute ad making that claim. Despite the low power
associated with only having two data points, and the dummy
variables are coded to account for part of the quarter being
covered, we were still able to at the .001 level, reject the
hypothesis of no change.
IN addition, ~as I testified to, in the AJPH
analysis, which was the final version of this that
benefitted from a great deal of suggestions from people, we
could have detected with 80 percent power, about half a
percent change on average.
So this is very much like the comments I was
making about the epidemiology. It's very important to look
at all the data.
Now we can sit here and talk about Bellflower.
Obviously you're...
MR. RUPP: We're now talking about Beverly Hills.
MR. GLANTZ: Or Beverly Hills as long as you
want. But you need to really look at all the cities. I
would not have published a paper on just Beverly Hills.
MR. RUPP: It was originally published on four
cities, was it not?
MR. GLANTZ: That was all the data that was
available.
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1731

1
2
3
4
5
6
7
8
9
I0
ll
12
13
14
15
17
18
19
20
21
22
23
24
25
545
MR. RUPP: Why, in light of the statements that
you've made, did you just not eliminate Beverly Hills from
your computation?
MR. GLANTZ: Because we didn't want to be
accused of being selective in the data. We reported all of
the cities that were available.
MR. RUPP: When you say you could conclude with a
high degree of certainty that there was no drop, you are
ignoring, are you now, the lumping of bar and restaurant
sales, and the reporting and data problems that we discussed
at such great and laborious length at the beginning of our
discussion.
MR. GLANTZ: I don't think that's an accurate
characterization. If you read our AJPH paper and many of
the other things, we are cognizant of that as a limitation
in the study. All studies have some sort of limitations.
But if you go back and look at the slide which I prevented
for Beverly Hills, you'll see that the points for the
quarters that the ordinances -- when I say quarters, I'm
talking about calendar quarters -- were in force, pretty
much fell on the line, established by the underlying secular
trend.
For any of the alternative explanations that
you're proposing to explain our results to be true, there
would have had to have been, for example, a huge shift in
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
Ti1011-1732

1
2
3
4
5
6
7
8
9
I0
Ii
12
13
14
15
16
17
18
19
20
21
22
23
24
25
546
how much people were drinking. Or alternatively, one
hypothesis that was advanced was that people suddenly
started understating their taxes. That was one other
alternative that was suggested.
MR. RUPP: Another possibility is that people
were having a shorter or smaller lunch in the bar area of
the restaurant which had been expanded. Is that a
possibility as well? It was under the law an option
available to restauranteurs and...
MR. GLANTZ: I don't know if people did that or
not. I can tell you that the owner of Jacopos who is the
restauranteur who is the nominal head of the Beverly Hills
Restaurant Association, has written a letter to the New York
City Council saying that the claim of the drop was
fabricated, and he actually was smoke-free now, and
regretted having anything to do with it.
I'm aware of any affirmative evidence to support
the assertions that you're making.
MR. RUPP: I'm not making assertions, I'm asking
questions.
Let me ask you to look at Exhibit C, would you do
that for me?
MR. GLANTZ:
MR. RUPP:
Okay.
I'm going to move away from the
percentage stuff and we're going to look at restaurant sales
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1733

1
2
3
4
5
6
7
8
9
I0
ll
12
13
14
15
16
17
18
19
20
21
22
23
24
25
547
directly.- This chart shows Bellflower restaurant sales as
reported by the SBE from the first quarter of 1986 through
the third quarter of 1993. As you state in your reports,
Bellflower imposed a 100 percent ban on smoking in
restaurants, but not in bars, in March of 1991. That is at
the end of the first quarter of 1991.
MR. GLANTZ: Okay.
MR. RUPP: The city repealed the ban in March of
1992 or the first quarter of 1992, isn't that correct?
MR. GLANTZ: March would actually, yes, March is
in the first quarter of '92 still, yes.
MR. RUPP: When I look at Exhibit C, and I've
marked here, focusing on overall sales within restaurants,
what I'm finding is when the ban was introduced it was
accompanied by a very substantial loss of sales, sales
continued at a low level when the first quarter in which the
ordinance was repealed, you have a very substantial upward
move, and now we're focusing only on Bellflower, I
understand that, and I'm not suggesting that the same
happened elsewhere, it may or may not.
Isn't this consistent with, and tend to show, a
very substantial fall-off in sales with the imposition of a
no-smoking law, even one that did not ban smoking in the bar
area of restaurants and a very substantial increase in sales
when the ban was taken away?
BAYLEYREPORTING, INC.
(202) 234-7787 (800) 368-8993
Ti1011-1734

1
2
3
4
5
6
7
8
9
i0
ii
12
13
14
15
16
17
18
19
20
21
22
23
24
25
548
MR. GLANTZ: No. The reason for that is if you
look after your second arrow, you'll notice that the sales
continued to drop quite substantially after the ordinance
was repealed, and if you look back to like the second
quarter of 1987, third quarter of '87, you see similar big
drops. So the change which you're pointing to between your
two arrows could very well be simply underlying random
variation or underlying economic conditions, because you can
take this graph that you've put forward -- I wouldn't do
this, but you could take the graph you've put forward and
argue that repealing the ordinance made sales go down
because the third quarter 1993 data is lower than ~he period
the ordinance was in force. I wouldn't draw that...
MR. RUPP: It's a very odd coincidence though, is
it not? Here's another way of depicting the same data.
This depicts Bellflower restaurant sales, change in sales,
one quarter to the other, modeling them against the prior
quarter in the...
MS. SHERMAN: Mr. Rupp, do you have a copy of
that exhibit that you're asking Professor Glantz to comment
on?
MR. RUPP: Excuse me?
MS. SHERMAN: Have you a copy of...
(Pause)
MR. RUPP: What this would tend to do, I take it,
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
Tl1011-1735

1
2
3
4
5
6
7
8
9
i0
ii
12
13
14
15
16
17
18
19
20
21
22
23
24
25
549
is ease out any problems that were simply a function of
seasonality in the restaurant business, because now we're
comparing like quarter with like quarter.
MR. GLANTZ: It would deal with some of the
seasonality. There are many other of the important issues
that you raised aren't handled with this kind of a
correction.
MR. RUPP: Yes, and Ms. Sherman reminds me that I
should identify this again as Exhibit D.
(The document referred to was marked for
identification as Exhibit D.)
MR. GLANTZ: Yes.
MR. RUPP: Maybe this is a coincidence, maybe
it's not, but what you find here is during the period the
restaurant smoking ban was in effect, but not a ban in
smoking in bars, what you found in the. city of Bellflower
was a very significant decrease in sales overall. From one
quarter to... When one compares the ban year against the
non-ban year, or the ban quarter against the comparable non-
ban quarter of the preceding year. Do you not?
MR. GLANTZ: Of course, Mr. Rupp, you can draw
whatever conclusions you want from this. I would not...
Again, you're presenting me with these data. I don't have
time to do a formal analysis. But looking at this graph,
and based on our analysis, this could very well be a
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T!1011-1736

1
2
3
4
5
6
7
8
9
I0
ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
55O
reflection of underlying variability. I think you could use
these same data to make the following. I wouldn't do this
again, but I think you could argue that repealing the
ordinance was bad for business because in two of the
subsequent quarters to repealing it, you had even bigger
drops in business.
The other thing that's important to realize is
that in the period in question, the California economy was
in the tank. I know that very well, because my salary got
cut because of it at the university. And this may well be
reflecting the underlying economic problems of California.
MR. RUPP: And it was certainly reflected in the
automobile sales during those...
MR. GLANTZ: It's hard to read, but if you look
at the 1987 second, third, and fourth quarters, you see
comparable drops.
MR. RUPP: Absolutely.
MR. GLANTZ: So my looking at this would say the
theory that you advance is one theory one could advance.
It's not clear to me that the changes you're observing here
are more than the underlying variability.
MR. RUPP: But it's an interesting coincidence,
is it not?
MR. GLANTZ: Yes, there are many coincidences.
MR. RUPP: There are, indeed.
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T11011-1737

1
2
3
4
5
6
7
8
9
i0
ll
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
551
Let me ask, and we're almost near the end, you'll
be happy to know that.
MR. GLANTZ:
MR. RUPP:
I'm okay.
Let me ask you to look at these
exhibits, and again, there are a great many numbers, and...
MR. GLANTZ:
MS. SHERMAN:
read that, Mr. Rupp.
That I cannot read from here.
There's no way that anybody can
look at.
can see.
MR. RUPP: There are only two numbers we have to
These are charts from your papers.
MR. GLANTZ: This is correct. At least the one I
MR. RUPP: I think you'll see that the next one
is as well. Ad I've labeled these for the record Exhibit
E(1) and Exhibit F(2) for reasons that will be obvious to
know.
(The documents referred to were marked for
identification as Exhibit E(1) and F(2).)
MR. GLANTZ: Yes.
MR. RUPP: Exhibit E(1) and Exhibit F(2), and I'm
going to refer first to Exhibit E(1).
I'd ask you to focus on Beverly Hills, and the
number 21651. That, I take it, shows total bar and
restaurant sales in Beverly Hills during the first quarter
of 1987.
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
Tl1011-1738

1
2
3
4
5
6
7
8
9
i0
II
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
552
I take it that that figure is designed to be a
summation of these three figures from Exhibit F(2). 1748,
5234, and 18165. Are they not? Is that correct?
MR. GLANTZ: Exhibit F(1) doesn't have Beverly
Hills on it.
MR. RUPP: Excuse me, I'm asking you to compare
E(1) with F(2).
MR. GLANTZ: I don't have F(2).
(Pause)
MR. GLANTZ: I have E(1) and F(1) right now.
MS. SHERMAN: Here's E(2) and F(2).
(Pause)
MR~ RUPP: E(1) and F(2).
MR. GLANTZ: Okay, that makes sense.
MS. SHERMAN: I thought you had given me two
complete sets, and you didn't.
MR. RUPP: I thought I did, too.
JUDGE VITTONE: Do you want to sit here?
MR. RUPP: If you'll do that one more time, I
promise you we are very near the end of this.
Dr. Glantz, again, my question is this. This
21651 figure is supposed to b~ a summation from Exhibit
E(1), a summation of the three figures on Exhibit F(2) of
1748, 5234, and 18165. Is that not correct?
MR. GLANTZ: If it's not, it's another
BAYLEYREPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1739

!
2
3
4
5
6
7
8
9
I0
II
12
13
14
15
16
17
18
19
20
21
22
23
24
25
553
typographical error. I can testify that the sum that was
used in the analysis is correct.
MR. RUPP: I think the sum that you used in the
analysis was 21651, while the correct figure, as we compute
it, is 25147. The reason this is significant, of course, is
that this is the quarter in Beverly Hills immediately
preceding the ban.
MS. SHERMAN: Mr. Rupp, the figures will add...
MR. RUPP: No.
MS. SHERMAN: ...as they'll add.
MR. GLANTZ: This is an important point. This is
a testament to the fact that I don't proofread.
The way we did this, and this is very important,
was at least in these three, the three sub-numbers which are
on F(2) were entered into the computer and then the computer
was told to add the numbers up, and the computer sum is the
number that was used in the statistical analysis.
Now if in the process, so that the number that we
have in the statistical analysis was actually the sum of
these numbers. Now whether the 21651 number is a typo or
one of these other three numbers has an error in it, that I
can't tell you. But I can tell you that the number which
was used in the analysis, these things did add up the way
they were supposed to because we used a computer to do the
addition. Unfortunately, we didn't have a way to print that
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1740

2
3
4
5
6
7
8
9
I0
II
12
13
14
15
16
17
18
19
20
21
22
23
24
25
554
Out in a way that we could reproduce, so all these numbers
had to be manually typed in.
This is an embarrassing point that we didn't
proofread these numbers.
MR. RUPP: Let me look at another, and I don't
mean to embarrass you, but I'm trying to make points of
significance. Embarrassment is not one of them.
MR. GLANTZ: I don't see this as a significant
issue.
MR. RUPP: All right.
Let me ask yoU to look at the number that I'm
going to point to now at the bottom of E(1). The number is
21673. Would you tell me whether that number is correct?
To do so, you'd have to look at Exhibit F(2).
MR. GLANTZ: The only way to answer whether that
number is correct, I can't do that here. It's to go back to
the raw data files and cross check the numbers that are in
there with the numbers that are printed here, and I can
submit that in a post-hearing...
MR. RUPP: One or the other is wrong, isn't that
obvious?
MR. GLANTZ: There was a typo on one of those two
numbers. But the important point, and I really want to
stress this, we did not take the numbers off these pages for
the actual statistical analysis. Those were in the
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1741

1
2
3
4
5
6
7
8
9
I0
ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
555
computer,-were very, very carefully checked, and we printed
them out on a line printer and had a secretary copy them.
We thought we had caught all the typos.
MR. RUPP: There, undoubtedly, Dr. Glantz, will
be a good deal more discussion about the economic impact of
a possible smoking ban in restaurants or various kinds of
restrictions, and you will have opportunities to weigh in on
that debate, as will others.
Let me ask two concluding questions and try to
draw you out in your thoughts. The first is this.
Given the cities that you've looked at which are
three ski resorts in Colorado and a number of the cities in
California, do you believe that it's possible to generalize
those results so far as the impact of smoking bans,
including smoking bans that are complete restrictions, that
is bans both in the restaurant area as well as the bar area,
both within California and Colorado and to the rest of the
country? That is, do you believe you've seen enough, it's
just really quite clear. If OSHAdecides to ban smoking in
restaurants, there will not be a single customer.who will
refuse to go into restaurants, smoking customer who will
refuse to go into restaurants at that point. Is that the
position you're taking?
MR. GLANTZ: You've made several statements that
I don't necessarily agree with. In particular, that not a
BAYLEY REPORTING, INC.
(202} 234-7787 (800) 368-8993
TI1011-1742

1
2
3
4
5
7
8
9
i0
II
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
556
single smoking customer would go into a restaurant. That
may happen. It also may happen that non-smoking customers
will start going into restaurants.
Based on the evidence which is available to us at
this point, which is all the available data that we could
locate, and given the tremendous variability in ahe cities
that we analyzed in terms of rural versus urban in terms of
socioeconomics in terms of underlying smoking rates, and
given the power of the study as we published it in the
American Journal of Public Health, which I think is our best
analysis of this, not this first pass, I think there's no
evidence that this will be bad for business.
MR. RUPP: But the model that you've used and
that we've spent such a great deal of time talking about is
the same model that's used throughout, isn't it, including
the most recent publication?
MR. GLANTZ: Yes.
MR. RUPP: So whether those models are good
models or bad models, we can tell from our discussion that
we've just gone through that people ultimately will decide
who's right about it, correct?
MR. GLANTZ: That's correct, and I think they're
good models. They also passed the peer review system twice,
once in this preliminary report through the Institute for
Health Policy Studies, and then through the American Journal
BAYLEYREPORTING, INC.
(202) 234-7787 (800) 368-8993
Tl1011-1743

1
2
3
4
5
6
7
8
9
I0
ii
12
13
14
15
16
17
18
19
20
21
22
23
24
25
557
of Public-Health. The reviewers found this a reasonable
thing to do. Although the early version, there were several
criticisms of using the total sales for the reasons we've
discussed, which is why we've gone to the other approach,
which was sent to people who have no interest in this issue
whatsoever, especially by JPH, and it passed that hurdle.
MR. RUPP: Is outdoor dining as viable an
alternative, outside of California as it is inside
California 12 months per year?
MR. GLANTZ: I just had lunch outdoors today.
MR. RUPP: It's summer in Washington, I'll have
you know.
MR.. GLANTZ: I'll accept that for the record.
The one thing I can tell you living in California
is that relatively few of the restaurants that I frequent,
and even in San Francisco, which has a very temperate
climate, have outdoor dining areas.
MR. RUPP: Do you know the percentage of outdoor
dining seating in California, or outdoor restaurant sales as
a percentage of total restaurant sales?
MR. GLANTZ: No, I don't.
MR. RUPP: It would be an interesting point to
pursue though, wouldn't it?
MR. GLANTZ: I don't really think it would make
too much difference. I've traveled quite a lot, and the
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T!1011-1744

!
2
3
4
5
6
7
8
9
I0
ii
12
13
14
15
16
17
18
19
20
21
22
23
24
25
558
restaurants that I see in San Francisco, the makeup of them
isn't all that different. A significant fraction of people
eat in places like Denny's and McDonald's and fast food
places which are not all that different in California.
Plus, when people talk about California they think about Los
Angeles. But we also have the Sierras. In San Francisco it
rains if we're not having a drought, four or five months a
year, which makes outdoor dining not possible or it's very
cold. It's freezing. I don't know about today, but when I
left it was freezing there.
So I don't think that... Let's put it this way.
I haven't seen any affirmative data that would convince me
that that's a significant problem.
MR. RUPP: Your Honor, thank you very much for
your patience.
JUDGE VITTONE: Thank you, Mr. Rupp.
MR. RUPP: And also to you, Ms. Sherman.
MS. SHERMAN: Mr. Rupp, can we get together some
hard copy of this?
MR. RUPP: We certainly can. So we don't take up
everyone's time in the room, I will stay after the hearing,
Your Honor, and we can make sure that we have the various
exhibits sorted and copies are made. They are numbered in a
way that's appropriate for the Reporter, and we can present
you a complete package in the morning.
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
Ti 1011-1745

1
2
3
4
5
6
7
8
9
I0
Ii
12
13
14
15
16
17
18
19
20
21
22
23
24
25
- JUDGE VITTONE :
Mr. Grossman?
MR. GROSSMAN:
I would appreciate that.
559
Your Honor, could we take a two
minute break before we begin?
JUDGE VITTONE: Certainly.
(Whereupon, a brief recess was taken.)
JUDGE VITTONE: We're back on the record.
MR. GROSSMAN: I want to read into the record a
complete list of those for whom I'm asking questions.
JUDGE VITTONE:
you mentioned yesterday?
MR. GROSSMAN:
JUDGE VITTONE:
for the record.
MR. GROSSMAN:
In addition to some of the people
Yes, the list is more complete.
Mr. Grossman, identify yourself
I'm Ted Grossman. I'm here on
behalf of R.J. Reynolds under Dockets No. 170 and 200; the
National Licensed Beverage Association under Docket 229; the
Ohio Licensed Beverage Association under Docket 221; the
Licensed Beverage Association, Docket 141; the Oregon
Smokers Rights Group, Docket 28; Sara Mahler, No. 191;
William Pfeffer, Jr., Docket No. 60; L. Susan Alsop, Docket
No. 232; Fay de Everhart, Docket No. 237; Roth Associates,
Inc., Docket No. 77; and ChemRisk, Docket No. 204.
Dr. Glantz, I listened carefully as I could to
your testimony earlier, and I believe you said that it is
BAYLEYREPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1746

1
2
3
4
5
6
7
8
9
i0
ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
56O
your belief that there is no evidence of a threshold of risk
for exposure to ETS, is that accurate?
Excuse me, Dr. Glantz. Is Ms.
JUDGE VITTONE:
Sherman still here?
started.
MR. GROSSMAN: Yes.
MR. GLANTZ: I'd appreciate it if she was here...
MS. SHERMAN: I'm sorry.
JUDGE VITTONE: Ms. Sherman, we're getting
MR. GLANTZ: Could you repeat the question?
MR. GROSSMAN: Certainly.
Dr. Glantz, it's accurate to say that you
testified earlier that you believe there is no evidence of a
threshold for risk to ETS?
MR. GLANTZ: Yes, that's my belief.
MR. GROSSMAN: By that you mean that no matter
how dilute ETS, presents a health problem?
MR. GLANTZ: If there was one molecule of a
compound in each, yes, around that would be a much smaller
health problem than if there was more of them, but there is
no evidence that I'm aware of of a threshold affect for
cancer, and I think that our evidence on heart disease is
consistent with that.
MR. GROSSMAN: You're referring to a threshold
both in the concentration of ETS and the environment and as
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T!1011-1747

1
2
3
4
5
6
7
8
9
i0
ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
561
to the length of time to which one is exposed to ETS?
(Pause)
MR. GROSSMAN: Is that correct?
MR. GLANTZ: I'm just thinking about it.
(Pause)
MR. GLANTZ: I would say based on current
theories of carcinogenicity, yes.
MR. GROSSMAN: Based upon your view that there is
no threshold as to either time of exposure of concentration
of exposure, I gather you support a total ban on smoking in
restaurants?
(Pause)
MR. GLANTZ: My reasons for supporting the OSHA
regulation in general is that that's proved to be the
simplest, most effective way to eliminate the risks
associated with passive smoking.
MR. GROSSMAN:
smoking in restaurants?
MR. GLANTZ:
So you support a total ban on
I support the rules as proposed by
OSHAwhich involve restrictions.
MR. GROSSMAN: One of the restrictions as of now
is a total ban on smoking in restaurants.
MR. GLANTZ: That's your characterization.
OSHA,
I thought, was very careful to present an alternative
characterization.
BAYLEYREPORTING, INC.
(202) 234-7787 (800) 368-8993
T!1011-1748

2
3
4
5
6
7
8
9
l0
ll
12
13
14
15
16
17
18
19
20
21
22
23
24
25
562
- M~. GROSSMAN: Let's go to another point, if you
want to quibble over that, and I think it is a quibble. Dr.
Glantz, you support the OSHA regulation that would prohibit
anyone from working in a room dedicated to smoking, is that
correct?
MR. GLANTZ: Yes. There are some exceptions,
reasonable exceptions in the OSHA rules.
MR. GROSSMAN: Could you identify one for me?
MR. GLANTZ: People are allowed in those rooms
when there is not active smoking going on, as I understand
the rule.
MR. GROSSMAN: Only for the purpose of cleaning
the room, is that correct?
MR. GLANTZ: That's my understanding.
MR. GROSSMAN: So far as you understand, the
regulation and it was testified to yesterday, I believe you
were here when OSHA was testifying as to the regulation?
MR. GLANTZ: I heard about half their testimony.
MR. GROSSMAN: The regulation requires that if a
company dedicates a room to smoking work cannot be conducted
in that room except that people can come in and clean the
room when smoking is not going on. That's your
understanding, isn't it?
MR. GLANTZ: Yes.
MR. GROSSMAN: And you support that regulation?
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI 1011-1749

1
2
3
4
5
6
7
8
9
I0
Ii
12
13
14
15
16
17
18
19
20
21
22
23
24
25
563
- MR. GLANTZ: Yes. Subject to any amendments they
may make in light of this hearing, and then I'll have to see
whether I like what they produce.
MR. GROSSMAN: But as of now you support a
regulation that would prohibit individuals to smoke in their
own offices with the door closed.
MR. GLANTZ: Yes.
MR. GROSSMAN: That's because.you believe that by
smoking in their own offices they are nonetheless, polluting
the environment of others around them?
MR. GLANTZ: Yes, as long as there's a shared
building ventilation system.
MR. GROSSMAN: Apartment buildings also share
building ventilation systems, is that correct?
MR. GLANTZ: I'm not an expert on ventilation
systems. I came to testify about passive smoking and heart
disease in our restaurants.
MR. GROSSMAN: You have been in apartment
buildings that have shared ventilation systems, haven't you?
MR. GLANTZ: I don't really know. When I've gone
to apartment buildings I haven't checked out the
ventilation.
MR. GLANTZ: You haven't checked out the
ventilation in office buildings either, have you?
MS. SHERMAN: Your Honor, I think he's arguing
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1750

1
2
3
4
5
6
7
8
9
I0
Ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
with the witness. The witness has already said that he
doesn't have any knowledge or opinion about apartment
building ventilation.
MR. GROSSMAN:
MS. SHERMAN:
MR. GROSSMAN:
witness' testimony goes.
JUDGE VITTONE:
I'm trying to...
Can we move on?
I'm trying to see where this
564
He's a layman in this area.
MR. GROSSMAN:
MR. GLANTZ:
(Laughter)
Well, he said he's not an expert.
You stay in hotels, don't you?
Yes. I attempted to last night.
MR. GROSSMAN: Some of them have central
ventilation, is that correct?
MR. GLANTZ: I'M not an expert on ventilation.
MR. GROSSMAN: Have you ever been in a building
that had vents to a central ventilation system?
MR. GLANTZ: The University of California UC
Hospital does. And in fact, despite the fact that the air
intake to that ventilation system is on a very windy hill,
they've not put a no smoking sign up out on the street
because people inside were complaining about the ETS being
drawn in from the street, which I found quite remarkable.
So that one building did. But I really think...
I'm happy to do my best to answer your questions, but I am
BAYLEYREPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1751

1
2
3
4
5
6
7
8
9
I0
Ii
12
13
14
15
16
17
18
19
20
21
22
23
24
25
565
not a ventilation expert.
MR. GROSSMAN: I'm not asking you to be a
ventilation expert, and I don't expect that you are one.
I'm not suggesting that you are one. But so long as
individuals, so long as a building has a shared ventilation
system, you believe that any smoking in the building
constitutes a hazard to others in the building, is that
correct?
MR. GLANTZ: To at least some of the people, yes.
We had an example at our hospital which in fact was one of
the precipitating events that led it to become smoke-free,
where a patient was having a very hard time with ETS
exposure from someone smoking in a room up the hall on the
shared ventilation system.
Chancelor's wife.
MR. GROSSMAN:
She happened to be the Vice
It doesn't make any difference
whether the building is used for work, for leisure, or as a
residence.
MR. GLANTZ: I'M not an expert on ventilation,
sir.
MR. GROSSMAN: I'm saying if it's the same
building with the same ventilation system, people smoking in
the building constitute, in your testimony, a hazard to
others, whether the building is used for work, for a
residence, or for leisure, isn't that correct?
BAYLEYREPORTING, INC.
(202) 234-7787 (800) 368-8993
Ti1011-1752

1
2
3
4
5
6
7
8
9
i0
ii
12
13
14
15
16
17
18
19
20
21
22
23
24
25
566
MR. GLANTZ: My views on this are based on
reading the general scientific literature and speaking to
experts.
Your Honor, I'm very uncomfortable being asked...
I'm here as an expert, and one of the things I've learned is
that you express strong opinions about things you know
about, and you don't answer questions about things you
don't.
Now I can speak as someone who walks around, and
whether or not I was in a room that had a radiator or not,
but I don't really think I'm qualified to answer the
questions you're asking, sir.
MR. GROSSMAN: I think anyone in the United
States is qualified to answer the question I'm asking, which
is...
MS. SHERMAN: Mr. Grossman, don't you think that
it would be more useful if you asked these questions of
somebody who knew something about this issue?
MR. GROSSMAN: I'm trying to test Dr. Glantz's
testimony. He says there is no threshold and he supports
your regulation.
MR. GLANTZ: Yes.
MR. GROSSMAN: I'm simply trying to find out
whether there's any difference in his opinion between
exposure in the workplace...
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1753

1
2
3
4
5
6
7
8
9
i0
ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
567
MS. SHE~4AN: Because scientific...
MR. GROSSMAN: You're cutting me off.
JUDGE VITTONE: Ms. Sherman, let him get his
statement out, then I will make a ruling, okay?
MR. GROSSMAN: I am simply trying to find out
whether he believes that there is any material difference
between exposure to the same molecules, as he puts it, in
the work place, or any place else in our environment.
Now Dr. Glantz, it doesn't make any difference to
you...
doctor?
JUDGE VITTONE: Do you understand the question,
MR.. GLANTZ: That's not a question about
ventilation, and yes, I would agree that if you're exposed
to a certain toxin, a cardiotoxin, when it gets to your
heart or your blood vessels or your platelets, those
platelets don't know whether you were in a building, in a
house, or standing on Mars. The material has arrived at the
target site for action.
MR. GROSSMAN: It is possible in your view, to be
exposed to ETS out of doors as well as indoors, is that
correct?
MR. GLANTZ: Yes.
MR. GROSSMAN: There have been some efforts to
preclude smoking in certain outdoor places in California,
BAILEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
Ti1011-1754

1
2
3
4
5
6
7
8
9
i0
II
12
13
14
15
16
17
18
19
20
21
22
23
24
25
568
and you have supported that, is that correct?
MR. GLANTZ: Yes. There are certain outdoor
environments, and I think it's not just been California,
like stadiums, where even though it's open to the air, you
have very strong micro environments, and flow patterns, and
I believe that that's been one of the reasons that people
have... Plus general public pressure, have made stadiums
smoke free, which I think is a good idea:
Again, I'm not an expert on local air flow
patterns at Candlestick Park, other than knowing it's cold
there.
MR. GROSSMAN: I understand that, but I'm just
trying to find out if you believe that exposure to ETS
outside a building constitutes a health risk.
MR. GLANTZ: It is possible.
MR. GROSSMAN: In a work environment where
smoking is not allowed int the building and where there is
no dedicated room under negative ventilation set aside for
smoking as a leisure activity, I believe the regulations
presume that people will smoke outdoors of the building.
I'm sure you have been past buildings that have no smoking
policies, with many people smoking outside the building.
You have seen that...
MR. GLANTZ:
MR. GROSSMAN:
Oh, yes.
Do you believe that standing
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1755

1
2
3
4
5
6
7
8
9
i0
II
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
569
outside the building where many people are smoking,
immediately outside the building where many people are
smoking, constitutes a potential health risk?
MR. GLANTZ: It could. It depends on the
specific local micro environment. The fact is, you can
simply walk past that place.
MR. GROSSMAN: How about at a bus stop?
MR. GLANTZ: It depends on where the bus stop is.
You're asking me to testify about matters of which I am not
an expert.
layman...
an expert.
MR. GROSSMAN:
MR. GLANTZ:
Let me put it to you this way ....
If you'd like my opinions as a
MR. GROSSMAN: No, I'm asking you your opinion as
You testified earlier that you believed that
there are 30 to 50,000 cardiovascular deaths a .year ....
MR. GLANTZ: Thirty to 60.
MR. GROSSMAN: Thirty to 60, attributable to ETS,
is that correct?
MR. GLANTZ: Yes.
MR. GROSSMAN: That wasn't limited to the
workplace was it?
MR. GLANTZ: That was based on total exposure
everywhere. Now it is my understanding that the OSHArisk
BAYLEYREPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1756

2
3
4
5
6
7
8
9
i0
II
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
570
estimates-are limited to workplace exposure.
MR. GROSSMAN: But your testimony was not limited
to the work place, is that correct?
MR. GLANTZ: My testimony was addressing the
question of is there good and compelling evidence that
passive smoking causes heart disease, and I based it on the
totality...
MR. GROSSMAN: And as part of the testimony that
you offered, you offered a number of the proposed, a certain
number of deaths per year. AS a result of cardiovascular
problems resulting from, you believe, exposure to ETS.
MR. GLANTZ: Yes.
MR. GROSSMAN: Those exposures that you're
referring to are not only exposure in the workplace but
outside the workplace.
MR. GLANTZ: Yes.
MR. GROSSMAN: Some of those exposure take place
in the home, is that right?
MR. GLANTZ: Yes.
MR. GROSSMAN: Some of those exposure take place
in social encounters, is that correct?
MR. GLANTZ: A small fraction, yes.
MR. GROSSMAN: Some of those exposures take place
out of doors, is that correct?
MR. GLANTZ: A small fraction.
BAYLEYREPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1"757

1
2
3
4
5
6
7
8
9
I0
ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
571
MR. GROSS~.~AN: Some of those exposures take place
in transit, in cars, is that correct?
MR. GLANTZ: That's correct, but the time
budgeting studies which have been done have shown that the
three primary sites of exposure that account for almost all
of it, are work places, homes, and restaurants.
MR. GLANTZ: Petty Jenkins, who I believe is one
of the witnesses, has done some very good work on this and
she can give... What I know about this work is mostly what
she's told me. I wouldn't...
~MR. GROSSMAN: As you see it...
MR. GLANTZ: I would say on a population, again,
speaking as a layman, on a population basis, the bowling
alley for bowlers is a relatively small fraction, and I
believe Peggy may even have data on that. I'm not sure.
But her data are quite clear. The workplace, restaurants,
and the home are the three main sites of exposure.
MR. GROSSMAN: Don't the data referred to by the
OSHA Federal Register citation also refer to social
encounters in general?
MR. GLANTZ: In reading the 0SHA submission, I
concentrated on the areas of my expertise. I don't recall
exactly what they said.
MR. GROSSMAN: You view ETS as a societal problem
generally, is that correct?
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1758

1
2
3
4
5
6
7
8
9
I0
ll
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
572
- MR. GLANTZ: All air pollution is a problem which
is dealt with at a societal level.
MR. GROSSMAN: One aspect of that as you see it
is ETS, is that correct?
MR. GLANTZ: In fact ETS is a very major source
of toxic chemical exposure in air pollution for most people.
Much worse than exposure outdoors in general.
MR. GROSSMAN: And you view it as a societal
problem?
MS. SHERMAN: I believe that question's already
been asked.
MR. GROSSMAN: Yeah, but it wasn't answered.
It's a simple.yes or no.
You view the question of ETS exposure as a
societal problem in general, isn't that correct?
MR. GLANTZ: I believe that the question of
regulating exposure of people to toxins is something we deal
with at a society level.
hearing today.
MR. GROSSMAN:
That's why we're having this
If you could have your 'druthers,
would you ban all smoking?
MR. GLANTZ: No.
MR. GROSSMAN: Where would you allow it?
MR. GLANTZ: I would allow people, smoking be
something engaged in by consenting adults in private, where
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1759

l
2
3
4
5
6
7
8
9
10
ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
573
they won't hurt their children or other people, and in fact
that's what's happening in large parts of the country.
MR. GROSSMAN: What does private mean?
MR. GLANTZ: To where people are not
involuntarily exposed.
MR. GROSSMAN:
MR. GLANTZ:
MR. GROSSMAN:
MR. GLANTZ:
Where is that?
I don't know.
Well...
For example in California today,
according to John Piersons' data, half the households
occupied by adult smokers are now smoke-free. There is no
law or rule compelling people to do that, but as parents
have come to appreciate that their smoking is hurting their
children, they've chosen to smoke away from it.
MR. GLANTZ: What question are you asking?
MR. GROSSMAN: I'm asking what do I mean by
private. And in this case...
MR. GLANTZ: No, that wasn't the question.
MR. GROSSMAN: ...going into the back yard.
MR. GLANTZ: That wasn't the question.
JUDGE VITTONE: Ask your question.
MR. GROSSMAN: The question is, where would you
allow smoking so as not to subject others to the risks that
you believe they are subjected to?
MR. GLANTZ: I think I've answered that question.
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T!1011-1760

6
7
8
9
i0
ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
MR. GROSS~.IAN: Where?
MS. SHERMAN: He already answered it.
not like his answer, but I believe he said...
574
You might
MR. GROSSMAN: Could you identify the types of
places where people could smoke as you see it, so as not to
subject others to risk.
MR. GLANTZ: Well one thing people have been
choosing to do in California is smoke outside, away from
other people.
MR. GROSSMAN: In areas outside where other
people are not around?
MR. GLANTZ: I don't know the answer to that
question exactly, how people are doing it.
MR. GROSSMAN: I'm not asking you how people do
it. I'm asking you as an expert, remember you said before
you were comfortable only answering questions as an expert.
MR. GLANTZ: Yes.
MR. GROSSMAN: I'm asking you a question as an
expert who offered the opinion that there is no evidence of
a threshold for ETS exposure risk. Where people can smoke
without subjecting, in your opinion, others to risk.
MR. GLANTZ: I think the suggestion made by OSHA
is a good one, separately ventilated smoking areas. They
have them at the San Francisco airport, for example, when I
flew out here. I think going outside, away from non-smokers
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1761

1
2
3
4
5
6
7
8
9
i0
II
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
575
is fine. -I'm sure there are many other ways that smokers
could accommodate to this.
MR. GROSSMAN: Outside, away from non-smokers.
MR. GLANTZ: Yes. Or in ways that non-smokers
are not involuntarily exposed.
MR. GROSSMAN: So you believe that the outdoor
environment should be regulated to an extent, too, that
there should be smoking areas outside as well as inside?
MR. GLANTZ: No, I've never advocated...
MR. GROSSMAN: I'm not asking whether you're
taking an advocacy position, I'm asking you as a scientist,
whether you believe it is appropriate, whether it would
limit the risk of others to have outdoor, non-smoking and
smoking areas.
JUDGE VITTONE: Dr. Glantz, if you've never
thought of the question, answer it that way. I'm not trying
to prompt you to give an answer, but...
MR. GLANTZ: It's not an issue I've really
considered as an expert. When people have asked me do I
think we should outlaw smoking outdoors which some
politicians have suggested, I told them I thought it was not
necessary. But that's not the question you're asking. I
haven't really thought about that issue.
MR. GROSSMAN: Let me just see if I can clarify a
statement that you made in your earlier testimony that I
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1762

1
2
3
4
5
6
7
8
9
i0
ii
12
13
14
15
16
17
18
19
20
21
22
23
24
25
576
think may-have been in unintended error.
Do you recall you were talking about risk ratios,
confidence levels, and the rules of chance?
MR. GLANTZ:
MR. GROSSMAN:
and the rules of chance.
that regard?
Pardon me?
Risk ratios, confidence levels,
Do you recall your testimony in
MR. GLANTZ: Yes.
MR. GROSSMAN: You suggested that a confidence
level is intended to limit the likelihood that a cause and
effect relationship... I'm sorry, let me start that again.
Was it your testimony that a confidence level
demonstrates for the rules of chance a cause and effect
relationship?
MR. GLANTZ: No. That all by itself is not
sufficient.
MR. GROSSMAN: I thought you left that
implication, and I wanted to clarify that.
The fact that the lower limit of a confidence
level is over one, does not demonstrate a cause and effect
relationship, is that correct?
MR. GLANTZ: No observational study taken alone
does that. What I testified to in terms of ETS and heart
disease, is that there's a long chain of evidence running
from test tube experiments through epidemiology studies
BAILEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
Ti1011-1763

1
2
3
4
5
6
7
8
.9
i0
Ii
12
13
14
15
16
17
18
19
20
21
22
23
24
25
577
which come together and support the conclusion that there's
a causal relationship.
MR. GROSSMAN: By itself, the epidemiology is not
something upon which you would rely...
MR. GLANTZ: Pardon me?
MR. GROSSMAN: By itself, an epidemiological
relationship is not something on which you would rely to
establish a causal relationship.
MR. GLANTZ: That's not an accurate
representation of my view. There are times that the only
evidence you have available is the epidemiological evidence.
The thing that makes the heart disease case particularly
strong is that in addition to the epidemiological data we
have the experimental biochemical and clinical data that I
summarized, so it makes the case much, much stronger, but I
believe it is possible to draw causal conclusions from
epidemiology if appropriate. It depends on the specifics of
the case at hand.
MR. GROSSMAN: The fact that a confidence level
is over one, the lower limit of the confidence level is over
one, does not demonstrate through the rules of chance or
otherwise, that an exposed population necessarily has an
incidence of disease relating to its exposure, isn't that
correct?
MR. GLANTZ: No, I don't think that's a true
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T11011-1764

1
2
3
4
5
6
7
8
9
i0
II
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
578
statement~ It does demonstrate that there is a relationship
between exposure and the presence of a disease, above what
you would expect from chance.
MR. GROSSMAN: Let's look at an example. Are you
familiar with the statistical relationship between smoking
and cirrhosis of the liver?
MR. GLANTZ: No.
MR. GROSSMAN: Let me represent to you that there
is a strong correlation between smoking and cirrhosis of the
liver, and that it's a dose-dependent relationship. That
doesn't suggest though, doctor, that smoking causes
cirrhosis of the liver, but rather it relates to ~he
confounder that people who smoke heavily often drink
heavily, isn't that correct?
MR. GLANTZ: That's a correct statement, and
that's why in the heart disease studies controlling for the
confounding variables, particularly age, I think, is very
important. I think the evidence, as I said earlier, that
Judd Wells has developed and published, that the more
confounders you control for, the stronger the relationship
gets is particularly important here. Confounding can go in
both directions. It can do as you suggested or it can
obscure a real relationship, too.
MR. GROSSMAN: But it is, indeed, important to
control for confounders and to control for all confounders.
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1765

1
2
3
4
5
6
7
8
9
I0
II
12
13
14
15
16
17
18
19
20
21
22
23
24
25
579
MR. GLANTZ: No, not all. The better the study
is, the more of the potential confounding variables you
account for, but the fact that something is a potential
confounder doesn't mean that it's a problem. It could be,
and a good study, the better the study is the more of those
confounding variables will be controlled for. Again, Wells
showed that the better the studies were, the stronger the
risks were for ETS and heart disease.
MR. GROSSMAN: Doctor, you travel widely?
MR. GLANTZ: Now and then, yes. More than I
want.
MR. GROSSMAN: As part of your work, attending
conferences or otherwise, you've traveled abroad?
MR. GLANTZ: Yes,
MR. GROSSMAN:
MR. GLANTZ:
MR. GROSSMAN:
MR. GLANTZ:
And have you traveled to Asia?
I was in Japan twice, yes.
Have you traveled to Europe?
Yes.
MR. GROSSMAN: Have you noticed the level of
public smoking in Japan?
MR. GLANTZ: When you go to these meetings they
lock you in a hotel, and I was at the World Conference on
Smoking and Health where environmental tobacco smoke wasn't
a problem. And I noticed that they had non-smoking cars on
the trains and the planes and subways, which I sat in. So
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1766

1
2
3
4
5
6
7
8
9
I0
ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
58O
really can't comment upon that. I've read that there's more
of it, but my direct experience, I managed to avoid it.
MR. GROSSMAN: And in Europe the same would be
true? You've managed to avoid public smoking in Europe?
MR. GLANTZ: In Europe, I've only been to Europe
once in recent years, and we went to one restaurant. But
again, I was there lecturing at a university and there was
no smoking in the lecture halls, and I was lecturing eight
hours a day.
I would say that there are fewer restrictions on
smoking, public smoking in Japan and Asia and Europe than
there are in parts of the United States. I think that's
generally appreciated.
MR. GROSSMAN: There are fewer restric6ions on
public smoking in Japan, parts of Asia and Europe, and
there's also a great deal more smoking in Japan than in the
United States, isn't that correct?
MR. GLANTZ: Again, you're moving me into an area
where I'm not an expert. It is my recollection... I'd
rather not get into that because it's a complicated
question. There are differences between men and women,
there are differences between prevalence and consumption
among smokers, and I think those are important variables. I
know enough to know that I really... You should talk to
someone who is an expert on differential smoking rates
BAYLEYREPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1767

1
2
3
4
5
6
7
8
9
i0
Ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
581
between countries, I think.
MR. GROSSMAN: Let me represent to you the
statistics of the U.S. Surgeon General and the Ministry of
Health and Welfare of Japan on rates of smoking.
In Japan in 1985, the 1985 numbers are the most
recent statistics available for both the United States and
Japan in the same year. 1985, 33.2 percent of American men
smoked, adult men smoked, over the age of 20.
MR. GLANTZ: Could you repeat that?
MR. GROSSMAN: In 1985, 33.2 percent of American
males over the age of 20 smoked cigarettes~
MR. GLANTZ: American males?
MR. GROSSMAN: American males. 33.2 The number
in Japan was 64.6 percent of all Japanese males over the age
of 20 smoked.
If one goes back to 1955, 52.6 percent of
American males smoked; and 81.4 percent of Japanese males
smoked cigarettes.
You said earlier that you were familiar with an
author, doctor, named Takisi Hirayama?
MR. GLANTZ: Yes.
MR. GROSSMAN: You're also familiar with Ernest
Wynder and his writings?
MR. GLANTZ: Yes.
MR. GROSSMAN: And do you subscribe to the
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1768

1
2
3
4
5
6
7
8
. 9
i0
ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
journal Cancer?
MR. GLANTZ:
MR. GROSSMAN:
Cancer?
MR. GLANTZ:
MR. GROSSMAN:
582
No.
Are you familiar with the journal
Generally.
Have you ever read an article by
Wynder, Hirayama and others entitled, "The Comparative
Epidemiology of Cancer Between the United States and Japan"?
MR. GLANTZ: I have not read that paper.
MR. GROSSMAN: Doctor, based upon the numbers of
the Surgeon General of the United States and the Ministry of
Health and Welfare of Japan, it would show a level of
smoking in Japan that is 50 to I00 percent higher than the
United States, depending on the year in question. And based
further on the statistics in the Wynder Hirayama article,
which I will represent to you on consumption per capita of
those who smoke, indicating that the average male smoker in
the United States, 1986, smoked 23 cigarettes. The average
male smoker in Japan smoked 25. In 1980 the average male
smoker in the United States smoked 22 cigarettes. The
average male smoker in Japan smoked 24.5.
Given the fact that far more Japanese men smoke
cigarettes; secondly, that those Japanese men who smoke
cigarettes smoke, on average, more cigarettes than the
average American man who smokes; one would anticipate
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T11011-1769

1
2
3
4
5
6
7
8
9
I0
ll
12
13
14
15
16
17
18
19
20
21
22
23
24
25
583
through your testimony that both the rates of lung cancer
and heart disease would be greater in Japan than the United
States, is that correct?
MR. GLANTZ: No, that's not a reasonable
conclusion to draw, and I'd like to address heart disease
because that's what I'm here to talk about.
There are, as we've discussed, many other
confounding variables with heart disease.. In fact, they are
more than confounding, they sort of work together. The
heart disease rates in Japan are relatively low; in fact
much lower than you would expect based on their cigarette
consumption. Most people think that's a reflecti6n of
dietary differences. They have very low cholesterol diets.
One of the things I was unable to present for lack of time
in my testimony is evidence that the benzopyrene and other
PAHs in cigarette smoke bind selectively to cholesterol and
facilitate the atheroscloratic process, so it may well be
that certain of these dietary factors are necessary for
smoking to have the effects that it does.
For example, when Japanese move to America and
change their diet, then their heart disease rates change.
MR. GROSSMAN: And lung cancer rates go up as
well.
MR. GLANTZ: That I can't speak to.
MR. GROSSMAN: All right.
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
Ti1011-1770

1
2
3
4
5
6
7
8
9
i0
ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
584
Doctor, let me see if I can adjust your testimony
slightly. When you said there is a correlation with
cholesterol, you're not referring to dietary cholesterol,
are you? You're referring to saturated fat intake, isn't
that correct?
MR. GLANTZ:
MR. GROSSMAN:
MR. GLANTZ:
MR. GROSSMAN:
It depends.
I'm not quite...
I'm sorry.
There are a number of foods that
are common in the Japanese diet, including shellfish, that
are very low in saturated fat, but nonetheless have fairly
high dietary cholesterol. And the profound difference
between the Japanese diet and the American diet is in
saturated fat intake, isn't that correct?
MR. GLANTZ: I'm not an expert on dietary
differences. The statements that i've made to you are a
reflection of my general understanding of the literature and
the question which comes up fairly frequently in our
editorial board discussions at the Journal of the American
College of Cardiology when talking about Japanese studies.
And in general, on cardiologic issues. This is one issue
that I've heard discussed.
I'm not presenting myself as an expert on
transnational dietary differences. The fact that the ETS
risks persist across countries at relatively consistent
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1771

1
2
3
4
5
6
7
8
i0
Ii
12
13
14
15
16
17
18
19
20
21
22
23
24
25
585
levels, however, suggests to me that these dietary
differences are not important in terms of the overall ETS
risk.
MR. GROSSMAN: You're familiar with the World
Health Organization?
MR. GLANTZ: Yes.
MR. GROSSMAN: Do you rely on their statistics in
general?
MR. GLANTZ: The work that I do, I don't have
much need to rely on their statistics. I presume they're a
credible source, but I've never really dug into it.
MR. GROSSMAN: Based upon the published
literature indicating that the highest level of male smoking
in the world is in Japan, one would expect, based upon your
testimony, that life expectancy in Japan would be relatively
low, wouldn't one?
MR. GLANTZ: No. I've really addressed that.
There are other factors that play a role in this.
I do know that the World Health Organization has
said passive smoking causes heart disease at about the
magnitude we've estimated.
MR. GROSSMAN: In the 1993 World Health
Statistics Annual, which is the most recent volume published
by the World Health Organization, the average male life
expectancy at birth in Japan was 76.4 years. In the United
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T11011-1772

1
2
3
4
5
6
7
8
9
10
II
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
586
States it-was 71.9 years. In fact, the average male life
expectancy in Japan, the country with the highest smoking
rate in the world, was the highest life expectancy in the
world.
MR. GLANTZ: There are many things that
contribute to life expectancy. The availability of prenatal
care which is a big problem in the United States, is very
high in Japan. The nature of their medical service system
is quite different than it is here, and you don't have the
problems that we have of uninsured and people not getting
medical treatment.
There's no question that smoking causes heart
disease and other diseases, but no one has said, I wouldn't,
no one sensible would, would say that smoking is the sole
cause of death. There are many, many other contributing
factors. The differences in terms of their medical system
in Japan are very, very important .contributing factor when
you look at life expectancy at birth.
JUDGE VITTONE:
you going to be?
MR. GROSSMAN:
JUDGE VITTONE:
little bit, we have one more person to follow you.
MR. GROSSMAN: I'm going as fast as I can.
almost done.
Mr. Grossman, how much longer are
Probably ten minutes.
If you can tighten that up a
I'm
BAYLEYREPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1773

1
2
3
4
5
6
7
8
9
I0
ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
587
Even if one looks at life expectancy past birth,
say at the age of 45, there is a significant difference
between life expectancy in Japan and the United States. In
Japan, the World Health Organization numbers indicated that
male life expectancy as of age 45 was an additional 33.3
years, and in the United States, 30.8 years. That factors
out questions of prenatal care, doesn't it?
MR. GLANTZ: That's true, but I wouldn't make the
cut point there because most of the big impacts of smoking
on heart disease are on like people starting around 40. So
it would be more interesting to see cut points where you cut
it at like 39. So I don't think that in and of itself is
enough to exonerate smoking as a cause of disease in
smokers.
MR. GROSSMAN: But it does indicate to you that
there are many other factors that contribute to heart
disease and to life expectancy.
testimony.
MR. GLANTZ:
MR. GROSSMAN:
I've said that all through my
And the fact that virtually all
Japanese men smoked 20 years ago, and that two-thirds do
now, whereas fewer than a third of American men smoke now,
indicates that other factors are more powerful than smoking
in determining both heart disease incidents and life
expectancy, isn't that correct?
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1774

5
6
7
8
-9
I0
ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
588
~.L~. GLANTZ: Again, I'm not an expert, but it's
my understanding that they end up getting things like
stomach cancer, which is a very rare disease here.
Again, the fact that despite all of these
differences, the observe risks of passive smoking and heart
disease from the Japanese data is quite consistent with what
we observe here in the United States, suggests to me that
the issues which you're raising, which are legitimate issues
to think about and to discuss, are not a problem in
interpreting the data.
MR. GROSSMAN: To the extent that the difference
in fat intake or cholesterol intake accounts for this
startling difference in life expectancy between the United
States with its comparatively low smoking rate and Japan
with its comparatively high smoking rate, that indicates a
need to change the American diet, is that correct?
MR. GLANTZ: I'm not an expert on diet.
MR. GROSSMAN: You are an expert on
cardiova.scular disease, is that correct?
MR. GLANTZ: That's true. And the American H~art
Association and most cardiologists would recommend that
Americans lower their intake of fatty foods.
MR. GROSSMAN: Do you believe that an employer
with a cafeteria has an obligation to provide low saturated
fat diets to its workers?
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T11011-1775

1
2
3
4
5
6
7
8
9
I0
ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
" MR. GLANTZ:
now doing that.
MR. GROSSMAN:
obligation to do so?
MR. GLANTZ:
589
Most of the places I'm aware of are
Do you believe that they have an
I think if they care about their
employees it's a good thing to do, and I think there's a
demand for it.
MR. GROSSMAN: Leaving aside caring for their
employees and demand, if American employers provided a diet
similar to the Japanese diet and allowed smoking as it's
allowed in Japan, since you've testified that there are no
ethnic factors that are a strong correlation with heart
disease, you would have to assume...
MR. GLANTZ:
MR. GROSSMAN:
MR. GLANTZ:
I didn't say that, sir.
You testified...
I did not. I specifically did not
say that. I said independent of other ethnic differences
such as hypertension, so let's accurately quote what I said,
please.
MR. GROSSMAN: You said that independent, you
said there is an increased prevalence of hypertension among
blacks, but apart from that...
MR. GLANTZ: I said that wasn't an accurate
representation. That was an example of one of the
differences, and those effects lead to... It's the
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1776

1
2
3
4
5
6
7
8
9
I0
Ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
59O
hypertension that has the effect, rather than a statement
that the effect of hypertension in black people is different
from the comparable level of hypertension in white people,
and I do not believe, I'm not sure, but I'm not representing
as saying that's the only difference.
MR. GROSSMAN: Going back to another part of your
testimony...
MR. GLANTZ: I was trying to clarify the point.
MR. GROSSMAN: Going back to another point, you
testified that Japanese-Americans who adopt the American
lifestyle die like Americans.
MR. GLANTZ: Pardon me?
MR. GROSSMAN: Japanese-Americans who adopt the
American lifestyle have a health profile that is similar to
other Americans.
MR. GLANTZ: Ultimately, yes. And it's unlike
the health profile of Japanese in Japan. That's my
understanding.
MR. GROSSMAN: What I'm asking you is, if
American employers provided a Japanese diet to their workers
and allowed their workers to smoke as they do in Japan, the
life expectancy of Americans would increase pursuant to your
testimony as you understand it, isn't that correct?
MR. GLANTZ: I don't know that I would draw that
conclusion. There's a fundamental difference, though. If I
BAYLEYREPORTING, INC.
(202) 234-7787 (800) 368-8993
Ti1011-1777

1
2
3
4
5
6
7
8
9
i0
ii
12
13
14
15
16
17
18
19
20
21
22
23
25
591
go to UCSF and all they serve at our cafeteria is greasy,
fatty foods, I can bring a bag lunch. I have no control,
directly, over the air that I'm breathing at my work site,
and I think that's a fundamental difference between the two
examples that you're making.
MR. GROSSMAN: Doctor, you have no basis to say,
isn't it correct, that smoking, even direct smoke, plays as
great a role in heart disease as dietary factors?
MR. GLANTZ: The American Heart Association and
most cardiologists have said that smoking is the leading
controllable risk factor for heart disease, so I think
that's not an accurate statement.
MR. GROSSMAN: Based upon differences between
American and Japanese diets and smoking, based on
differences in the incidence of heart disease in those two
countries~ there is no basis to say that, isn't that
correct?
MR. GLANTZ: I think that that's not the way
scientists make decisions. I can tell you that the
consensus in the cardiologic community and the
official position of the American Heart Association in
reviewing all the evidence, not simply the suppositions that
you've advanced to me, is that smoking is a leading
controllable risk factor for heart disease in smokers.
So, you have constructed a hypothetical case
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T11011-1778

1
2
3
4
5
6
7
8
9
I0
I!
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
592
based largely on material I haven't read, and if you want to
draw a hypothetical conclusion from it that's your business,
but my understanding of the current views is that smoking is
the leading preventible risk factor for heart disease.
Period.
MR. GROSSMAN: Have you made independent studies
to determine the extent to which dietary saturated fat
intake or exercise contribute to heart disease?
MR. GLANTZ: No.
MR. GROSSMAN:
MS. SHERMAN:
MR. GROSSMAN:
All right. Doctor...
Mr. Grossman. Please.
I have a couple of, just,
unrelated questions to what I just said. Very quick
questions. Doctor, you spoke earlier about a paper on
California restaurants that you published.
MR. GLANTZ: California and Colorado. Yes.
MR. GROSSMAN: In what journal was that
published?
Health.
MR. GLANTZ: The American Journal of Public
MR. GROSSMAN: Was that paper -- that paper is an
economic paper, is that correct?
MR. GLANTZ: Yes.
MR. GROSSMAN: Was it offered to any journal of
economics?
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1779

1
2
3
4
5
6
7
8
9
i0
ll
12
13
14
15
16
17
18
20
21
22
23
24
25
593
- MR. GLANTZ: No. We thought the, The American
Journal of Public Health has economists who review. They
publish articles on health economics, and that's the leading
journal in the area. It's the most prestigious journal in
the area.
MR. GROSSMAN:
MR. GLANTZ:
In the area of economics?
In the area of health, generally,
including health economics.
MR. GROSSMAN: Was your, to your knowledge, was
your article on restaurants in California and Colorado peer-
reviewed by a panel of economists?
MR. GLANTZ: It was peer-reviewed by a panel of
experts selected by the editor, and that is a fine journal
and they made it a fine journal by.;.
MR. GROSSMAN: That's not the question.
MR. GLANTZ: ...selecting appropriate reviewers.
They don't tell me who the reviewers are.
MR. GROSSMAN: To your knowledge, there were no
economists who peer-reviewed your article, is that correct?
MS. SHERMAN: Excuse me. I believe he testified
that he didn't know who the reviewers were.
MR. GROSSMAN: Okay. Whether byname or
otherwise, to your knowledge your article was not peer-
reviewed by any economist, is that correct?
MR. GLANTZ: To my knowledge, it may have been
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1780

1
2
3
4
5
6
7
8
9
i0
ii
12
13
14
15
16
17
18
19
20
21
22
23
24
25
594
reviewed by economists. It may not have. Knowing the
Journal I would expect it was reviewed by economists,
because the editor there is a very careful guy.
MR. GROSSMAN: Now, you referred earlier to
certain typographical errors and other errors in your
publication. In order to give us an opportunity to ensure
the accuracy of your calculations and otherwise, will you
provide to R.J. Reynolds the raw data upon which your
publications that you have referred to in this testimony are
based?
MR. GLANTZ: That's all a matter of public
record.
MR. GROSSMAN: All of the raw data?
MR. GLANTZ: Sure. It's the State Board of
Equalization Report...
MR. GROSSMAN: I'm not...
MR. GLANTZ: Excuse me, sir. Subject to the
couple of letters of correction that we've received from Bob
Rossi and that has been, which you appear to have already.
MR. GROSSMAN: I'm not referring only to the
economics article but to the other articles on which you
have testified.
MR. GLANTZ: Which other articles?
MR. GROSS~.~N: Have you referred at any time in
your testimony to studies by yourself on incidences of heart
BAYLEYREPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1781

1
2
3
4
5
6
7
8
9
i0
ll
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
595
disease by those who are exposed to passive smoke?
MR. GLANTZ: The results of those studies are
based on the published literature which are available in any
library.
MR. GROSSMAN: There's no independent work that
you did...
MR. GLANTZ: We haven't done any independent
epidemiological studies.
MR. GROSSMAN: Doctor, could you just state for
the record the amount by which you believe heart disease
deaths would be reduced in the United States by the OSHA
regulation as it currently stands?
MR. GLANTZ: That I cannot do, because I haven't
done that calculation.
MR. GROSSMAN:
MR. GLANTZ:
MR. GROSSMAN:
MR. GLANTZ:
MR. GROSSMAN:
One other thing, Doctor...
I believe it would be significant...
One other thing, Doctor...
...if I could give you a number.
You said earlier in answer to my
questioning that you're not a ventilation expert and you
cannot comment on the extent to which ventilation in
apartment buildings may vitiate risk of others in apartment
buildings from exposure to ETS. Do you recall that
testimony?
MR. GLANTZ: Yes. Because I don't know of, I
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1782

1
2
3
4
5
6
7
8
9
I0
II
12
13
14
15
16
17
18
19
20
21
22
23
24
25
596
don't design building ventilation systems for apartment
buildings. I've been in apartments where every unit is
steam heated. I used to live in one.
MR. GROSSMAN: Well, Doctor, do you recall that
in response to questions by, I believe, Mr. Dinegar -- you
were asked, "Is ventilation sufficient to remove ETS from
the work environment?" and you said, "Ventilation is not
sufficient"?
MR. GLANTZ: That's my understanding based on
talking with people who are expert in the area.
MR. GROSSMAN: Okay. And so ventilation wouldn't
be sufficient in apartment buildings either. Is that
correct?
MR. GLANTZ: I don't know about how apartment
buildings are constructed, sir.
MR. GKOSSMAN: Is this a construction problem or
is this -- it doesn't depend on whether it's an apartment
building or a work building. It just depends on the
ventilation system.
MR. GLANTZ: And people who are knowledgeable
about how such systems are constructed can answer your
question.
MR. GROSSMAN: So are you suggesting that there
are ventilation systems that are currently available in
apartment buildings that if applied to work buildings would
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
Tl1011-1783

1
2
3
4
5
6
7
8
9
i0
Ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
597
remove the ETS problem as you see it from work buildings?
MR. GLANTZ:
was in had steam heat.
the rooms.
Grossman.
Well, the last apartment building I
So there was no connection between
HEARING OFFICER VITTONE: All right. Mr.
Gentlemen. We're not getting anywhere with this.
MR. GROSSMAN: All right. Thank you very much,
Your Honor. Thank you.
By the way, Dr. Glantz, you are not a medical
doctor, are you?
MR. GLANTZ: No, but I am a professor of medicine
at the University of California.
MR. GROSSMAN: Have you ever treated a patient
with heart disease?
MR. GLANTZ: No.
MR. GROSSMAN: Thank you very much.
HEARING OFFICER VITTONE: Mr. Lowe. Mr. Lowe,
would you repeat who you represent and your name, please.
MR. LOWE: My name is Michael Lowe. I'm
representing the Washington Technical Information Group,
Docket No. 103, and I'm also asking questions on behalf of
Robert Michaels, Docket No. 106.
HEARING OFFICER VITTONE: Mr. Lowe, can you give
me an estimate? Repeat what your estimate was? How long
you'd be.
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T11011-1784

1
2
3
4
5
6
7
8
9
I0
ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
598
MR. LOWE: An estimate of time?
HEARING OFFICER VITTONE: Yes.
MR. LOWE: I'm not sure I can give an accurate
estimate after watching the proceedings.
HEARING OFFICER VITTONE: Just give me an
estimate.
MR. LOWE: I would think 20 minutes to 30
minutes.
HEARING OFFICER VITTONE: All right. It is now
6:30. If you could keep it closer to 20 minutes I think we
would all appreciate it.
Dr. Glantz, if you would keep your answers
limited. It is at the end of the day. This is the last
person who has some questions for you. Please try to
restrict your answers directly to the question.
MR. LOWE: Thank you, Your Honor. Good evening,
Dr. Glantz. I understand it's been a long day. But I'm not
an attorney. I'm going to try to ask you a few very clear
questions about some of the material that I've reviewed
either in your written, submitted testimony or in what you
spoke about this morning, simply for clarification as I try
to understand the process you've gone through in order to
better understand the conclusions you've arrived at.
Isn't it true, Dr. Glantz, that many of the
studies you relied on in your testimony involved active
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T11011-1785

1
2
3
4
5
6
7
8
9
i0
ii
12
13
14
15
17
18
19
2O
21
~.2
23
24
25
599
smoke, even though this hearing is about environmental
factors?
MR. GLANTZ: A couple of them, for example the
platelet study comparing the effects of active and passive
smoking, had active smoking in it. The study on free
radicals and reperfusion injury could be interpreted either
way. But I would say the epistudies are all passive smoking
studies, and most of the experimental studies involved
models of passive exposure.
The only one, as I say, the only one I can think
of that had active smoking in it was the platelet study.
There are probably a couple of others, but I can't recall
what they are,
MR. LOWE: For the benefit of my clarification
I'd like to step through some that have come to mind for me.
The 1985 McMurray study on exercise performance
pooled data from smokers and non-smokers, didn't it?
MR. GLANTZ: That's true. They compared the
effects of passive smoking and smokers and non-smokers.
MR. LOWE: And they didn't separate those
individuals.
MR. GLANTZ:
MR. LOWE:
correct?
Yes, they did.
They lumped the data.
Is that
MR. GLANTZ: I don't believe so. If you want, I
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1786

1
2
3
4
5
6
7
8
9
I0
ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
6OO
can stop and check, but I don't believe so.
MR. LOWE: If they had considered both active and
passive or non-smokers, wouldn't this make it difficult to
separate the possible effects of ETS exposure from those of
mainstream smoke?
MR. GLANTZ: You mean if they, if they just
pooled them all into one bin without looking at the non-
smoker, the passive smoker separately from the active
smokers?
MR. LOWE:
MR. GLANTZ:
MR. LOWE:
Yes.
I'd agree with that.
In the 1978 Aranow study on exercise
performance, it included active smokers, didn't it?
MK. GLANTZ: In, my recollection is they were
treated separately. And there have been other studies --
if, I actually think that was just passive, but, again, to
answer this I'd have to review the study.
MR. LOWE: I have a copy of the Aranow paper with
me, and if I can read you a section out of the materials,
and I will just read a very brief portion of it. It
included ten men. Eight subjects were ex-smokers, two
subjects smoked two or four cigarettes daily. So, again, I
ask you, does this represent a combination of smokers and
non-smokers?
MR. GLANTZ: Well, if you actually have those two
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
Tl1011-1787

1
2
3
4
5
6
7
8
9
I0
ii
12
13
14
15
16
17
18
19
20
21
22
23
24
25
601
papers with you I'd prefer to take a brief break and read
them and see what I think rather than relying on
representations.
MR. LOWE: The material I just read you is from
The New England Journal of Medicine article in 1978.
MR. GLANTZ: No, I have the paper right here. I
have the paper here.
HEARING OFFICER VITTONE: What's your question,
Mr. Lowe? Do you have a question, or...
MR. LOWE: I asked Dr. Glantz if in fact this
study included subjects that were smokers and non-smokers.
Active smokers.
HEARING OFFICER VITTONE: All right.
MR. GLANTZ: Okay. In the Aranow study two of
the subjects had smoked two to four cigarettes daily but did
not smoke for at least 16 hours before the study or during
the study on each of the three study mornings. That's a
very important point, because the effects which are being
studied here resolve very quickly.
MR. LOWE: Dr. Glantz, I...
MR. GLANTZ: Wait. Wait. Sir, you asked a
question. I want to give an accurate answer. The ex-
smokers, in terms of the material in this study, I don't see
that as a problem at all because, again, the kind of effects
that they're measuring resolve very quick, within a day or
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T11011-1788

7
8
9
I0
ll
12
13
14
15
16
17
18
19
20
21
22
23
24
25
602
SO of smoking cessation among active smokers.
There have been subsequent studies which are
cited in our testimony which I believe were a bit cleaner on
this. I don't see this as... I don't see that, I mean,
it's a thing that I think you can legitimately criticize the
study for but I don't think it's a fatal flaw in the study.
MR. LOWE: Can you answer my question as to
whether or not it included smokers or non-smokers?
MR. GLANTZ:
to the study. Period.
MR. LOWE:
It included people who smoked prior
And perhaps subsequent to it.
Thank you. Are you aware that there
is, or if there have been any government investigations of
Dr. Aranow's body of work?
MR. GLANTZ: Yes.
MR. LOWE: Are you aware of the Horvath
Commission's recommendations?
MR. GLANTZ: I'm not specifically aware of that.
I know that subsequent to the publication of the 1978 paper
there were claims of scientific impropriety brought against
Dr. Aranow which were substantiated. The only reason, and
in fact for that reason, we almost didn't cite this paper in
our original, Bill Parmley's and my original 1981 -- pardon
me, 1991 -- publication. But the fact that we could find
other studies done in other laboratories that produced
corroborative results, we included it, and since to my
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T11011-1789

1
2
3
4
5
6
7
8
9
i0
ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
603
knowledge'there's been no question raised about this...
~.~R. LOWE: But from my reading of your statement,
you did include it and you did reference it, which, as a
scientist, is a procedure most of us go through in order to
gain credibility for our body of work.
MR. GLANTZ: Well, we could, we could delete the
citation to this study from our work without affecting our
conclusions whatsoever because the similar results have been
obtained by other independent investigators.
MR. LOWE: Additionally, you relied upon several
Czechoslovakian studies on rabbits and tobacco smoke, didn't
you?
MR. GLANTZ: Yes.
MR. LOWE: These studies~were a primary basis for
your conclusions regarding the effects of ETS on cellular
metabolism, isn't that true?
MR. GLANTZ: They were not our sole references,
but they were important studies.
MR. LOWE: If I recall, you cited some of the
data from those studies this morning...
MR. GLANTZ:
MR. LOWE :
MR. GLANTZ:
MR. LOWE :
That's true.
...and showed us a slide.
Yes.
Are you aware that these studies were
designed to examine the effects of active smoking and not
BAYLEYREPORTING, INC.
(202) 234-7787 (800) 368-8993
Tl1011-1790

1
2
3
4
5
6
7
8
9
10
II
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
604
ETS?
MR. GLANTZ: The exposures that were created were
ETS-type exposures, probably more so than active smoking,
because what they did was, the rabbits were put in exposure
chambers and then cigarette smoke was blown into the
exposure chambers. And that, I think, is a better design
for studying passive smoking than active smoking, as was
pointed out in some of the.cross-examination of OSHA
yesterday. There are differences between active and passive
smoking.
MR. LOWE :
MR. GLANTZ:
MR. LOWE:
Let's focus on this study, Doctor.
Okay.
I'd like to read you a quote from the
study, or from the same authors about this experimental
design. The first quote is: "The aim of the present study
was to investigate the effect of cigarette smoking on the
oxidating processes of heart muscle at the sub-cellular
level." And the second quote I'd like to read you:
"In our
experiment we tried to simulate using inhalation of
cigarette smoke in animals the situation in humans after
active smoking."
Now, I understand I don't have your years of
experience in environmental tobacco smoke research, but to
me, this sounds like an effort to duplicate an active
smoking situation.
BAY]hEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1791

1
2
3
4
5
6
7
8
9
I0
II
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
605
MR. GLANTZ: And I think for the reasons that
were brought out in the testimony, or in the cross-
examination of OSHAyesterday, that they much more
accurately represented a passive smoking environment. The
smoke that the rabbits were inhaling was diluted sidestream
smoke. It was not hot, which is the smoke that a smoker
inhales, and the mixture was different.
So I think, they may have set.out to do that, and
I think that their data is of relevance in understanding the
effects of active smoking. But I also think, because of the
nature of the exposure that they gave, it's really equally
good and probably better as a study of passive smoking.
MR. LOWE: Dr. Glantz, I notice in your
Curriculum Vitae that you have taught on experimental
design, and I find the comment you made not to be consistent
with the standards I would expect in a paper or in a
research project that was going to investigate that type of
exposure.
MR. GLANTZ:
MS. SHERMAN:
Well, well...
Is that a question?
MR. LOWE: That is certainly not consistent with
what environmental tobacco smoke has been characterized.
MS. SHERMAN: Mr. Lowe, is that a question or is
that testimony.
MR. LOWE: Excuse me?
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T11011-1792

1
2
3
4
5
6
7
8
9
i0
Ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
606
MS. SHE~4AN: Were you asking Mr. Glantz a
question or were you just giving general testimony?
MR. LOWE: Until I was interrupted I was going to
say, in view of those issues, do you still claim this was
designed for passive smoking?
MR. GLANTZ: I think that the data that they
produced is more relevant to the issue of passive smoking
than active smoking because of the way they constructed
their exposures.
MR.-LOWE: And you are better suited, in a better
position to make that the statement than the authors?
MR. GLANTZ: I am in a position to make my own
independent scientific judgements based on what I read, and
I have from time to time looked at papers, not just on this
but in other areas, and drawn conclusions from them based on
my best judgement. That's why I'm an associate editor of
The Journal of the American College of Cardiology, dealing
specifically with these...
MR. LOWE: Let's move on to another study that
you've talked about. You relied upon a 1989 study by Davis,
et. al. for your conclusions about platelets, didn't you?
MR. GLANTZ:
studies on platelets.
different authors.
MR. LOWE:
That was one of a large number of
There were several by several
Excuse me. I asked you if you relied
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T11011-1793

1
2
3
4
5
6
7
8
9
i0
ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
607
upon this-one. I believe it's cited in your paper.
MR. GLANTZ: Yes. That was which? Can you tell
me, since I don't have the reference list memorized, which
one you're referring to?
MR. LOWE: In your submitted testimony it's
reference number 30. It's cited on page I0. It's the
Davis, et. al. paper, "Passive Smoking Affects Endothelial
and Platelets." There are only I0 subjects in that study.
Isn't that correct?
MR. GLANTZ:
MR. LOWE:
Yes.
Isn't it true, Doctor, that the
authors of the data study didn't know what significance
their data might or might not have for ETS exposure?
MR. GLANTZ: I don't understand the point you're
making.
MR. LOWE: The point I'm making is I believe you
used that study to buttress an opinion you've presented, and
yet the authors of the study, the investigators that
conducted it, made the following statemen6, which I'll read
for your benefit.
MR. GLANTZ:
it appears?
MR. LOWE:
believe it's page 389.
paragraph.
Could you tell me where in the paper
It's on the last page of the paper.
It's in the first complete
"The significance of enhanced platelet
BAILEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T11011-1794

1
2
3
4
5
6
7
8
9
i0
ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
608
aggregation formation and an increased concentration of
endothelial carcasses, of endothelial cells in blood, after
passive smoking is not known."
So they simply said they did not understand the
relevance of this. Is that correct?
MR. GLANTZ: I wish you'd read the next sentence,
however. It says, quote...
MR. LOWE: I didn't ask you about that, did I?
MR. GLANTZ: Well, wait. Wait. Sir, you're
taking this very much out of context.
They go on to say, "However, both platelet
activation and endothelial damage are prominent among the
mechanisms thought to be involved in atherosclerosis and
arterial thrombosis. Epidemiologic'studies are needed to
determine whether repeated episodes of passive exposure to
tobacco smoke during a period of years enhance the
development of atherosclerosis and its complications in non-
smokers."
MR. LOWE: Dr. Glantz, I can read it.
MR. GLANTZ: You are, you are... I'm sorry.
This is very important, because you gave a little speech
earlier.
HEARING OFFICER VITTONE: Dr. Glantz.
MR. LOWE: I'm sorry. He's given a speech
accusing me of...
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
Ti1011-1795

1
2
3
4
5
6
7
8
9
I0
Ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
609
HEARING OFFICER VITTONE: Dr. Glantz, he's not
giving a speech right now. Dr. Glantz, when I ask you to
stop I expect that you're going to stop.
MR. GLANTZ: Okay. I'm sorry.
HEARING OFFICER VITTONE: You don't take it from
your students. This is my classroom, Dr. Glantz.
MR. GLANTZ: I'm sorry, Your Honor. It's been a
long day.
HEARING OFFICER VITTONE: That's right. Now.
You put it in a context. Do you have a question?
MR. LOWE: The second sentence that Dr. Glantz
elected to read to us all also has the term "thought" in it.
"It's thought." Is this a hypothesis? Or is this a fact?
MR. GLANTZ: This paper was written, published in
1989, which was five years ago. They suggested further
research was needed, which is not an unusual comment for
professors to make, to work this out. I think at the time
this paper was written, five or six years ago, the
statements they included were quite reasonable.
I have interpreted the results in this paper in
the context of the data that's available this year. Today,
in 1994. And the important thing in this paper is the data,
which in Figure 2 shows passive smoking significantly
affects platelet aggregation ratio, and in Figure 3, or,
pardon me, Figure 4 -- oh, wait -- Figure 3, which shows
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T11011-1798

1
2
3
4
5
6
7
8
9
I0
Ii
12
13
15
16
17
18
19
2O
21
22
23
24
25
610
passive smoking significantly affects endothelial carcass
cell count. Okay? Despite the small sample size these
results were significant at the .002 level. The important
thing about this in terms of my...
MR. LOWE: Dr. Glantz, you talked about...
MR. GLANTZ: ...testimony is the data it
includes. Pardon me.
HEARING OFFICER VITTONE: Okay.
MR. LOWE: You talked about this paper this
morning. You represent it as being supportive of part of
your testimony, and my point was the authors of it did not
make the same representations and I'm not sure that
reconstruction of scientists is what we're here for~
But let's move on to another question. This
morning in your statement you relied upon a 1986 study of
platelets by Burg, Huber, et. al., didn't you Doctor?
MR. GLANTZ: Yes.
MR. LOWE: The authors of this study were
concerned that stress might have produced the results they
obtained. Isn't that right?
MR. GLANTZ: Again, if you'll point me to where
they talk about that I will be happy to look at it.
HEARING OFFICER VITTONE: For the record that's
number 32 in his testimony. Is that correct?
MR. GLANTZ: Yes. Le~ me check and make sure
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T!1011-1797

1
2
3
4
5
6
7
8
9
I0
II
12
13
14
15
16
17
18
19
20
21
22
23
24
25
611
that...
testimony.
HEARING OFFICER VITTONE: Page 41 of his
MR. GLANTZ: Yes. It's number 32.
MR. LOWE: Well, if we can turn to page 37,
column i, at the bottom of that column on the left hand
side, let me again read one of their statements: "Since
platelet aggregation has been shown to..."
MR. GLANTZ: Excuse me. Let me find it. Let me
find it. How far down the column?
MR. LOWE: It's in the last paragraph on the left
side of page 37. It's starting with the third sentence.
"Since platelet aggregation has been shown to vary with
emotional stress, this could have lead to a different
platelet behavior after acute smoking. We did not measure
plasma epinephrine concentrations parallel to platelet
function in this study."
Isn't it true, Doctor, that the authors of the
paper were uncertain about their results from the
laboratory, that their results from the laboratory applied
to real life?
MR. GLANTZ: Pardon me. Could you repeat the
question?
MR. LOWE: Isn't it true that the authors of this
study were uncertain as to whether or not their in vitro
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T11011-1798

1
2
3
4
5
6
7
8
9
i0
ii
12
13
14
15
16
17
18
19
20
21
22
23
24
25
612
study had-any relevance to in life situations?
MR. GLANTZ: Okay. I need a minute to read this.
MR. LOWE: They have that specific statement...
MR. GLANTZ: Sir. Sir. I know. I found the
statement but I'd like to read it. The whole statement
because, as I noted before, I viewed your statement as an
out of context quote.
Well, I... You Honor, this is the same problem.
He's read one sentence but not the rest of the paragraph.
Can I read the rest of the paragraph into the record?
HEARING OFFICER VITTONE: Why don't you just
explain the...
MR. GLANTZ: The...
HEARING OFFICER VITTONE: ...question. Wait a
minute. Why don't you, what's the question.
MR. LOWE: They go on and say, I think since I,
they say, "However, if one compares blood pressure and heart
rate before and after smoking two cigarettes in smokers and
non-smokers, one will find no statistically significant
changes in blood pressure and similar marked increases in
heart rate in both groups. Despite not being statistically
significant, there was an obvious increase in systolic and
diastolic blood pressure after smoking two cigarettes in a
non-smoking group. This increase could have reached
statistical significance if more patients had been studied.
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
Tl1011-1799

!
2
3
4
5
6
7
8
9
!0
Ii
12
13
14
15
16
17
18
19
20
21
22
23
24
25
613
Nevertheless, it seems unlikely that different agarnergic
stimuli" -- the issue the questioner is raising -- "were
responsible for the difference in platelet behavior before
and after acute smoking."
So what the authors have done here -- and this is
standard scientific procedure -- is they have raised a
possible concern and then they've dealt with it. And I
think in both this case and the previous one you simply
ignored the second half of the paragraph, where the authors,
in both cases, showed that this was a hypothetical concern
and then presented affirmative evidence...
MR. LOWE: I listened to you this morning. You
presented a number of potential mechanisms which you moved
into a holistic theory which has very few threads that ties
it together from my experience and reading. Did you take
the same care to interject the uncertainty and potential
issues that would cloud the interpretation of those studies?
I didn't hear them, if you did.
Wait.
That's fine. I'd like to move on.
HEARING OFFICER VITTONE: Well, wait a minute.
MR. GLANTZ: Do I have to answer?
HEARING OFFICER VITTONE: Just a second.
Let him answer it now.
asked him a question.
MR. GLANTZ:
You've
The first thing is, I was asked to
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T11011-1800

1
2
3~
4
5
6
7
8
9
i0
ll
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
614
keep my testimony as short as possible. I think if you look
at our paper, the circulation paper with Bill Parmley that
was subjected to extensive peer review in one of the two
leading cardiology journals and published as a reasonable,
prudent statement and prudent assessment of the evidence.
Since then the American Heart Association has done its own
assessment and reached similar conclusions.
Now, perhaps you would have written the paper
differently than I would have. Everyone has their own
approach. But the reviewers of what is one of the two
leading journals in cardiology from editors who are very
tough and careful people, found our statements supported by
the evidence.. And the fact that you can take a couple of
out of context quotes from papers written six or eight years
ago doesn't change what the evidence says today.
MR. LOWE: Let me pursue this, very briefly,
because I'd like to move on and it's very late.
Is it your testimony that your submitted
statement for the record here does not reach the same
standards that you would utilize in professional publication
of an article?
MR. GLANTZ: No. I think in writing my submitted
statement, the written statement, I wrote that -- other than
the fact that it was for a different audience and hence I
tried to simplify things and present it more in lay terms,
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T11011-1801

1
2
3
4
5
6
7
8
9
i0
ii
12
13
14
15
16
17
18
19
20
21
22
23
24
25
615
it was written to the same standards I would write something
I would submit to a journal. It would be written
differently.
MR. LOWE: But the issues that I've raised with
you about actual interpretation, perhaps misrepresentation,
miscategorization of studies, are from that ~estimony.
MR. GLANTZ: I don't agree with your
characterization of my work. I think we, ve been very
careful to accurately represent this work. I think that you
have taken out of context quotes from these papers to build
a case that simply isn't true.
I wrote my testimony. I stand on it. I think it
represents my best judgement of what the evidence says
today.
MR. LOWE: I heard you state this morning that
because of your notoriety or whatever that you are confident
that your work will be very carefully revlewedby others.
You have a 1980 article cited in your Curriculum Vitae
entitled "Biostatistics: How to Detect, Correct and Prevent
Errors in the Medical Literature." By the way, published
in this circulation also.
MR. GLANTZ: Yes.
MR. LOWE: I guess that I don't have the same
confidence that you have in the accuracy of your submitted
testimony. I have one other area that...
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
Tl1011-1802

1
2
3
4
5
6
7
8
9
I0
ii
12
13
14
15
16
17
18
19
20
21
22
23
24
25
616
MR. GLANTZ: Wait. Can I respond to that, sir?
HEARING OFFICER VITTONE: You know, you're both
going to keep arguing back and forth.
MR. GLANTZ: Well, he has his right to...
HEARING OFFICER VITTONE: You've defended
yourself very well.
MR. GLANTZ: Thank you.
HEARING OFFICER VITTONE: You know, his questions
are not testimony.
MR. GLANTZ: Okay.
HEARING OFFICER VITTONE: His questions are not
testimony. The only testimony is what you give. Okay?
MR. LOWE: Dr. Glantz, you mentioned earlier that
you serve on the California State Scientific Review Panel on
Toxic Air Contaminants. Is that correct?
MR. GLANTZ: Yes.
MR. LOWE: And I believe you mentioned that to
tie in your experience in risk assessment.
MR. GLANTZ: Yes.
MR. LOWE: If I correctly understood that. Are
you familiar with the risk assessment procedures that
various regulatory bodies go through in trying to determine
the potential harm of carcinogens, potential carcinogens or
non-carcinogens to the public?
MR. GLANTZ: I am familiar with the California
BAILEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1803

1
2
3
4
5
6
7
8
9
I0
II
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
617
risk assessment guidelines, which are the rules under which
we operate.
MR. LOWE: In those guidelines, do they allow
exposures to carcinogens?
MR. GLANTZ: Under the -- the way the process
works in California, the risk assessment step and the risk
management are completely separated. Our committee is
charged with reviewing the scientific accuracy of risk
assessment documents.
The issue you raise is a risk management issue,
which is something that we have no direct involvement with.
We certify a report under the law as not seriously deficient
under the California law...
MR. LOWE: And is it your...
MR. GLANTZ: Excuse me, sir. You asked the
question. Let me answer it.
That has been taken, after we have approved it
and it has been approved by the California Air Resources
Board to the risk management phase, and it is up to the
regulators to decide what to do abo~t the risks which we say
have been accurately identified by the California Office of
Environmental Health Hazard assessment. We have nothing to
do with the question of what levels to regulate or whether
to even regulate at all. And you're asking...
MR. LOWE: Is it your testimony that California
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T11011-1804

1
2
3
4
5
6
7
8
9
I0
II
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
618
does not establish permissible exposures to carcinogens in
the risk assessment process?
MR. GLANTZ: That's right. The risk assessment
process has nothing to do with that as it's implemented
under AB-1807 in California. At least our piece of it. It
may happen later in the process, but I frankly have no idea
what they do. And I don't care, frankly. That's not our
job to make...
MR. LOWE: And is that also the cases for other
regulatory bodies that make these types of risk assessment
calculations, including some that you've noted that you've
worked with, including those of the EPA, OTA and other
bodies?
MR. GLANTZ: I have worked with the EPA and the
OTA. I've worked with the OTA as a reviewer for one of
their documents. To my knowledge, OTA is not a risk
management organization. The work I've done with the EPA
had to do with preparing some materials and reviewing some
materials for them and, again, had nothing to do with risk
management. So I have no knowledge of exactly how those
agencies deal with risk management.
MR. LOWE: If I were to represent to you that all
of the agencies we've just discussed, including California,
EPA, OTA, and others, had at one time or another represented
that the risk of various compounds -- carcinogens and non-
BAYLEYREPORTING, INC.
(202) 234-7787 (800) 368-8993
T11011-1805

1
2
3
4
5
6
7
8
9
I0
iI
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
619
carcinogens -- should be addressed on a dosed response
basis. Do those agencies recognize that various toxins may
be more toxic at higher levels than at lower levels?
MR. GLANTZ: In terms of carcinogenicity, that's
the general assumption that is made. In terms of heart
disease, which to my knowledge none of them have dealt with
in the area of passive smoking, I believe the evidence
supports a very steep dose response curve at low doses and a
qualitative difference in the response between smokers and
non-smokers. And I believe that the risk management
approaches that would be appropriate with ETS and heart
disease may be different than when you're dealing with
carcinogens.
These organizations, to my knowledge, have not,
up until OSHAbecame involved in this issue, really looked
at the question of heart disease as having an environmental
component.
MR. LOWE: If the dose response curve is very
steep -- and you'll have to help me here, I'm not a
biostatistician -- how steep is steep before there is no
dose response? Does that mean that at one tested
concentration you saw a response and at a higher
concentration you saw the same response -- exactly the
same -- so that as you graphed that you had a vertical line?
MR. GLANTZ: Well, in terms of the bleeding times
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
Ti1011-1808

1
2
3
4
5
6
7
8
9
!0
ii
12
13
14
15
16
17
18
19
20
21
22
23
24
25
62O
that we observed in, in fact in all of our studies -- I know
we have shown you one -- that's what happened. We found
very similar effects at all doses that we. looked at.
If you look at the Burg, Huber platelet studies,
they were showing that you got essentially the same effect
if actively smoking two cigarettes as passively smoking in
non-smokers, in terms of platelet function, and that
suggests to me that it's a very, very steep curve.
The other thing that's important, which I
mentioned in my testimony, is that ETS is a gratuitous
pollutant. It's not necessary as part of the manufacturing
process and to my knowledge...
MR. LOWE: Did I ask you anything about that?
MR. GLANTZ: Well, but, you see you're asking
response.
steep.
MR. LOWE: I was trying to ask you about dose
MR. GLANTZ: Okay. To my knowledge, it's very
HEARING OFFICER VITTONE: All right. Thank you.
MR. LOWE: For non-carcinogens, do those same
agencies acknowledge a dose response?
MR. GLANTZ: The only non-carcinogen which we
have dealt with on the scientific review panel in terms of
non-cancer in-points is lead, which is currently under
BAYLEY REPORTING, INC.
(202} 234-7787 (800) 368-8993
Tl1011-1807

1
2
3
4
5
6
7
8
9
i0
ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
621
review, and I don't think it would be appropriate for me to
discuss that at this point because this is currently being
hotly debated. How to handle that.
MR. LOWE: Hasn't the government established safe
exposure levels of lead in the past? And we recognize that
those have changed over time and that there are allowable
levels in drinking water?
MR. GLANTZ: You may well be correct. I'm not
representing myself as an expert in different strategies of
risk management. I think my service on the California State
Scientific Review Panel is of relevance in terms of my
knowledge of risk assessment techniques which, the way we
handle it in California, is completely divorced by law from
the way -- from the questions you're asking. So I can
respond to these things as an interested layman, but I'm not
expert on the risk management procedures used by any of the
agencies that you're dealing with.
MR. LOWE: If I understood what you've said,
you've also stated that you're not that familiar with risk
assessments, either.
MR. GLANTZ: No. I did not say that, sir. I am
quite familiar with it. I've been on this panel for many
years and been reappointed to it two or three times because
of my recognized expertise in the area.
~K%. LOWE: What is the role of nicotine in any of
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T11011-1808

1
2
3
4
5
6
7
8
9
i0
ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
622
the effects we've talked about today that you're concerned
about?
MR. GLANTZ: Nicotine is an important element in
the action of second-hand smoke on the heart. The issue
having to do with free radical scavenging and reperfusion
injury has been clearly proven to be related to nicotine.
MR. LOWE: Excuse me. Let me go through these
one at a time. With free radical scavenging, as I
understand in your testimony, this could be a contributor
answer it.
MR. GLANTZ:
MR. LOWE:
MR. GLANTZ:
Well, the free radical...
...a separate radical...
Now, you asked the question, let me
The data that shows that nicotine per se is very
important in terms of the reperfusion injury due to free
radicals is from experimental data that shows that when you
give nicotine you make the effect worse, and when you give a
free radical scavenger, an exogenous free radical scavenger,
you can block the nicotine effect. That is about the most
direct evidence that you can have.
There are other... Nicotine also -- oh, and
another thing which is very important in that study that I
didn't mention is that's at doses of nicotine which are so
low that they don't provoke any hemodynamic change. Higher
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T11011-1809

1
2
3
4
5
6
7
8
9
i0
II
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
623
doses of nicotine will increase heart rate and blood
pressure and increase cardiac contractility.
Now, the platelet effects, I believe, are
probably not due to nicotine. There are other constituents
in the smoke.
MR. LOWE: Even though nicotine may affect
cardiac contractility, blood pressure, are those
pathological events in and of themselves?
MR. GLANTZ: If you have an individual whose
cardiovascular -- whose heart and cardiac circulation -- is
compromised, then the effects -- these effects -- could be
precipitating events which push them over the edge.
MR. LOWE: But I didn't hear you limit the risk
of that to people with advanced coronary heart disease,
which I assume you're referring to.
MR. GLANTZ: No, but you asked a very specific
question, and that is: Could the exposure to nicotine
precipitate a specific pathological event?
I think that the effects that we're dealing with,
some of the effects -- and this is one thing that makes
heart disease very different from cancer -- some of the
effects of smoking and passive smoking on the heart are due
to the immediate poisoning from the nicotine, carbon
monoxide and many other compounds in the smoke. Other of
the effects are cumulative and long-term damage and for
BAYLEYREPORTING, INC.
(202) 234-7787 (800) 368-8993
T!1011-1810

1
2
3
4
5
6
7
8
9
I0
Ii
12
13
14
IS
16
17
18
19
20
21
22
23
24
25
624
example, to the extent that nicotine affects platelet
activity and to the extent that activated platelets
participate in damage to...
MR. LOWE: I didn't ask about those.
MR. GLANTZ: ...you've got those obstructed ....
MR. LOWE: I asked you about blood pressure...
MR. GLANTZ: Then the nicotine is contributory.
MR. LOWE: I asked you about the blood pressure.
MR. GLANTZ: And my answer to the blood pressure
question specifically, and limiting to blood pressure, is
those changes could precipitate an event. Also chronic
elevations in blood pressure are a bad thing for the heart
too.
MR. LOWE: Are you familiar with any natural
substance in our body that affects blood pressure?
MR. GLANTZ: Oh, there are many.
MR. LOWE: What would be the most likely one that
you could mention? What's the most common one that's
implicated in blood pressure elevation, pathologically?
MR. GLANTZ: Pathologically, it's probably the
reniangiotensin system.
MR. LOWE: And is that implicated in the process
you're talking about?
MR. GLANTZ: I haven't said that it is.
MR. LOWE: What about norepinephrine...
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1811

1
2
3
4
5
6
7
8
9
i0
II
12
13
14
15
17
18
19
2O
21
22
23
24
25
625
MR. GLANTZ: It aggravates the chronic
hypertension.
MR. LOWE: What about norepinephrine and
epinephrine? Do they modify cardiac contractility, heart
rate...
MR. GLANTZ: Yes.
MR. LOWE: Depolarization in the heart?
MR. GLANTZ: Yes.
MR. LOWE: And blood pressure.
MR. GLANTZ: Yes.
MR. LOWE: Thank you. That's all, Your Honor.
HEARING OFFICER VITTONE: Thank you, Mr. Lowe.
Ms. Sherman, do you have anything you want to have
clarified? Any redirect of the witness?
MS. SHERMAN: I was hoping to have the evening to
think about it and do it first thing tomorrow morning.
HEARING OFFICER VITTONE: We have three witnesses
tomorrow. I thought that the reason we stayed here so late
was to make sure that he could leave.
MS. SHERMAN: Okay. Well, if we can have a five
minute break I'd be happy to ask the questions now.
HEARING OFFICER VITTONE: How long were you going
to take?
MS. SHERMAN: Five or ten minutes.
HEARING OFFICER VITTONE: Fine. You get a five
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T11011-1812

1
2
3
4
5
6
7
8
9
i0
II
12
13
14
15
16
17
18
19
20
21
22
23
24
25
626
minute break.
(Whereupon, a brief recess was taken.)
HEARING OFFICER VITTONE: Ms. Sherman.
MS. SHER~N: Yes. I do have some questions for
Dr. Glantz. I will try to be brief.
Do you think that the Bellflower data that Mr.
Rupp asked you about represents a fatal flaw in your
restaurant study?
MR. GLANTZ: No, I don't. He was really focusing
on a couple of quarters worth of data and I think it's
important to look at our -- the thing I testified to as our
publication in The American Journal of Public Health, which
included many more cities and many more quarters of data,
and with the epidemiology studies, it's important to look at
all the data taken together. That increases the power of
the study to detect a real effect and it also reduces your
chances of a false positive conclusion.
MS. SHERMAN: So, then, just so I can understand
better for the record, most of Mr. Rupp's questions dealt
with a preliminary study and your testimony dealt with a
later study?
MR. GLANTZ: That's right. The initial four city
study which we almost exclusively dealt with was our first
attempt to look at this data, which we did because there was
a lot of interest in it. But we recognized that there was a
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T11011-1813

2
3
4
5
6
7
8
9
i0
ll
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
627
need for more data so that's why we continued to collect
information and ultimately submitted it for publication in
The American Journal of Public Health. Which it covers the
initial study he talked about, had four cities with a few
quarters of experience with the ordinances. The paper I
testified to today had 15 cities with many, many more
quarters of data.
MS. SHERMAN: Speaking of restaurants, I believe,
perhaps in your written testimony, there was some reference
to an epidemiological study involving elevated risks of
waitresses and waiters. Do you believe this to be a
reasonably decent study?
MR. GLANTZ: Yes. The study referred to is a
paper by Michael Siegel called "Involuntary Smoking in the
Restaurant Workplace: A Review of Employee Exposure and
Health Effects" which shows that restaurant workers have
much higher exposures to environmental tobacco smoke than
workers in general and a commensurate increase in their
levels of lung cancer.
work.
MS. SHERMAN:
I think this is a very good piece of
I have not read the study myself.
However, I have heard various comments and one of the
questions I heard asked was, were the people he studied
smokers themselves? Do you happen to know the answer to
that?
BAILEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1814

1
2
3
4
5
6
7
8
9
i0
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
628
MR. GLANTZ: Yes. Some of the people who were
looked at in that study were smokers but he was showing
elevations in risk even above what you would expect based on
their smoking rates.
MS. SHERMAN:
MR. GLANTZ:
And he was...
He didn't... Siegel did not -- his
paper was a review of the literature and so he was comparing
data, looking and analyzing data other people had collected.
So he didn't directly measure whether people smoked or not,
but what he showed was that the lung cancer rates among,
say, waitresses as a group were higher than what you would
expect based on their smoking rates. So there was an
additional effect on top of any effects that smoking might
have.
But here we're looking at both the non-smoking
waitresses and the smoking waitresses thrown into one pot
and the overall lung cancer rate was higher than you would
expect based on their rate of smoking alone -- of active
smoking.alone. And he drew similar conclusions for other
categories of food service workers, and I think it's a
reasonable analysis.
MS. SHERMAN:
among the non-smokers?
MR. GLANTZ:
constructed.
Did he do a separate analysis just
No. That wasn't the way this was
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
Tl1011-1815

1
2
3
4
5
6
7
8
9
i0
ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
629
MS. SHE~4AN: Would the study have been large
enough to have allowed that?
MR. GLANTZ: Again, he was comparing -- looking
at rates in different groups, so that's really not a
relevant question, I don't think.
MS. SHERMAN: You testified before about the
Burg, Huber and Davis paper, at some length I believe, or
you answered questions on it. Were the cautionary
statements made by Berg, Huber & Davis appropriate at the
time they wrote the paper?
MR. GLANTZ: Yes. In both cases they raised
potential concerns about their data and then addressed those
concerns as b~st as they could. In the case of Davis, he
suggests that we needed to do more research. But even at
the time he said that this is certainly strongly suggestive
of an effect.
MS. SHERMAN: Do you understand these cautionary
statements to mean that one cannot interpret the study in
light of subsequent studies published after the mid-80's?
MR. GLANTZ: Absolutely not. I think that the
statements that they made at the time were appropriate and
scientifically prudent. What we have done is use the data
that they published, the conclusions that they drew, in
light of the information that's been developed in the eight
or ten years since this work was done and looked at this in
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
Ti1011-1816

1
2
3
4
5
6
7
8
'9
I0
ii
12
13
14
15
16
17
18
19
20
21
22
23
24
25
630
the context of all of the data.
MS. SHERMAN: Is this accepted scientific
practice, to look at a study in light of later studies and
perhaps come to different conclusions than the original
authors?
MR. GLANTZ: Well, first of all, we didn't come
to different conclusions than the original authors. The
original authors both concluded passive smoking had an
important effect on platelet activity and in one case
endothelial cell carcasses, which means damage to the lining
of the arteries. So there's no difference in our
interpretation of their data.
The thing -- the whole discussion dealt with how
to interpret cautionary statements about the interpretation
of those results at the end, and basically what both authors
were saying is that we need more information to draw firm
conclusions, and since then a great deal more information
has been developed. But it's very important to stress that
we didn't interpret their data any differently than they did
in terms of what they reported. The question is, what's the
larger context in which you interpret those findings.
MS. SHERMAN: And are you aware of other
reputable scientists besides yourself who have in the past
interpreted studies, perhaps not Berg, Huber, but other
studies, in light of subsequent evidence?
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1817

1
2
3
4
5
6
7
8
9
I0
ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
631
MR. GLANTZ: Yes. Every scientist does that.
That's how we advance our knowledge.
MS. SHERMAN: I believe youtestified concerning
the effects of environmental tobacco smoke and heart disease
by citing a study involving rabbits.
MR. GLANTZ: Yes.
MS. SHERMAN: I think you even showed a slide
about that. Could the results that you found be attributed
to increasing the catecholamine levels?
MR. GLANTZ: No, they couldn't. We showed that
when you reduced the catecholamine levels, the sort of
nervous things that were talked about at the end in the
previous cross-examination, that that did reduce the
development of fat deposits in the arteries. But when we
exposed the rabbits to environmental tobacco smoke you still
got an increased effect, whether or not the catecholamines
were present. And what that says to us is that the effects
of ETS on the arteries is not a catecholamine effect. It's
a direct effect of the ETS rather than being mediated
through changes in the nervous system.
MS. SHERMAN: One last question. You had an
interesting slide on reperfusion injury. Could you clarify
the effects of low doses of nicotine on the reperfusion
injuries that you discussed?
MR. GLANTZ: Yes. What happens when you stop the
BAYLEYREPORTING, INC.
(202) 234-7787 (800) 368-8993
Tl1011-1818

1
2
3
4
5
6
7
8
9
i0
ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
632
flow of blood to a part of the heart muscle and then start
it again the muscle doesn't contract as well. It doesn't
shorten as much. And what the study in question showed is
that you exposed, if you give -- in this case dogs -- a low
dose of nicotine, so low a dose that it didn't provoke any
of the kind of changes in heart rate or blood pressure that
we were talking about in other parts of the discussion, that
that made the reperfusion injury twice as bad. And then if
you gave a drug which was a free radical scavenger, the
effect of the nicotine was eliminated.
And so what that means is that the nicotine
itself was what was aggravating the reperfusion injury. And
it was done at a very, very low dose of nicotine, too.
MS. SHERMAN: It was one or two cigarettes worth?
MR. GLANTZ: It was the nicotine equivalent of
one cigarette administered over a brief -- I think about ten
minutes. Administered intravenously. But it was not a big
enough -- see, higher doses of nicotine provoke changes in
heart rate and blood pressure and how hard the heart has to
work. And the importance of this study is that it showed
that nicotine levels way below those which provoke changes
in blood pressure and heart rate still have significant
adverse effects on the heart under these conditions.
MS. SHERMAN: All right. Thank you, Dr. Glantz.
That's all I have.
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
TI1011-1819

1
2
3
4
5
6
7
8
9
I0
ii
12
13
14
15
16
17
18
19
2O
21
22
23
24
25
MR. GLANTZ : Thank you.
HEARING OFFICER VITTONE:
633
Thank you, Ms. Sherman.
Thank you, Dr. Glantz. That concludes your testimony.
MR. GLANTZ: Thank you.
HEARING OFFICER VITTONE: We will recess and
resume tomorrow morning at 9:30 at the Department of
Interior Auditorium at 1849 C Street NW, and we will be
there tomorrow and on Friday.
Thank you very much.
MR. TYSON: Your Honor, may I ask the sequence of
witnesses?
MS. SHERMAN: When the schedule was developed, I
believe it was just meant to locate a witness on a day. Let
me try to find... The schedule that I have shows that Mr.
Levine will be first, Mr. Steenburg second and Mr. Sammet
third. We will at least try to start with Mr. Levine. I'm
not sure about the travel plans of Mr. Steenburg and so will
have to take it as it comes.
HEARING OFFICER VITTONE: Thank you.
(Whereupon, at 7:30 p.m. the hearing was
recessed, to reconvene at 9:30 a.m. on Thursday, September
22, 1994.)
BAILEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
Ti1011-1820

1
2
3
4
5
6
7
8
9
I0
ii
12
13
14
15
16
17
18
19
20
21
22
23
24
25
REPORTER'S CERTIFICATE
634
TITLE:
DATE:
LOCATION:
Indoor Air Quality Proposed Rule Hearings
September 21, 1994
Washington, D.C.
This is to certify that the attached proceedings
were held according to the record and that this is the
original, complete, true and accurate transcript which has
been compared to the reporting or recording accomplished at
the hearing.
BAYLEY REPORTING, INC.
September 21, 1994
BAYLEY REPORTING, INC.
(202) 234-7787 (800) 368-8993
T!1011-1821
